Identifizierung und Untersuchung von apoptose-assoziierten Proteinen mit proteom-analytischen Methoden by Badock, Volker
 Identification and Investigation of Apoptosis-associated 
Proteins by Proteome-analytical Methodologies
 
vorgelegt von
Diplom-Chemiker
Volker Badock
aus Marl
Vom Fachbereich 5 - Chemie-
der Technischen Universität Berlin
zur Erlangung des akademischen Grades
Doktor der Naturwissenschaften
- Dr. rer. nat. -
genehmigte Dissertation
Promotionsausschuss:
Vorsitzender: Prof. Dr. G. Renger
Berichter: Prof. Dr. J. Salnikow
Berichterin: Prof. Dr. B. Wittmann-Liebold
Tag der wissenschaftlichen Aussprache: 27. September 2000
Berlin 2000
D 83
 D a n k s a g u n g  /  A c k n o w l e d g e m e n t s
 
 |  1
 
D
 
ANKSAGUNG
 
 / A
 
CKNOWLEDGEMENTS
 
Die vorliegende Dissertation wurde in der Zeit von Oktober 1997 bis September 2000
in der Abteilung Proteinchemie des Max-Delbrück-Centrums für Molekulare Medizin
angefertigt.
Ich möchte mich herzlich bei Frau Prof. Dr. B. Wittmann-Liebold bedanken für die Mög-
lichkeit, diese Arbeit in ihrer Gruppe zu erstellen und ihr Vertrauen, das sie mir entge-
gengebracht hat. Durch ihre beeindruckende Begeisterung für die wissenschaftliche
Arbeit im Allgemeinen und die Proteinchemie im Besonderen hat sie mich immer wie-
der indirekt motiviert. 
Herrn Prof. Dr. J. Salnikow danke ich ebenfalls herzlich für die Begutachtung dieser Ar-
beit.
Mein besonderer Dank gilt allen Mitarbeitern der Gruppe Proteinchemie für das ange-
nehme Arbeitsklima (insbesondere die zahlreichen Kuchen- und Eisrunden) und die
immer währende Hilfsbereitschaft: Dr. Joachim Bötzel, Gerlinde Grelle (ich danke Dir
für die ASA Messungen), Dr. Dierk Jorcke, Susanne Kostka, Dr. Regine Kraft, Dr. Eva-
Christina Müller (ich danke Dir für die Einführungen am Q-Tof und alles drumherum),
Helga Neubauer (ein Wunder, dass du es so lange mit mir ausgehalten hast, danke für
alles), Dr. Albrecht Otto (du kanntest in diesen Labor wirklich jede Schraube; hast Dir
immer Zeit genommen, wenn ich Probleme hatte; ich habe einfach viel von Dir gelernt),
Margitta Schümann (ich danke Dir für die Einführungen in die zwei-dimensionale Gele-
lektrophorese) und Beate Wittmann. Danken tue ich auch denen, die nicht mehr am
MDC sind: Dr. Ekkehard Brockstedt, Bettina Faass, Dr. Bernd Thiede und Dr. Monika
Ühlein. 
Für die ausgezeichnete und unkomplizierte Kooperation danke ich Dr. Ulrike Steinhu-
sen, Dr. Anke Rickers und Claus Reimertz aus der Gruppe von Dr. Kurt Bommert. Be-
sonders danken möchte ich auch Dr. Kurt Bommert für seine Diskussionsbereitschaft,
seinen guten Ideen und Anregungen und seine Hilfsbereitschaft bei Problemen aller
Art.
Bedanken möchte ich mich auch bei Frank Eßmann, Olaf Schäfer und Jan Schwen-
kenbecher, die mir alle Drei in den letzten drei Jahren sehr ans Herz gewachsen sind,
ohne sie wäre die Zeit nur halb so schön und halb so kulinarisch gewesen.
Dank auch an Dirk Böttcher, der mir meine Festplatte aus dem Nirwana zurückgeholt
hat und Franziska Müller, die diese Arbeit von den gröbsten Rechtschreibfehlern be-
freit hat. 
Natürlich möchte ich mich bei Dörte bedanken, die mir beim Schreiben dieser Arbeit
den Rücken freigehalten hat und mir immer wieder neue Energie gegeben hat durch
ihre unvergleichliche Art und Weise.
Ich widme diese Arbeit meinen Eltern, die mir das Studium ermöglichten und mich wäh-
rend diesem immer unterstützt haben.
 Z u s a m m e n f a s s u n g
     ZUSAMMENFASSUNG
Identifizierung und Untersuchung von apoptose-assoziierten Pro-
teinen mit proteom-analytischen Methoden
Dipl.-Chem. Volker Badock
Das Wissen über das Proteom, die Gesamtheit aller vom Genom exprimierten Protei-
ne, eröffnet den Zugang zu einer Vielzahl von Informationen über (i) ob und wann ein
bestimmtes Genprodukt translatiert wird, (ii) die relative Konzentration von Genproduk-
ten und (iii) das Ausmaß von posttranslationalen Modifikationen. Keiner dieser Infor-
mationen kann von der DNA alleine vorhergesagt werden. Im Rahmen dieser Arbeit
sollte mit Hilfe der Proteomanalyse der zelluläre Prozess der Apoptose, auch program-
mierter Zelltod genannt, untersucht werden. Apoptose ist ein hochgeordneter Prozess
mit charakteristischen morphologischen und biochemischen Veränderungen der Zelle.
Der programmierte Zelltod spielt eine wichtige Rolle während der Embryonalentwick-
lung, Differenzierung und Metamorphose. Epitheliale Zellen sterben durch Apoptose,
wenn sie ihren Zell-Zell oder Zell-Matrix Kontakt verlieren, diese Form des Zelltodes
wird auch Anoikis genannt. Da der molekulare Mechanismus, welcher der Anoikis zu-
grunde liegt, noch unzureichend geklärt ist, sollte das Ziel dieser Arbeit sein, Proteine
zu identifizieren, die am apoptotischen Prozess in Epithelzellen beteiligt sind. Dazu
wurden die Proteine aus den humanen Brustzelllinien H184A1 und HBL-100 durch die
hochauflösende zwei-dimensionale Gelelektrophorese (2-DE) aufgetrennt und die er-
haltenen 2-DE Proteinmuster mit denen von apoptotischen Zellen verglichen. Apopto-
se wurde in diesen Zellen entweder durch Applikation von Staurosporin (ein
Proteinkinaseinhibitor) ausgelöst oder dadurch, dass die Zellen gehindert wurden, Zell-
Zell oder Zell-Matrix Kontakte auszubilden. Durch Silberfärbung konnten auf einem 2-
DE Gel mit der Größe von 23 x 30 x 0.075 cm annährend 4000 Proteinspots gezählt
werden. Obwohl die Apoptose von massiven morphologischen Änderungen der Zelle
begleitet ist, zeigten die 2-DE Proteinmuster von Zellen 20 h nach Auslösung der Apo-
ptose keinerlei Anzeichen für eine wahllose Degradation von Proteinen. Durch Ver-
gleich der apoptotischen und der nicht-apoptotischen 2-DE Proteinmuster, der
sogenannten subtraktiven Analyse, wurden zusammen 31 Proteinspots beobachtet,
die eine signifikant unterschiedliche Intensität in beiden Zuständen aufwiesen.  Diese
Spots wurden mit massenspektrometrischen Techniken, hauptsächlich Elektrospray-
Tandem-Massenspektrometrie (ESI-MS/MS), identifiziert. Diese varianten Protein-
spots stammten von 11 apoptose-assoziierten Proteinen und ihren individuellen Modi-
fikationen: Keratin 15, Keratin 17, Keratin 18, Vimentin, Lamin A, Lamin C,
Desoxyuridin 5´-Triphosphat Nukleotidhydrolase-Nukleare Isoform (DUT-N), Hitze-
schockprotein 27 kDa (HSP27), Myosin schwere Kette, heterogenes nukleares Ribo- |  2
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                          nukleoprotein C1/C2 (hnRNP C1/C2) und Cofilin. Die Beteiligung von Keratin 18,
Lamin A und C, Vimentin, DUT-N und hnRNP C1/C2 während der Apoptose konnte
schon in früheren Untersuchungen gezeigt werden. Diese Proteine dienten daher als
Positivkontrollen. Proteinspots von HSP27 und Cofilin verschwanden nach Auslösung
der Apoptose, offensichtlich durch einen Dephosphorylierungsvorgang. Anhand der 2-
DE Gele konnte gezeigt werden, dass Keratin 15 und 17 während der Apoptose ge-
spalten werden. Durch Untersuchungen mit dem spezifischen Tetrapeptid-Inhibitor Z-
DEVD-fmk konnte gezeigt werden, dass Caspase-3 oder Caspase-3 ähnliche Protea-
sen für die Spaltung verantwortlich sind. Die genauen Spaltstellen in Keratin 15 und
Keratin 17 konnten durch ESI-MS/MS bestimmt werden: In Keratin 15 und Keratin 17
wurde eine Spaltstelle in der Linker L1-2 Region mit der Erkennungssequenz VEMD
gefunden und in Keratin 17 eine weitere an der Position D416. Desweiteren konnten  ge-
naue Spaltstellen in β-Catenin und E-Cadherin gefunden werden. Beide Proteine sind
an der Zell-Zell Adhäsion beteiligt und werden spezifisch während Anoikis gespalten.
Darüberhinaus ist β-Catenin am Wnt-Signalweg beteiligt. Fünf Spaltstellen konnten in
β-Catenin (D32, D83, D115, D751 und D764) und eine in E-Cadherin (D752) durch N-termi-
nale Sequenzierung und Massenspektrometrie bestimmt werden. Im humanen UV Ex-
zisions-Reparaturprotein Rad23 Homolog B (hHR23B) konnte ebenfalls an der Stelle
D165 eine Spaltstelle bestimmt werden.
Insgesamt wurden in der humanen Brustepithelzelllinie H184A1 109 Proteine identifi-
ziert, 94% davon mit ESI-MS/MS und 6% mit MALDI-MS durch „peptide mass finger-
printing“. Mit diesen Daten und Informationen wurde eine internet-basierende 2-DE
Datenbank aufgebaut (URL: http://141.80.156.97/groups/fg-doerken/2DE_EPI/2-DE/
index.html), die einen Vergleich mit 2-DE Proteinmustern von anderen Brustepithel-
zellen erlaubt.
Ergänzend zu den Untersuchungen in Epithelzellen wurde ebenfalls die Apoptose in
Mitochondrien, isoliert aus B-Zellen, untersucht. Nach anti-IgM induzierter Apoptose in
der BL60 Zelllinie wurden die Mitochondrien isoliert und deren Proteine durch die 2-DE
aufgetrennt und mit den entsprechenden Proteinmustern von nicht-apoptotischen Mi-
tochondrien verglichen. Es wurden jedoch nur geringe Unterschiede zwischen beiden
Zuständen beobachtet. Zwei variante Proteinspots konnten identifiziert werden: Pyro-
vat Dehydrogenase E1 α und Inosine 5´-Monophosphat Dehydrogenase 2.
Ein großer Nachteil der zwei-dimensionalen Gelelektrophorese und damit der
gesamten Proteomforschung ist, dass nur ein geringer Teil der zellulären Proteine auf
einem 2-DE Gel sichtbar gemacht werden können. Der große Teil der Proteine liegt in
der Zelle nur in geringer Konzentration vor, so dass er nicht mit herkömmlichen
Methoden sichtbar ist, noch durch massenspektrometrische Methoden identifiziert
werden kann. Daher wurde eine Methode entwickelt, Proteinproben, von Zelllysaten |  3
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  stammend, aufzutrennen, d.h. vorzufraktionieren und die Proteinmenge gleichzeitig
anzureichern. Dazu wurde das gesamte Zelllysat auf eine Umkehrphasen-
Hochdruckflüssigkeitschromatographie (RP-HPLC) Säule geladen und die Proteine
mit einem 5-Stufen-Gradienten wieder von der Säule eluiert, wobei in jedem Schritt die
Acetonitril-Konzentration erhöht wurde. Proteine jeder Stufe wurden anschließend
durch 2-DE getrennt, so dass aus einer Probe fünf 2-DE Gele resultierten. Durch
mehrere HPLC Läufe nacheinander kann die Proteinmenge beliebig gesteigert
werden. Die Reproduzierbarkeit der Methode ist ausreichend, um Proben von
apoptotischen und nicht-apoptotischen Zellen zu vergleichen und unterschiedlich
exprimierte Proteine identifizieren zu können.  |  4
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         ABSTRACT
Identification and Investigation of Apoptosis-associated Proteins by
Proteome-analytical Methodologies
Dipl.-Chem. Volker Badock
The knowledge of the proteome, the proteins expressed by the genome, provides in-
formation on (i) if and when predicted gene products are translated, (ii) the relative con-
centrations of gene products, and (iii) the extent of post-translational modifications,
none of which can be accurately predicted from the DNA alone. In this study, proteome
analysis was used to investigate the phenomenon of apoptosis (programmed cell
death) on the protein level. Since the molecular mechanisms underlying the process of
apoptosis in epithelial cells (anoikis) are still not well understood, the aim of this study
was to identify proteins involved in anoikis. Proteins derived from human breast epithe-
lial cell lines H184A1 and HBL-100 were separated by high resolution two-dimensional
gel electrophoresis (2-DE). After silver-staining, more than 4000 protein spots could be
visualized on a single 2-DE image of a size of 23 x 30 x 0.075 cm. The apoptotic 2-DE
protein patterns have not revealed a complete degradation of cellular proteins confirm-
ing that apoptosis is a highly regulated process. Comparison of the 2-DE images of ap-
optotic and non-apoptotic cells by subtractive analysis showed that 31 protein spots
were altered significantly in intensity after induction of apoptosis. These variant protein
spots included 11 apoptose-associated proteins with their individual modifications: ker-
atin 15, keratin 17, keratin 18, vimentin, lamin A, lamin C, desoxyuridine 5´-triphos-
phate nucleotidehydrolase (DUT-N), heat shock protein 27 kDa (HSP 27), myosin
heavy chain, heteronuclear ribonucleoproteins C1 and C2 (hnRNP C1/C2) and cofilin.
Disappearance of HSP 27 and cofilin spots after induction of apoptosis can presumedly
be explained by a dephosphorylation of these proteins. The specific cleavage of keratin
15 (K15) and keratin 17 (K17) after induction of apoptosis was confirmed by Western
blot analysis. Inhibition studies with the tetrapeptide inhibitor Z-DEVD-fmk revealed
that the cleavage of K15 and K17 is a result of caspase-3 or caspase-3 like proteases.
The exact caspase recognition sites could be determined in K15 and K17 by mass
spectrometry. Furthermore, five caspase recognition sites could be determined in β-
catenin, one in E-cadherin and one in human UV excision repair protein RAD23 ho-
molog B (hHR23B).
Altogether, 109 proteins were identified in the H184A1 cell line by mass spectrometry
(94% of the proteins by ESI-MS/MS) leading to a construction of an internet-based 2-
DE database (URL: http://141.80.156.97/groups/fg-doerken/2DE_EPI/2-DE/index.ht-
ml) facilitating the comparison with other 2-DE patterns of human breast epithelial cells. |  5
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    Anti-IgM-mediated apoptosis in mitochondria was investigated by separation of all mi-
tochondrial proteins of B cells by 2-DE. Only minor differences between apoptotic and
non-apoptotic mitochondria could be observed. Two variant protein spots were present
in amounts sufficient for an identification by mass spectrometry: pyruvate dehydroge-
nase E1 α and inosine-5'-monophosphate dehydrogenase 2. 
A method was developed based on reversed phase liquid chromatography (RP-HPLC)
which facilitates the enrichment of less-abundant proteins and the prefractionation of
complex protein mixtures such as cell lysates prior to 2-DE. The crude cell lysates con-
taining 9 M urea were loaded directly onto the column and the proteins were eluted in
a five-step gradient with increasing concentrations of acetonitrile resulting in five 2-DE
gels. The reproducibility of this method allows the comparison of  2-DE protein patterns
of apoptotic and non-apoptotic cells. In principle, the rate of enrichment has no limits if
several subsequent LC runs are pooled.  |  6
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P r e f a c ePREFACE
PRESIDENT CLINTON ANNOUNCES THE COMPLETION OF THE FIRST
                     SURVEY OF THE ENTIRE HUMAN GENOME
   Hails Public and Private Efforts Leading to This Historic Achievement
                               June 26, 2000
Today, at a historic White House event with British Prime Minister Tony
Blair, President Clinton announced that the international Human Genome
Project and Celera Genomics Corporation have both completed an initial
sequencing of the human genome -- the genetic blueprint for human beings.
[...]
This press release from the White House announces the near end of the sequencing
of the human genome. The question arises if this is the day when science reaches its
ultimate goal or rather the starting point of another genetic revolution. The human ge-
nome might enable us to predict the proteins that can potentially be generated, but not
where and when or at which level. It cannot tell us the cell types in which proteins will
be expressed and at which stage of development or differentiation this will happen. Nor
can it take into account the enormous diversification of structure that results from alter-
nate splicing, gene insertion and other kinds of rearrangements. Between the stored
biological information, the genes, and the functional representatives, the proteins, sev-
eral highly complex events take place: transcription of the gene sequence and transla-
tion into proteins at the ribosoms and modification of the proteins by covalently bound
groups (the so-called post-translational modifications) in the endoplasmic reticulum or
in the Golgi apparatus. Some scientists estimate that the 100 000 human genes code
for approximately 20 million different proteins. So one of the famous dogmas of biology,
the one-gene-one-enzyme hypothesis is no longer tenable. Whatever the truth is con-
cerning the gene number in mammals, the complexity of interactions between the en-
vironment, genes and their products is tremendous. For example, investigating the
biochemical background of a human disease means to keep in mind that only 2% of
human diseases result from a single gene defect, and that the genetic background of
the individual often has a significant impact on the severity of the disease. The study
of gene expression at the level of messenger RNA is a promising approach to describe
a biological system. mRNA-based approaches are extremely powerful and open the
feasibility for automation by using DNA chips and arrays (Harrington et al., 2000; Lock-
hart and Winzeler, 2000), however, it is important to realize that these arrays measure
message abundance rather than the actual protein levels (the functional molecules). A
protein cannot be synthesized without its mRNA being present, but proteins still occur
in the cell when their mRNA is no longer present, and conversely one can have high
amounts of mRNA and no translation into protein. A study showed that there is a cor- |  1 4
P r e f a c erelation coefficient of 0.48 between mRNA abundance and protein amount in a cell at
a given time (Anderson and Seilhammer, 1997). Therefore, alternative approaches are
necessary that investigate all mature proteins under precisely defined conditions, the
Proteome. Proteome indicates the proteins expressed by the genome whereby every
cell type or tissue has its own proteome, and this represents only a part of the genome.
The term proteome was first used in late 1994 (Wasinger et al., 1995) which indicates
that proteome research or in short proteomics is a relative young science.  |  1 5
I n t r o d u c t i o n1 INTRODUCTION
1.1 Proteome and Proteomics
The proteome, unlike the genome, is not a fixed feature of an organism, it is rather a
highly dynamic object. It changes with the state of development, in the cells or tissues
or even with the environmental conditions under which an organism finds itself (Fig. 1).
Therefore, methodologies have to be used which allow the surveying of the biological
complexity of a certain proteome at a given time. Although in 1975 the possibility of a
complete resolution of thousands of proteins was first recognized after the develop-
ment of two-dimensional gel electrophoresis (2-DE) (Kaltschmidt and Wittmann, 1970;
Klose, 1975; O'Farrell, 1975), proteome research was not feasible at that time. Analy-
sis of the total protein complement of a genome has only recently become a consider-
ation due to improvements in: (i) sensitivity and applicability of mass spectrometry to
the analysis of proteins separated by 2-DE, (ii) increase of the reproducibility of 2-DE
and (iii) sensitive protein staining methods.
The technologies required to separate large numbers of proteins, to identify them, and
to study their modifications is outlined in (Fig. 2).  Despite its drawbacks, 2-DE is still
the core technology of proteome studies. 2-DE still needs higher reproducibility, and an
inter-laboratory comparison of gel images is not yet practicable due to different gel sys-
tems. Furthermore, 2-DE encounters great problems in the separation of highly basic
or hydrophobic proteins, extremely large or small proteins are not visible on a 2-DE gel
image and finally polyacrylamide is a poor matrix for all subsequent protein-chemical
investigations. As mentioned above, 2-DE patterns describe the protein composition of
a biological compartment at the moment of removing it from the biological surrounding.
This protein composition may then be compared between two different biological sys-
Figure 1  The proteome as a highly dynamic object: environmental and biological influences on the pro-
tein expression. Transcriptome comprises the levels of all detectable mRNA species. |  1 6
I n t r o d u c t i o ntems. For example, two different biological systems can be healthy and diseased
states, prior to and after an application of a pharmacon on a cell, or every other param-
eter that influences protein expression. The comparison of 2-DE patterns is performed
by subtracting the spot intensities of one pattern from those of other ones. This concept
of protein subtractive analysis was formulated by Aebersold and Leavitt (Aebersold
and Leavitt, 1990). For protein identification, proteins have to be extracted out of the
gel matrix. In principle two different ways of extracting the protein are in widespread
use: electroblotting onto an inert membrane or in-gel digestion with a proteolytic en-
zyme. The latter way is more straightforward and more compatible with mass spectro-
metric analysis.
1.1.1 Sample Preparation and 2-DE
Sample preparation is the most crucial step in proteome research and has the highest
impact on the reproducibility. The goal of sample preparation is to maximize
solubilization and disaggregation in the absence of protein degradation due to
proteolysis. This is complicated by the hydrophobic nature of many molecules being
membrane-associated. The quality of subsequent results depends on a high level of
solubilization and good laboratory practice. For each cell or tissue type, a specific
method must be developed. The extent of recovery of membrane and cytoskeltal
proteins is variable, with some proteins being completely solubilized while up to 10%
of the cell protein remains in the pellet after extraction. Especially membrane-
associated proteins are underrepresented on 2-DE gels whereby they represent about
30% of total protein (Paulsen et al., 1998; Wallin and von Heijne, 1998). Recent
developments including the use of thiourea (Rabilloud, 1998), tributylphosphine
(Herbert et al., 1998), and novel zwitteragents (Chevallet et al., 1998) have improved
sample solubilization greatly.
High resolution two-dimensional gel electrophoresis is currently the most powerful
protein separation method. The resolution of up to 10 000 proteins from a single
Figure 2  The proteomic steps: starting form a biological sample taken from exactly defined conditions.
Proteins of the sample were solubilized and separated by two-dimensional gel electrophoresis. After gel
staining and subtractive analysis, spots of interest were excised, digested and the peptides obtained
were analyzed by mass spectrometric techniques. MS data were used for database search to identify
the protein. |  1 7
I n t r o d u c t i o nmixture has been exemplified (Klose and Kobalz, 1995). 2-DE is based upon a net
charge fractionation followed by a mass-driven separation. Molecular separation in the
first dimension is performed by isoelectric focusing (IEF), and in the second dimension
by sodium dodecyl sulfate polyacryamide gel electrophoresis (SDS-PAGE) (Laemmli,
1970). During isoelectric focusing, proteins are concentrated into narrow bands within
a continuous pH gradient after migration in an electrical field until they arrive at or near
a position with no net charge, i.e., their isoelectric point. The efficiency of focusing is
improved by increased voltage. The pH gradients necessary for IEF are generated by
carrier ampholytes moving freely within an acrylamide matrix inside a glass tube, while
Immobilines are covalently bonded to the acrylamide matrix (Bjellqvist et al., 1982;
Görg et al., 1988). This latter immobilized pH gradient (IPG) technique with immobiline
strips has the great advantage that the pH gradient cannot drift. Therefore, proteins do
not change their position after reaching the isoelectric point and IEF can be performed
as long as wanted. In addition, the commercially available IPG strips have a higher
protein loading capacity in comparison to carrier ampholytes and their handling is
easier and less time-consuming. However, the optimum of resolution is obtainable with
carrier ampholytes as demonstrated by Klose and Kobalz (see above). 
The separation matrix employed for the second dimension is polyacrylamide cross-
linked with bisacrylamide. The effective pore size of a polyacrylamide gel acts as an
impediment to the migration of proteins. The strong anionic detergent SDS is used to
solubilize and dissociate proteins into single polypeptide chains giving the proteins an
approximately equal negative charge and a similar shape. The molecules in PAGE are
thus separated on the basis of their relative molecular masses alone. Without specific
modifications, molecules in the range of 10-200 kDa can be resolved. Smaller and
larger proteins can be resolved based on methods described by Schägger (Schägger
and von Jagow, 1987) and Wenisch (Wenisch et al., 1993).
1.1.2 Mass Spectrometry
Although improvements in the sensitivity and automation of Edman protein microse-
quencing have occurred (currently 500 fmol - 2 pmol), this methodology is still time-
consuming and restricted to purified proteins and peptides. In addition, no N-terminal
sequence can be obtained due to a blocked N-terminus resulted during the biosynthe-
sis or by trace componds present in buffers. The amounts of the most abundant pro-
teins in a 2-DE gel are in the low picomole or femtomole level, corresponding to few
nanogram or even sub nanogram amounts of material. This means that the amounts
of interesting proteins are usually below the level on which Edman degradation can be
applied and alternative methods and techniques have to be found. The advent of mass
spectrometry for biomolecules in the late 1980s by the development of new ionization
techniques opened the opportunity towards the analysis of proteins in higher sensitivity |  1 8
I n t r o d u c t i o nand at more speed. In the past decade, several important innovations have extended
the capability of mass spectrometry and it has become the analytical method of choice
in functional proteomics.
1.1.2.1 Functional Principle
Mass spectrometer consist of three essential parts (Fig. 3). The first, an ionization
source that converts molecules into gas-phase ions. Once ions are created, individual
mass-to-charge ratios (m/z) are separated by a second device, a mass analyzer, and
transferred to the third, an ion detector. 
The Ionization Process
The general problem to be solved was to convert the polar, non-volatile biomolecules
into intact, isolated ionized molecules in the gas phase. The introduction of soft ioniza-
tion techniques, electrospray ionization (ESI) (Fenn et al., 1989) and matrix-assisted
laser desorption/ionization (MALDI) (Karas and Hillenkamp, 1988) made mass spec-
trometry accessible for proteins and carbohydrates.
Electrospray ionization creates ions directly from liquids at atmospheric pressure by
means of a strong electric field (Gaskell, 1997; Kebarle and Tang, 1993). The sample
solution is introduced into the mass spectrometer by a gold-coated glass capillary (na-
nospray) (Wilm et al., 1996) or by a metal capillary which is connected via a fused silica
capillary to a syringe pump or other liquid sources like HPLC or CE. A potential differ-
ence is placed between the capillary tip and the interface plate of the mass spectrom-
eter. The electric field generates charged droplets in the form of a fine mist. These
droplets shrink by solvent evaporation and a chronology of so-called "Coulomb explo-
sions" resulting in the formation of desolvated ions. The ESI process can be disturbed
by the presence of low level of salts, buffers and detergents, which can form adducts
with the analyte or suppress the formation of analyte ions. A characteristic of ESI is the
formation of highly charged ions without fragmentation.
First attempts to use laser light as mass spectrometric ionization method for organic
molecules date back to the 1970s. The breakthrough came with the incorporation of an
analyte into the cystalline structure of small UV-absorbing molecules (the matrix),
Figure 3  The three components of a mass spectrometer: an ionization source, mass analyzer and
detector. |  1 9
I n t r o d u c t i o nwhich provided a vehicle for ions to be generated (Karas and Hillenkamp, 1988). The
analyt is incorporated in a large excess of matrix molecules forming a matrix/analyte
crystal. This cystal must absorb at the wavelength of the laser (commonly 337 nm of a
nitrogen laser) for ionization to occur. When the laser strikes the matrix cystals, the en-
ergy deposition causes rapid heating of the crystals because the matrix molecules emit
the absorbed energy in form of heat. The rapid heating causes sublimation of the matrix
crystals and expansion of the matrix and analyte into the gas phase. Ions may be
formed through gas phase proton-transfer reactions in the expanding gas-phase
plume. MALDI is more tolerant to the presence of salts and buffers because analyte
incorporation into the matrix crystal serve to sequester the analyte from contamina-
tions. MALDI creates primarily single charged ions, providing a one-to-one correspond-
ence between ions in the mass spectra and the peptides or proteins in the mixture.
The Mass Analyzer
After the ionization process, singly and multiply charged ions have to be separated ac-
cording to their mass-to-charge ratio (m/z). Mainly two types of mass analyzer are in
widespread use: quadrupoles and time-of-flight mass analyzer.
A quadrupole consists of four parallel rods, in which opposite electrodes are electrically
connected. Mass separation is achieved by establishing an electric field in which ions
of a certain m/z value have a stable trajectory through the field. The electric fields are
created by simultaneously applying a DC voltage and AC voltage at RF frequencies to
each pair of rods. By increasing the magnitude of the DC and RF voltages while main-
taining the appropriate DC to RF ratio, stable trajectories are created for ions of differ-
ent m/z to pass through the quadrupole and reach the detector. The mass range of
quadrupole instruments reaches from m/z 10-4000 and is commonly connected to the
ESI ion source which produces multiply charged ions as described above.
MALDI is usually coupled to time-of-flight (TOF) mass analyzers. Mass-to-charge ra-
tions are determined by measuring the time it takes for ions to move through a field-
free flight tube. Given a constant accelerating voltage, all ions obtain the same kinetic
energy and the flight time is related to m/z ratio of a certain ion. A detector at the end
of the flight tube produces a signal for each ion species.
In addition to the described basic instrumentation, several dramatic improvements in
apparatus design and sample preparation have been established in the last years. In
MALDI-TOF-MS, the most important advances have been those of the ion reflector and
delayed extraction (Brown and Lennon, 1995), which together allow isotopic resolution
of peptides (R > 10 000 FWHM) and very high mass accuracies (< 10 ppm). The re-
flector acts as an ion mirror and thus enlarges the flight tube. Most importantly, a re-
flectron can also correct for minor kinetic energy differences among ions of the same |  2 0
I n t r o d u c t i o nm/z value and by this minimize variations in flight times. One contribution to the kinetic
energy distribution of ions is thought to result from their acceleration through the gas-
phase plume created during desorption. By delaying the extraction of ions from the ion
source the correlation of space and velocity components of the desorbed ions is con-
trolled and thus minimizing of kinetic energy distribution is obtained.
The use of infrared laser in MALDI allows the direct measurement from PVDF mem-
brane blotted proteins. After electroblotting, the membranes are soaked in matrix solu-
tion and the proteins can be analyzed. The sensitivity for protein detection is
comparable to that of silver-stained gels (Eckerskorn et al., 1992)
In ESI-MS, the invention of the capillary nanospray source (Wilm and Mann, 1996;
Wilm et al., 1996) has enabled to apply microliter amounts of a single sample with a
flow rate of only 20-40 nL/min. The coupling of an MS to a capillary HPLC with a 100
µm ID column increases the sensitivity approximately tenfold and the signal-to-noise
ratio by a factor of 30. A further advantage is that an HPLC system can easily be inter-
faced with an autosampler allowing automated sample application for high-throughput
analysis (Figeys and Aebersold, 1997; Figeys et al., 1998; Huang et al., 2000;
McGinley et al., 2000).
1.1.2.2 Sequencing of Peptides by Mass Spectrometry
Beside the accurate measurement of molecular masses to the low ppm level, mass
spectrometer are able to produce a second type of information based on sequential
fragmentation. Peptides can be fragmented within mass spectrometers using either
post-source decay (PSD) (Spengler et al., 1992), in-source decay (ISD) (Lennon and
Walsh, 1997) or collision-induced dissociation (CID) (Biemann and Scoble, 1987)
whereby PSD and ISD are restricted to MALDI machines. The method of choice for
peptide fragmentation and sequencing is currently CID, which is done in so-called tan-
dem mass spectrometer coupled to an ESI ion source. A triple quadrupole tandem
mass spectrometer (MS/MS) consists of two quadrupole mass analyzers and a colli-
sion cell (also a quadrupole or a hexapole) as shown in Fig. 4. 
However, CID is not restricted to ESI mass spectrometer, also MALDI instruments are
equipped with a collision cell. In MALDI-MS, two types of fragmentation processes oc-
cur after the laser desorbs the molecules. In-source decay ions are generated during
the ionization process itself (prompt fragmentation) and can be analyzed by delayed
extraction in the linear ion mode. Post-source decay ions are metastable ions, which
are formed in the field-free region of a TOF mass spectrometer. Their mass determina-
tion is based on using an electrostatical ion reflector. By contrast to MALDI-PSD or -
ISD fragmentation, CID is robust and continously producing a series of y ions (see for
details  7.1) from which a partial amino acid sequence can be deduced, especially if
tryptic peptides are fragmented. The recent introduction of ESI quadrupole time-of- |  2 1
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the high resolution and mass accuracy of TOF mass analyzers (Morris et al., 1997) and
simplifies the de novo sequencing of peptides.
1.1.3 Identifying Proteins Using Mass Spectrometry Data and Database 
Searching
Mass spectrometer are capable of generating data quickly and with high sensitivity
from a mixture of peptides. There is a direct relationship between mass spectrometry
data and amino acid sequences. Peptide molecular weight measurements are predic-
tive of amino acid composition, and peptide fragmentation information relates to amino
acid sequence. Both types of information can be correlated to protein sequences in the
database. A single peptide molecular weight, however, is not generally unique to a spe-
cific protein, due to sequence repeats which occur frequently, thus a collection of pep-
tides (≥ 3), the peptide mass fingerprint (PMF) must be used. In the technique of
peptide mass fingerprinting (Henzel et al., 1993; James et al., 1993; Mann et al., 1993;
Yates et al., 1993), proteins separated by 2-DE are either digested in-gel (Rosenfeld
et al., 1992) or on membranes after electroblotting (Aebersold et al., 1987) with a pro-
teolytic enzyme or reagent that specifically cleaves at certain amino acids (Fig. 5). The
identity of an unknown protein is determined by comparison of the PMF of the unknown
protein with the theoretical molecular weights of peptides that are predicted by cleav-
age at the same points of each of the proteins in a database by using software pro-
grams. 
Employing amino acid fragmentation data that are generated by MS/MS or PSD pro-
vides a high level of confidence in the identification because two informations can be
used: the molecular weight of the precursor ion and the fragment masses which include
a sequence information. A short series of fragment ions which yields a partial sequence
of two or three amino acids, the so-called "sequence tag", is up to 1 million-fold more
discriminating than the partial sequence information alone (Mann and Wilm, 1994).
Figure 4  The components of triple quadrupole tandem mass spectrometer: masses of peptides intro-
duced via an ion source are measured in the first mass analyzer of the instrument isolating one peptide
of interest (the parent ion) for dissociation in the collision cell. In the collision cell filled with inert gas,
peptides collide with gas particles and fragment. The dissociation products (daughter ions) are then
analyzed in the second mass analyzer. A tandem mass spectrum for a peptide produces a ladder of
fragment ions that represent amide bond cleavages. |  2 2
I n t r o d u c t i o nFurthermore, the identification process is not effected by the presence of peptides from
other proteins and is amenable to searching expressed sequence tag (EST) databases
(Neubauer et al., 1998).
1.1.4 Data Management and Bioinformatics
Proteome research produces enormous amounts of data: samples must be linked to
gels, gels to spots, spots to proteins and proteins to database entries. All these data
have to be organized to prevent confusion and also to make data accessible to other
scientists. Therefore, 2-DE databases were established and most of them are acces-
sible via the World Wide Web, for example the SWISS-2DPAGE (University Hospital
of Geneva) (Sanchez et al., 1995), the Danish Center for Human Genome (Celis et al.,
1996), the HEART-2DPAGE from the German Heart Institute (Jungblut et al., 1994),
and the human heart 2-DE database from the Max Delbrück Center in Berlin. 2-DE da-
tabases consist of a reference gel map for a given biological sample and a textual in-
formation on each spot that has been identified on a given master gel. This textual
section includes data on the apparent molecular weight and the estimated isoelectric
point, the name of the protein, the method of identification and cross-references to
SWISS-PROT and other databases. Access to the information stored in these databas-
es in most cases is given by clicking on a spot of a gel image, selecting a list of identi-
fied proteins or by keyword search.
1.1.5 Limitations of Proteomics
The main limitation of proteome research is that only the "tip of the proteomic iceberg"
can be visualized on a silver-stained 2-DE gel and in addition only a part of the proteins
are present at levels sufficient for mass spectrometric identification. Many disease-as-
Figure 5  Schematic diagram of a procedure for identification of gel-separated proteins. Protein spots
of interest were excised and digested in the gel matrix. The mixture of peptides was extracted out of
the gel and measured by mass spectrometry obtaining a so-called peptide mass fingerprint. Single
peptides can further analyzed by fragmentation using MS/MS techniques.  |  2 3
I n t r o d u c t i o nsociated proteins or drug targets are low-copy-number gene products that are present
in only low femtomole amounts and therefore difficult to identify (Fig. 6). Increasing the
quantity of protein loading on the gel may be a possible way out. The introduction of
immobilized pH gradient isoelectric focusing allows a loading capacity up to 15 mg pro-
tein on a single gel, which is not feasible when carrier ampholytes are used. However,
a higher protein amount loaded on the gel results in complex, poor resolved 2-DE pro-
tein patterns with dominant spots of high-abundant proteins. Therefore, the enrichment
of low-abundance proteins should be combined with prefractionation methods or the
use of IPG narrow pH gradients. There are, in principle, two alternative approaches to
enrich and prefractionate protein samples derived from cell lines or tissue: subcellular
fractionation and protein prefractionation. The preparation of subcellular organelles by
ultracentrifugation is based on size or density differences of the organelles (Diettrich et
al., 1998; McCaffery et al., 1997; Rabilloud et al., 1998). Another procedure uses free
flow-isoelectric focusing (FF-IEF), a technique that exploits the charge differences of
organelles (Weber and Bocek, 1998). Free flow-isoelectric focusing can also be used
as a protein prefractionation technique. Up to 9 mg protein/h can be separated contin-
uously resulting in 96 fractions (Burggraf et al., 1995). Several other approaches are
based on the principle of affinity chromatography such as heparin affinity chromatog-
raphy (Jungblut and Klose, 1986; Karlsson et al., 1999), hydroxyapatite affinity chro-
matography (Fountoulakis et al., 1999), dye ligands chromatography (Jungblut and
Klose, 1989) or immobilized metal affinity chromatography (IMAC) (Jungblut et al.,
Figure 6  Final concentration of a 20 kDa protein after 2-DE and how it varies with the quantity of cells
loaded onto the gel, and the copy number of the protein per cell. This based on 109 cells containing
100 mg protein (Wilkins et al., 1997). With a loading capacity of 10 mg per gel only the proteins present
at more than 100 000 copies per cell can be detected by Coomassie Blue staining (dashed line) and
easily identified using analytical procedures. Protein with a copy number of 1000 per cell are only de-
tectable by highly sensitive silver staining (permanent line), but difficult to analyze with analytical tech-
niques. |  2 4
I n t r o d u c t i o n1993). Some of these methods have in common that they reach only proteins which
have a specific affinity to the chromatographic material used. All other proteins pass
the column without retardation and are therefore not enriched. In some cases, howev-
er, this can be desired: the removal or reduction of albumin from serum or plasma by
adsorption to Cibachron Blue resins (Lopez, 1999; Walsh et al., 1984). Molloy et al. ex-
ploit the different solubilities of cell lysate proteins in buffer solutions with rising solubi-
lisation ability. Using a 3-step extraction protocol they obtained three protein mixtures
which were applied to 2-DE (Molloy et al., 1998). 
1.2 Apoptosis
Proteomics is a promising approach to investigate biochemical processes on the pro-
tein level. Therefore, proteome research is applied to investigate the phenomenon of
apoptosis.
1.2.1 General Features of Apoptosis
Apoptosis or programmed cell death (PCD) is a mechanism that allows cells to commit
suicide when stimulated by the appropriate trigger or the loss of survival signals.
Apoptosis is initiated for various reasons, such as when a cell is no longer needed
within the body or when it becomes a threat to the health of the organism. PCD plays
an important role in embryogenesis and metamorphosis. The aberrant inhibition or
initiation of apoptosis contributes to many diseases, including cancer, autoimmune
diseases, and neurodegenerative diseases. Apoptosis is a genetically programmed
event that can be triggered by a variety of internal or external stimuli: ligation of specific
death receptors, x-rays, chemotherapeutic drugs, or growth factor withdrawal. In
epithelial cells for example loss of matrix attachment results in apoptosis.
In principle almost every cell of an organism inherits the capacity of committing suicide.
However, the life span differs from cell to cell: epithelial cells lining the intestinal tract
live less than 1 week, an erythrocyte 120 days, a liver cell 1.5 years, and a bone-mak-
ing cell 25-30 years. In contrast to necrosis (cell death by injury), apoptosis is a well
regulated physiological process. Despite the differences in the initiation of the apoptotic
programme, the morphological and biochemical events are very similar. The cell be-
gins to shrink and pull away from other cells, bubble-like formations appear on its sur-
face, and chromatin in the cell´s nucleus condenses. The DNA is fragmented and the
cell breaks up into small, membrane-wrapped, "apoptotic bodies" which are promptly
taken up by scavenger macrophages or by ordinary cells in the neighborhood. Unlike
necrosis, apoptosis does not lead to a leakage of the contents of the cell and thus no
inflammatory response is induced. |  2 5
I n t r o d u c t i o n1.2.2 Caspases: Executioner and Undertaker of Apoptosis 
Caspases were implicated in the process of apoptosis with the discovery of ced-3, the
product of a gene required for cell death in the nematode Caenorhabditis elegans,
which is related to mammalian interleukin-1-β-converting enzyme (ICE or caspase-1).
The expression and subsequent activation of caspase-1 or ced-3 in mammalian cells
induces apoptosis (Miura et al., 1993) and caspase-1 has become the first identified
member of a large family of proteases. At least 14 caspases have been identified in
human (Thornberry and Lazebnik, 1998). The name of the family signifies that they are
cysteine-dependent aspartate-specific proteases (Alnemri et al., 1996). All of them
contain a conserved QACXG (amino acid single letter code) pentapeptide surrounding
the cysteine residue of the active centre (Nicholson and Thornberry, 1997). Caspases
exist in the cell as single chain zymogen of 30-50 kDa containing an N-terminal prodo-
main, a large subunit, a linker segment and a small subunit Fig. 7. For their activation
the N-terminal pro-domain has to be removed and the protein has to be cleaved into
the large (~ 20 kDa) and small (~ 10 kDa) subunit which together form the active het-
erodimer. Determination of the crystal structure of caspase-1 and -3 showed that two
heterodimers form a tetramer with two independent catalytic sites (Rotonda et al.,
1996; Walker et al., 1994; Wilson et al., 1994). An activated caspase can activate other
caspase precursors and as such build a cascade, which amplifies the initial proteolytic
signal. Caspases recognize at least four amino acids (P4P3P2P1) N-terminal to the
cleavage site of substrates with an absolute requirement for aspartic acid in the P1 po-
sition. The preferred tetrapeptide recognition motif differs significantly among caspases
and explains the diversity of their biological function. Their specifity is even more strin-
gent: not all proteins that contain the optimal tetrapeptide sequence are cleaved, im-
plying that tertiary structural elements may influence substrate recognition.
Caspase-2, -3, -6, -7, -8, -9, and -10 play major roles in apoptosis. They have been
classified as initiators and effectors based on their location in the protease cascade(s)
and their role(s) in apoptosis (Fig. 7): initiator caspases acting upstream of the point of
no return and effector caspases acting downstream of this commitment point. The ini-
tiator caspases are activated by autocatalysis and elicit a caspase cascade. Generally,
initiator caspases have long prodomains that provide a critical link between the death
stimulus and caspase activation. Pro-caspase-8 and -10 contain a death effector do-
main (DED) and pro-caspase-2 and-9 contain a caspase recruitment domain (CARD)
(Chou et al., 1998; Eberstadt et al., 1998). Effector caspases have short prodomains.
They are activated in a protease cascade triggered by initiator caspases and are in-
volved in cleavage of cellular substrates which are directly responsible for the charac-
teristic morphological changes during apoptosis. The first protein different from a
caspase found to be cleaved by active caspases was the DNA repair enzyme PARP
(poly (ADP)-ribose polymerase) (Lazebnik et al., 1994). Later other proteins were iden- |  2 6
I n t r o d u c t i o ntified as caspase substrates such as DNA fragmentation factor (DFF), gelsolin and p21
activated kinase 2 (PAK2) both being involved in cytoskeletal regulation (Kothakota et
al., 1997; Rudel and Bokoch, 1997). These proteins are cleaved by caspase-3 while
lamin A, a key structural component of the nuclear envelope, and the cytoskeletal com-
ponents keratin 18 and 19 are cleaved by caspase-6 (Caulín et al., 1997; Ku et al.,
1997; Takahashi et al., 1996). Finally a third group of caspases (caspase-1, -4, -5 and
-11) can be described and is involved in inflammatory responses.
1.2.3 Mitochondria in Cell Death Control
In principle, caspase aggregation and thus their activation can be performed by two dif-
ferent pathways. The first one involves the ligation of death receptors such as Fas
(FasR also called CD95) and the TNF receptor-1 (TNFR1) leading to the recruitment
and oligomerization of adapter proteins and mainly pro-caspase-8. The second one in-
volves the release of cytochrome c from the mitochondria into the cytoplasm following
the formation of a caspase-9 activating complex. Mitochondria are organelles with two
well-defined compartments: the matrix, surrounded by the inner membrane, and the in-
termembrane space, surrounded by the outer membrane. During apoptosis mitochon-
dria undergo major changes in membrane integrity. These changes concern both the
inner and outer mitochondrial membranes, leading to the dissipation of the inner trans-
membrane potential (∆Ψm) and/or the release of intermembrane proteins such as cyto-
chrome c (Liu et al., 1996). Cytoplasmic cytochrome c forms an essential part of the
so-called apoptosome, which is composed of cytochrome c, Apaf-1, and pro-caspase-
Figure 7  Scheme of caspase function and structure. Caspases-1 to caspase-10 have distinct roles in
apoptosis and inflammation. They are synthesized as zymogens consisting of a N-terminal prodomain,
which is highly variable in length (23-216 aa), and a small and large subunit. In the active enzyme, two
heterodimers associate to form a tetramer. All domains derive from the zymogen by cleavage at
caspase consensus sites (Asp-Xxx), implying that these enzymes can be activated either autocatalyti-
cally or by other caspases. |  2 7
I n t r o d u c t i o n9 (Li et al., 1997). The result is the proteolytic self-activation of caspase-9, which then
processes and activates caspases-3. Caspase-3 then cleaves effector substrates final-
ly resulting in apoptosis. Drop of inner transmembrane potential and thus cytochrome
c release may directly be caused by the pro-apoptotic Bcl-2 family member Bax (Jur-
gensmeier et al., 1998). It was observed that upon induction of apoptosis Bax translo-
cates from its cytoplasmic location to mitochondria (Wolter et al., 1997). Some Bcl-2
family proteins, including Bax, have the ability to form ion channels and thus open
pores or produce breaks in the outer membrane, allowing exit of cytochrome c. This
can be prevented by anti-apoptotic Bcl-2 family proteins (e.g., Bcl-2, Bcl-xL) which are
predominantly located in the outer mitochondrial membrane (Antonsson et al., 1997).
The mitochondrial pathway and the pathway via death receptors are not strictly sepa-
rated and allow cross-talk: Bid, a proapoptotic member of the Bcl-2 family, is directly
cleaved by caspase-8, and the C-terminal fragment acts on mitochondria to trigger cy-
tochrome c release (Li et al., 1998; Luo et al., 1998).
1.2.4 Anoikis: Apoptosis of Epithelial Cells
The current view of apoptosis is that every cell within a multicellular organism is pro-
grammed to die unless it receives external survival signals. Thus epithelial cells have
a default apoptotic machinery and require survival ligands to avoid apoptosis. Survival
signals are provided by hormones and cytokines (Raff et al., 1993), and through direct
cell contacts with extracellular matrix (ECM) (Frisch and Francis, 1994) and neighbor-
ing cells (Hermiston and Gordon, 1995). Anchorage-related apoptosis was discovered
in epithelial (Frisch and Francis, 1994) and endothelial (Meredith et al., 1993) cells that
were experimentally dissociated from their ECM. This form of apoptosis is termed
"anoikis" - the Greek word for "homelessness". Anoikis can also be observed in vivo in
normal skin (Polakowska et al., 1994), in colonic epithelial tissue (Hall et al., 1994), and
in the involuting mammary gland (Boudreau et al., 1995). Anoikis prevents detached
epithelial or endothelial cells from reattaching to new matrices and growing dysplasti-
cally, and is thus essential for maintaining appropriate tissue organization. Aberrant on-
cogenes of tumor suppressor genes can cause resistance to anoikis, thereby
contributing substantially to malignancy. Anoikis is also mediated by a well-ordered
cascade of caspases. However, the mechanism by which the caspase cascade is ini-
tiated following cell-matrix detachment is unknown. Some findings indicate a role of
death receptors or proteins with related death domains in triggering anoikis. Both, cas-
pase-8, which is physically associated with death receptors, and cleavage of the cas-
pase-8 substrate BID, were activated by cell-matrix detachment (Ashkenazi and Dixit,
1998; Li et al., 1998; Muzio et al., 1998). |  2 8
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Proteomics enables the global study of complex biological processes on the protein
level and gives an insight into the highly regulated network of protein expression,
protein modifications and protein interactions. Therefore, proteomics should be used
to investigate apoptosis in epithelial cells. Epithelial cells are characterized by strong
cell-matrix and cell-cell adhesion which both serve as survival signals. The loss of cell-
matrix or cell-cell interactions induces "anoikis", a specific form of apoptosis. Without
anoikis, detached cells could possibly reattach to inappropriately localized matrices
and resume growth. It was observed that malignant epithelial cells are resistent to
anoikis. Approximately 80-90% of the found malignancies in human originate from
epithelial cells. The exact mechanisms by which apoptosis is induced in epithelial cells
and the caspase cascade is initiated is unknown. The identification of known and
unknown  apoptosis-associated proteins may provide insight into the apoptotic process
in epithelial cells and permits the comparison of apoptosis with other cell types.
Furthermore, investigations on the protein level should reveal new caspase substrates,
which are highly relevant in terms of understanding apoptosis in general, and would
determine the relative importance of these substrates. Due to the high anoikis
sensitivity, the human breast epithelial cell line H184A1 was chosen as model sytem.
Caspases play a pivotal role in the apoptotic process which was proven by using a
variety of inhibitors. Identification of the exact cleavage site in their substrates may
allow conclusions about functional consequences. In several proteins the caspase
recognition site should therefore be determined by protein-chemical methods. 
Apoptosis research has recently revealed that the mitochondria constitute a major
regulator of cell death control. New apoptosis-associated proteins should be identified
by the comparison of the mitochondrial proteomes derived from apoptotic and non-
apoptotic B cells. Mitochondrial proteins should be separated by two-dimensional gel
electrophoresis and analyzed by proteome-analytical methods. For this reason 2-DE
should be optimized due to the high amount of membrane proteins in mitochondria. For
this investigations mitochondria isolated from the BL60 cell line were chosen as model
system.
Proteome research is limited by the detection and identification of low-abundance
proteins. Regulatory proteins which might play an important role in apoptosis are thus
out of scope of analysis by using standard proteome techniques. Therefore, methods
should be found for the enrichment of less-abundance proteins prior to 2-DE
separation and if possible to subfractionate complex protein samples. These methods
should meet some requirements: high reproducibility (allowing subtractive analysis),
compartibility with standard laboratory equipment without a great amount of expertise
and should be based on a third physical parameter of the proteins besides molecular
weight and isoelectric point.  |  2 9
M a t e r i a l2 MATERIAL
2.1 Instrumentation and Equipment
Mass spectrometer:
Electrospray ionization quadrupole time-of-flight mass spectrometer (Q-TOF MS) 
Q-TofTM equipped a Z SprayTM ion source (Micromass).
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometer (MALDI-
MS) TofSpec-2E (Micromass) equipped with a reflectron, time lag focusing technique,
gas cell and a nitrogen UV laser (337nm wavelength, 4 ns pulse with 180 µJ). 
Two-dimensional gel electrophoresis (2-DE):
DESAPHOR VA 300 gel chamber, DESAVOR VA gel casting rack and cyrostat Frigo-
stat were purchased from Desaga. Power supply EPS 3500 XL (Pharmacia) for the first
dimension and PowerPac 1000 (Bio-Rad) for second dimension. All further 2-DE
equipment were purchased from WITA GmbH. 
Gel dryer:
Gel dryer modell 583 and equipment (Bio-Rad).
Gel shaking machine:
SM-25 (Edmund Bühler)
Reversed phase high performance liquid chromatography (RP-HPLC):
Vydac C4 reversed phase column (2.1 x 150mm, 5µm, 300Å) (Phenomenex). UV/VIS
detector, two single-piston pumps LC-6A and system control unit SCL-6A (Shimadzu).
Degasser (Knauer), plotter ABI dual pen recorder (Applied Biosystems), fraction col-
lector LKB 7000 (LKB), reodyne injection valve (Knauer)
SmartTM System (Pharmacia) with a Vydac C4 reversed phase column (2.1 x 150mm,
5µm, 300Å) (Phenomenex).
N-terminal sequencer:
ProciseTM, 140C microgradient system, 785 programmable detector (PE-Applied Bio-
systems).
Amino acid analyzer:
S432 SYKAM analyzer (Sykam). |  3 0
M a t e r i a lElectroblotting apparatus:
Semi-dry blot apparatus Trans-Blot (Bio-Rad) and power supply  model 1000/500 (Bio-
Rad).
Centrifuges:
Optima TL100, Rotor TLA 120.2 (Beckmann)
Centrifuge 5415 C (Eppendorf)
Vacuum centrifuge: Speed Vac® (Savant)
Microconcentrators:
Microcon microconcentrators with a 3 kDa cut-off (Amicon)
2.2 Chemicals and Reagents
α-cyano-4-hydroxycinnamic acid Sigma
α-Thioglycerol Sigma
Acetic acid Roth
Acetonitrile, LiChrosolv Merck
Agarose, ulta pure BioRad
Amplifier solution Amersham
Aprotinin Sigma
Bromophenol blue Merck
CAPS Sigma
CHAPS Fluka,
Colloidal Coomassie Brilliant Blue G250 Serva
Coomassie Brilliant Blue R250 Serva
Deoxycholic acid Boehringer
Dithiothreitol (DTT) Merck
EDTA Merck
Ethylenediamine Merck
Fetal Calf Serum (FCS) Gibco
Formaldehyde, p. a. Merck
Glutaraldehyde Merck
Glycerol Merck
Glycine Roth
Hydrochloric acid, p.a. Merck
Leupeptin Sigma
Methanol, LiChrosolv Merck
Orthophthaldialdehyde (OPA) Merck |  3 1
M a t e r i a lPenicilline/Streptomycine Gibco
Phosphoric acid, p.a. Merck
polyHEMA Sigma
Protease inhibitor cocktail CompleteTM Boehringer
RPMI Biochrom
Servalyt pH 2-4 Serva
Silver nitrate Merck
Sodium acetate, p.a. Merck
Sodium carbonate, p.a. Merck
Sodium dodecylsulfate (SDS) Roth
Sodium thiosulfate Roth
Staurosporine (STS) Sigma
Thioglycolic acid, p.a. Merck
Thiourea, ulta pure Merck
Tributylphosphine (TBP) Sigma
Trichloroacetic acid (TCA) Merck
Trifluoroactetic acid (TFA) Fluka
Trifluoroethanol Sigma
Tris(hydroxymethyl)-aminomethane (Tris) Merck
Tris-HCl Merck
Urea, p.a. Merck
Urea, ultra pure BioRad
All gel solutions for the two-dimensional gel electrophoresis were purchased from
WITA GmbH. Chemicals for the automated N-terminal sequencing were purchased
from Perkin Elmer-Applied Biosystems. All further chemicals and reagents which are
not listed above were puchased in p.a. grade from Merck or Carl Roth GmbH & Co. 
2.3 Reversed Phase Material
214TPB2030 C4, 20-30 µm  particle size Vydac
218TPB2030 C18, 20-30 µm  particle size Vydac
Poros 50 R2 (C8/C18), 50 µm particle size Perseptive
Poros 50 R1 (C4), 50 µm particle size Perseptive
2.4 Proteins and Peptides
ACTH (18-39), human Sigma
Trypsin, bovine, modified Boehringer
[Glu]-fibrinopeptide Sigma
Substance P Sigma |  3 2
M a t e r i a lAngiotensin I Sigma
Angiotensin II Sigma
Z-DEVD-fmk inhibitor Calbiochem
Recombinant Caspase-2, -3, -6, -7, -8, -9 Pharmingen
Recombinant β-Catenin produced by U. Steinhusen, MDC
Recombinant SP1 Promega
Recombinant E-Cadherin produced by U. Steinhusen, MDC
Recombinant R23B produced by A. Rickers, MDC
2.5 Kits
ApoBRDUTM Pharmingen
Enhanced Chemiluminescence Kit (ECL) Amersham
TNT coupled Reticulocyte Lysate System Promega
2.6 Cell lines
H184A1:
non-tumorigenic human mammary epithelial cell line, chemically immortalized
HBL-100:
non-tumorigenic human mammary epithelial cell line, containing the SV40 genome
MCF-7:
human breast carcinoma cell line
BL60:
human Burkitt lymphoma B cell line (an anti-IgM-sensitive subclone BL60-2 was used
in this work) |  3 3
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3.1 Cell Culture
Cell culture was done by U. Steinhusen, A. Rickers and C. Reimertz from the group of
Dr. K. Bommert, Max Delbrück Center, Berlin.
3.1.1 Culture Conditions
The cell line H184A1 was cultured in DMEM HAM´s F12 medium supplemented with
5% fetal calf serum (FCS), 100 U/mL penicillin, 100 mg/mL streptomycin, 10 mg/mL
transferrin, 10 mg/mL insulin and 1.8 mg/mL hydrocortisol. The cell line MCF-7 was cul-
tured in DMEM supplemented with 10% FCS, 100 U/mL penicillin,100 mg streptomy-
cin/mL, 2 mM glutamax. The cell line HBL-100 was cultured in RPMI containing the
same supplements as DMEM. The cell line BL60 was cultured in RPMI, 10% FCS, 100
µg/mL penicillin-streptomycin, 1mM sodium pyruvate, 2 mM glutamine, 10 mM HEPES
pH 7.4, 20 nM bathocuproine disulfonic acid (BCS) and 50 µM α-thioglycerol.
3.1.2 Induction of Apoptosis
3.1.2.1 Anoikis-Induced Apoptosis
Anoikis in epithelial cells was induced by maintaining cells in suspension. To prevent
attachment of the cells 175 cm2 culture flasks were coated three times with 10 mL of
1% polyHEMA (poly(2-hydroxyethylmethacrylate)) dissolved in 96% ethanol by stirring
at 37 °C. Culture flasks were dried and washed three times with PBS. Cells from a con-
fluent cell layer were harvested by trypsination and transferred to polyHEMA-coated
culture flasks at a densisty of 1x107 cells (Frisch and Francis, 1994). Suspended cells
were harvested at different time points, washed twice with PBS and cell pellets were
either used directly or frozen in liquid nitrogen and stored at -80 °C for further analysis. 
3.1.2.2 Staurosporine-Induced Apoptosis
Alternatively, apoptosis in epithelial cells was induced by addition of 1 µM stau-
rosporine (0.5 mM stock solution in DMSO) into the medium of 80% confluent cell lay-
ers for up to 24 h. Detached cells were harvested by centrifugation of the culture
medium, still adherent cells by scraping in PBS containing protease inhibitors. Cells
were washed twice with PBS and cell pellets were frozen in liquid nitrogen and stored
at -80 °C for further analysis |  3 4
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Apoptosis in B cells was induced with 1.3 µg/mL goat anti-IgM F(ab´)2 fragments and
incubated for different times at 37 °C. Cell pellets were frozen in liquid nitrogen and
stored at -80 °C for further analysis.
3.1.2.4 Inhibition of Apoptosis
For inhibition of caspase activity cells were incubated with Z-DEVD-fmk, an irrever-
sible, cell permeable peptide inhibitor of caspase-3 like caspases at a concentration
range of 25-200 µM. The inhibitor was dissolved in DMSO (stock 50 mM) and was add-
ed to the culture medium 1 h prior to induction of apoptosis. DMSO alone was added
for a control. The final DMSO concentration did not exceed 0.5%.
3.1.2.5 Quantification of the Apoptosis-Rate
Epithelial Cells:
A sensitive method for the quantification of apoptotic cells is the detection of single- and
double DNA strand breaks which occur during apoptosis due to endonuclease activa-
tion. Strand breaks were detected by nick-end labelling with the nucleotide analog Br-
dUTP by the enzyme terminal transferase. Incorporation of the nucleotide analog was
detected with FITC-conjugated antibodies and measured by FACS-analysis (fluores-
cence activated cell sorting) using the APO-BRDUTM kit according to the manufactur-
er’s instructions. Approximately 1x106 cells were used in this assay. 
B Cells:
Acridine orange (3,6-bis-(dimethylamino)-acridine) is a dye that intercaletes unspecific-
ly in DNA molecules. The staining can be visualized by UV light. After 24 h of stimula-
tion with anti-IgM F(ab´)2 fragments, cells were stained with 5 µg/mL acridine orange
for 5 min and observed by fluorescence microscopy. The number of fragmented or con-
densed nuclei, which reliably indicates apoptosis, was determined.
3.1.3 Isolation of Mitochondria
Buffer A: 100 mM sucrose
20 mM MOPS (pH 7.4)
1 mM EGTA
Buffer B:
to 100 mL buffer A were added: 5 mL Percoll
10 mg digitonine
1 tablet/10 mL protease inhibitor cocktail |  3 5
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20 mM MOPS (pH 7.4)
1 mM EGTA
1 tablet/10 mL protease inhibitor cocktail
For the isolation of mitochondria 1-2 x 108 BL60-2 cells were used. Apoptotic and non-
apoptotic cells were separated by magnetic cell separation with anti-FITC magnetic mi-
crobeads after AnnexinV-FITC incubation as described previously (Rickers et al.,
1999). Cell subfractionation was performed according a modified protocoll of Bour-
geron et al. (Bourgeron et al., 1992).
All manipulations were performed at 4 °C unless otherwise stated. 1.5 mL cell suspen-
sion with 4-5 x 105 cells/mL were washed twice with buffer A and centrifuged 5 min at
500 g. The cell pellet was resuspended in 1 mL of buffer B. Cells were homogenized
with a potter. Homogenate was centrifuged 12 min at 1000 g to remove the nuclei and
still intact cells.  The collected supernatant was centrifuged 10 min at 9500 g. The re-
sulting pellet was washed twice with buffer C.  The mitochondria were then pelleted by
centrifuging at 14 000 g for 10 min.  Mitochondria were frozen in liquid nitrogen and
stored at -80 °C for further analysis (Isolation of the mitochondria was done by C. Re-
imertz from the group of Dr. K. Bommert, Max Delbrück Center, Berlin). 
3.2 High Resolution Two-dimensional Gel Electrophoresis (2-DE)
The principle of high resolution 2-DE was introduced by O´Farrell (O'Farrell, 1975) and
Klose (Klose, 1975). The method separates according to the physico-chemical param-
eters charge (isoelectric point) in the first dimension and size (molecular weigth) in the
second dimension. The protocol used here for two-dimensional gel electrophoresis is
based on the work of Klose and Kobalz (Klose and Kobalz, 1995) and combines isoe-
lectric focusing (IEF) using carrier ampholytes in the first dimension with sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in the second
dimension. 
3.2.1 Sample Preparation
The cell pellets of epithelia cells and pellets of the mitochondria of B cells were thawed
and during this procedure rapidly mixed with urea (7 M final concentration), thiourea (2
M final concentration), DTT (70 mM final concentration), 4% CHAPS, and with protease
inhibitor solutions. The final concentration of protease inhibitors, salts and buffers in the
protein sample was 1.4 µM pepstatin A, 1 mM PMSF, 1 mM benzamidine, 2.1 µM leu-
peptin, 1 mM EDTA, 1 mM KCl and 40 mM Tris/HCl. Finally, 2.5% carrier ampholytes
were added (Servalyt pH 2-4). Alternatively, 2 mM tributyl phosphine (TBP) was used |  3 6
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After 30 min of gentle stirring at room temperature, the samples were centrifuged at
100 000 g for 20 min. The clear supernatant was frozen at -80 °C. 
3.2.2 Amino Acid Composition Analysis
For protein quantification of cell lysates, amino acid composition was determined. A
volume of 1 µL of the crude cell lysate was hydrolysed by vaporphase hydrolysis (Melt-
zer et al., 1987) with 6 M HCl and 7% (v/v) thioglycolic acid as additive for 24 h at 110
°C. Dried hydrolysates were dissolved in sodium citrate buffer (0.15 M, pH 2.2) and an-
alyzed in a S 432 SYKAM analyzer after separation of the amino acids (except Cys,
Pro, Trp) by cation exchange chromatography and post column derivatization with or-
thophthaldialdehyde (OPA) reagent (amino acid analysis was done by G. Grelle from
the group of Protein Chemistry, Max Delbrück Center, Berlin).
3.2.3 First Dimension (Isoelectric Focusing, IEF)
During isoelectric focusing proteins migrate according an electric field within a pH gra-
dient to their isoelectric point, where they have no charge and, therefore, remain.
Separation gel solution: 3.5% Acrylamide
0.3% Piperazine diacrylamide
4% WITAlyte, pH 2-11
9 M Urea
5% Glycerol
0.06% TEMED
Cap gel solution: 12% Acrylamide
0.13% Piperazine diacrylamide
4% WITAlyte, pH 2-11
9 M Urea
5% Glycerol
0.06 % TEMED
Cathodic electrode solution: 5% Glycerol
9 M Urea
5% Ethylenediamine
Anodic electrode solution: 7.27% Phosphoric acid
3 M Urea
Regulation of electric current: 1 h 100 V
1 h 200 V
17.5 h 400 V
1 h 650 V
30 min 1000 V
10 min 1500 V
5 min 2000 V |  3 7
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mm for preparative gels were used. Glass tubes were inserted into a gel casting appa-
ratus (WITA GmbH). The vials containing the gel separation solution and the cap gel
solution (purchased ready-made in frozen condition from WITA) were thawed and con-
nected to a water-jet pump and degassed for 4 min. 25 µL of 0.8% ammonium persul-
fate solution was carefully mixed into 975 µL gel solution and the resulting solution is
poured into the reservoir of the gel casting apparatus. All the ends of the glass tubes
have to be immersed by the gel solution. The glass tubes were filled with the gel solu-
tion by 1 mL syringes, which were connected to the upper end of the glass tubes in that
way that the gel has a length of 20 cm with a space of 0.5 cm in the lower end of the
glass tube for the cap gel. The filled glass tubes were left for 30 min at room temperatur
to allow the gel solution to polymerize. 390 µL of degassed cap gel solution were mixed
with 10 µL 0.8% ammonium persulfate solution. The cap gel solution was loaded onto
the lower end of the separation gel and left for 30 min for polymerization. After polym-
erization the glass tubes were removed from the gel casting apparatus, a drop of water
was placed at the opening of each tube end (without contacting the gel surface) and
then the ends were tightly closed with a piece of parafilm. The gels were left under
these conditions for three days at room temperature. 
For running the first dimension the gel tubes were inserted into a IEF apparatus (WITA,
GmbH) consisting of an upper (anode) chamber and a lower (cathode) chamber. The
lower chamber and also the gel-free cap gel ends of the gel tubes were filled with de-
gassed cathodic electrode solution. The cap gel end of the gel tubes immersed in the
cathode solution. The two chambers were mounted one upon the other with a cylinder
as spacer in-between. Before the protein sample was applied to the anodic side of the
gel, the gel surface was dried with a fine strip of filter paper and then a 2 mm layer of
Sephadex (100 µL Sephadex suspension were mixed with 1.08 mg urea and 10 µL am-
pholytes 2-11) was loaded onto the separation gel. The volume of protein sample load-
ed onto the gels depended on the inner diameter of the glass tubes: 10-15 µL cell lysate
could be loaded onto an analytical gel and 30-35 µL onto a preparative gel. Subse-
quently, the sample was covered with a protection solution (5.3 M urea, 0.7 M glycine,
5% Servalyt 2-4) preventing the direct contact between sample and anode solution.
The degassed anode solution was loaded upon the protection solution and filled in the
anode chamber until all gel tubes were covered. The run was accomplished at RT and
the electric current was regulated as indicated above.
When the IEF run was finished, the anode and cathode solution were removed from
the tubes. Using a water-filled 1 mL syringe the gels were extruded from the cap gel
side into a gel groove. In the gel groove the gels were incubated for 10 min with an equi-
libration solution (125 mM Tris/H3PO4, pH 6.8, 40% glycerol, 3% SDS, and 65 mM
DTT). The grooves carrying the gels could be stored at -80 °C for a long period of time. |  3 8
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 A separation according mainly to the molecular mass is obtained after denaturation of
the proteins by SDS, an anionic detergent, giving the proteins a negative charge and a
similar shape by removing the secondary structure (Laemmli, 1970).
Gel solution: 15% Acrylamide
0.2% Bisacrylamide
0.375 M Tris-HCl, pH 8.8
0.03% TEMED
0.01% SDS
Electrode buffers: Cathode Buffer Anode Buffer
0.025 M Tris 0.025 M Tris
0.129 M Glycine 0.129 M Glycine
0.1 M SDS
200 µL Bromophenol blue
Cathode buffer was prepared freshly for each run, anode buffer could be used several times
Regulation of electric current: 0.75 mm Gels 1.5 mm Gels
15 min   65 mA 15 min   120 mA
6-7 h   85 mA 6-7 h   160 mA
For the second dimension a vertical gel system was used with a gel size of 23 x 30 cm.
The gel thickness was 0.75 mm for analytical gel and 1.5 mm for preparative gel, res-
pectively. The frozen, ready-made gel solutions (WITA GmbH) were thawed.  The inner
side of the glass plates were carefully cleaned to remove any dust. The gel cells were
assembled according to the instructions of the manufacturer using silicone grease to
seal the cells. The gel cells were then placed into the polymerization stand (WITA Gm-
bH). With the help of a syringe mounted on the bottom of the polymerization stand,
some milliliters of 40% glycerol were pushed into the gel cells to prepare space for the
first dimension. 73.5 mL gel solution (for an analytical gel) were mixed with 4.5 mL
1.28% ammonium persulfate solution and poured into the gel cells. A strip of parafilm
was put onto the upper slit of each gel cell so that an air-free contact to the gel solution
resulted. The gel solutions were then allowed to polymerize for 30 min. Thereafter, the
gel cells were turned upside-down and inserted again into the stand. The glycerol so-
lution was removed and replaced with an overlaying solution (285 mM Tris / 90 mM
Tris-HCl / 3.5 mM SDS) and the gels were stored at 4 °C overnight.
IEF gels were thawed and in the meantime the overlaying solution was removed. The
gel of the first dimension was then transferred with a pipette tip to the second dimen-
sion by holding the groove in contact with the edge of the glass plate. The IEF gels were
then overlayered with agarose solution (0.1 g agarose in 9.95 mL 125 mM Tris/H3PO4,
pH 6.8, 0.1% SDS) up to the edges of the glass cells to fix the IEF gel. When agarose
was gelatinized, the gel cells were inserted into the electrophoresis apparatus. The
anodic buffer temperature was kept at 11 °C. Electrophoresis of the SDS-polyacryla- |  3 9
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the bromophenol blue dye reached the marking line on the glass plates.
3.2.5 Gel Staining Procedures
3.2.5.1 Silver Staining
Fixation solution: 50% Ethanol
5% Acetic acid
Incubation solution: 30% Ethanol
0.5 M Sodium acetate
0.01 M Sodium thiosulfate
1.25% Glutaraldehyde 
Silver solution: 0.005 M Silver nitrate
0.01% Formaldehyde
Development solution: 0.24 M Sodium carbonate
0.01% Formaldehyde
Stop solution: 0.01 M EDTA
After electrophoresis, the gels were transferred into large white plastic container and
agitated for 2 h or overnight in the fixation solution. In the next step, the gels were shak-
en 1 h in the incubation solution and subsequently washed three times for 20 min with
bidistilled water.  The staining was performed by shaking the gels 30 min in an aqueous
silver nitrate solution. The gels were rinsed for 30 sec with bidistilled water and devel-
oped by intense shaking with aqueous development solution until the desired staining
intensity (3-5 min). The development process was stopped with an aqueous EDTA so-
lution. After each step the used solutions were removed by means of a water-jet pump.
The silver-stained gels were dried stored (see 3.2.6) (Heukeshoven and Dernick, 1988;
Klose and Kobalz, 1995).
3.2.5.2 Alternative Silver Staining 
Alternative silver staining was performed similarly to the method described in 3.2.5.1.
except the treatment with glutaraldehyde. The gels were incubated with fixation solu-
tion (see 3.2.5.1) for 2 h or overnight. The gels were then washed 10 min with 50% eth-
anol in water and additionally for 10 min with water to remove the remaining acid. The
gels were sensitized by 1 min incubation in 0.02% sodium thiosulfate, and they were
then rinsed with two changes of bidestilled water for 1 min each. After rinsing, the gels
were submerged in 0.1% silver nitrate solution. After 45 min, the silver nitrate solution
was then discarded, and the gels were rinsed twice with water for 1 min and then de-
veloped in 0.04% formaldehyde / 3% sodium carbonate / 0.0004% sodium thiosulfate
with intensive shaking. After the desired intensity of staining was achieved (10-30 min), |  4 0
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gels with 5% acetic acid. Silver-stained gels were stored in a solution of 1% acetic acid
in transparent foil at 4 °C until analyzed (Blum et al., 1987; Shevchenko et al., 1996).
3.2.5.3 Coomassie Brilliant Blue R 250 Staining
After electrophoresis, gels were fixed with fixation solution (see 3.2.5.1) for 2 h or over-
night. Gels were then transferred into the Coomassie staining solution (0.1 % Coomas-
sie Brilliant Blue R 250, 10% acetic acid, 50% ethanol in water) for 1 h. Destaining of
the gels was performed with destaining solution (5% ethanol / 12.5% acetic acid in wa-
ter) with several changes. Gels were sealed in transperent plastic foil and stored at 4
°C (Eckerskorn et al., 1988).
3.2.5.4 Colloidal Coomassie Brilliant Blue G 250 Staining
Colloidal Coomassie Brilliant Blue G 250 dye was purchased from Sigma and per-
formed according the instructions of the vendor. After electrophoresis, gels were fixed
with fixation solution (see 3.2.5.1) for 2 h or overnight. The gels were placed in the
staining suspension for 1-2 h. Excessive dye was removed by destaining solutions
(10% acetic acid in 25% methanol) (Neuhoff et al., 1988; Neuhoff et al., 1990).
3.2.6 Gel Drying
The stained gels were placed on two sheets filter paper and one sheet of cellophane
foil. The gels were then covered with one sheet of cellophane foil and one sheet of filter
paper. Cellophane foil and filter paper were soaked in water previously. The gels were
then dried in a gel dryer by exposing them to vacuum at 75 °C for 2 h (Klose and Ko-
balz, 1995). 
3.2.7 Evaluation of 2-DE Images
The silver-stained 2-DE images were scanned with a Linotype-Hell scanner. The imag-
es were processed using Photoshop (Adobe) and evaluated using Phoretix 5.0 soft-
ware (Phoretix). |  4 1
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3.3.1 One-dimensional SDS-Polyacryamide Gel Electrophoresis
Sample buffer: 125 mM Tris-HCl, pH 8.8
0.1% SDS
2% DTT
20% Glycerol
0.02%(w/v) Bromophenol blue
Stacking gel: 125 mM Tris-HCl, pH 6.8
4% (w/v) Acrylamide
0.8% (w/v) Bisacrylamide
0.1% (w/v)  SDS
Separation gel: 375 mM Tris-HCl, pH 8.8
15% (w/v) Acrylamide
0.8% (w/v) Bisacrylamide
0.1% (w/v) SDS
Electrophoresis buffer: 25 mM Tris-HCl, pH 8.8
190 mM Glycine
0.1% (w/v) SDS
For separation of HPLC fractions or in vitro caspase cleavage products one-dimension-
al SDS-PAGE was used (Laemmli, 1970). The above stated gel solutions were pre-
pared from stock solutions. The gels were polymerized by adding 0.1% TEMED and
1% ammonium persulfate. Samples were heated at 95 °C in 20 µL sample buffer for 5
min and briefly centrifuged. Electrophoresis was done at 70 V until the bromophenol
blue front reached the separation gel and then finished at 130 V. After electrophoresis,
gels were put directly into the Commassie Blue staining solution and stained as de-
scribed in 3.2.5.3 or transferred to membranes by electroblotting.
3.3.2 Electroblotting
For N-terminal sequence analysis or Western blot analysis electrophoretically separat-
ed proteins were transferred to 0.2 µm PVDF membrane ImmobilonTM P (Millipore) or
to 0.45 µm nitrocellulose (Schleicher & Schuell) by semi-dry blotting (Aebersold et al.,
1986; Vandekerckhove et al., 1985). A blot sandwich was made out of 3 layers filter
paper, gel, membrane and 3 layers filter paper. The anode filter papers were soaked
in anode transfer buffer (10 mM CAPS, pH 11 in 10% methanol) and the cathode filter
papers were soaked in cathode transfer buffer (10 mM CAPS, pH 11, 0.75% SDS in
10% methanol) (Matsudaira, 1987). The PVDF membrane was wetted with methanol
and then washed with anode transfer buffer. Air bubbles between layers were avoided
by gently rolling a glass rod over each layer. The electrotransfer was performed with
constant current (1 mA/cm2) for 2 h. After electroblotting, PVDF membranes were
stained with Coomassie Blue (0.1% Coomassie Brilliant Blue R 250, 10% acetic acid,
50% methanol in water) for 1 min and destained with 50% methanol. |  4 2
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Ponceau-S solution: 0.1% Ponceau-S in 5 % acetic acid
Blotto: 2% nonfat dry milk, 50 mM Tris-HCl, pH 7.5
150 mM NaCl, 0.1% Triton X-100
20-50 µg protein in sample buffer (see 3.3.1) were separated by SDS-PAGE and trans-
ferred to 0.45 µm pore-size nitrocellulose as decribed in 3.3.2 (Towbin et al., 1979). Af-
ter protein staining with Ponceau-S solution the membranes were blocked with Blotto
for 30 min at RT. The primary antibody was then incubated in Blotto for 1 h at RT. After
three times washing with Blotto for 10 min, membranes were incubated in Blotto with
HRP-conjugated secondary anti-mouse or anti-rabbit antibody for 30 min at RT. Final-
ly, membranes were washed three times for 10 min with Blotto, rinsed in water and de-
veloped with enhanced chemiluminescence kit as recommended by the manufacturer.
3.3.4 In Vitro Transcription and Translation of Keratin 15
Keratin 15  was transcribed from the pKH15-3 clone (a kind gift from R. Leube, Mainz,
Germany) and translated using the TNT rabbit reticulocyte system with the T7 polymer-
ase in the presence of 35S-methionine according the maufacturer´s instructions. The
samples were separated by SDS-PAGE and the gel was incubated in amplifier solution
for 20 min and dried on a vacuum dryer. Protein synthesis was detected by exposing
an imaging film for autoradiography.
3.3.5 In Vitro Cleavage of Proteins with Recombinant Caspases
Reaction buffer: 50 mM HEPES (pH 7.4), 0.1% CHAPS, 5 mM DTT
1 mM PMSF, 50 µM leupeptin, 200 µg/mL aprotinin
Proteins: 10 µg recombinant β-catenin
10 µg recombinant E-cadherin
in vitro translated keratin 15
16.5 µg recombinant R23B
Cleavage reactions were performed with recombinant β-catenin, recombinant R23B or
recombinant E-cadherin was digested with 100 ng of recombinant caspase-3 in reac-
tion buffer as described above for 2-4 h at 37 °C. Samples were then separated by
SDS-PAGE, blotted on PDVF membrane as described in 3.3.2 and analysed by N-ter-
minal sequencing (see 3.4). In the case of 35S-labelled in vitro translated keratin 15
cleavage reactions were performed with 25 ng  each of recombinant caspases-3, -6, -
7, -8 and -9 in 20 µL reaction buffer. The SDS-PAGE gel was incubated in amplifier-
solution for 20 min, dried and subsequently exposed to an imaging film for autoradiog-
raphy.  |  4 3
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Cells in PBS buffer were lysed by addition of 1:10 vol. 0.15% (w/v) desoxycholic acid.
Subsequently 1/10 vol. 70% TCA were added to the protein sample and left on ice for
30 min. Sample was centrifuged at 10 000 rpm for 30 min at 4 °C. The supernatant was
discarded, the precipitation was suspended with cold aceton and centrifuged again at
10 000 rpm for 20 min at 4 °C. The dried protein pellet was stored at -80 °C.
3.3.7 Protein Precipitation according Wessel and Flügge
400 µL methanol, 300 µL chloroform, and 300 µL water were added to 100 µL cell
lysate and agitated. After centrifugation at 10 000 rpm for 5 min the supernatant was
discarded and the precipitation washed with 300 µL methanol. The methanol was re-
moved by centrifugation at 10 000 rpm for 5 min and the obtained protein pellet was
dried and stored at -80 °C.
3.4 Automatic N-terminal Microsequencing
The N-terminal sequence analysis of proteins immobilized on PVDF membrane was
performed by automatic Edman degradation with a ProciseTM sequencer equipped with
a 140C microgradient system and a 785 programmable detector (PE-Applied Biosys-
tems). This method cleaves the N-terminal amino acid from a peptide or protein back-
bone and prepares the derivatized residue for its identification. In this way the amino
acids sequence of a protein is determined by repetitive chemical reaction. Edman deg-
radation comprises three individual steps: the coupling, the cleavage and the conver-
sion (Edman and Begg, 1967; Hewick et al., 1981; Wittmann-Liebold et al., 1976). 
Preparation of the sample: The Coomassie-stained protein bands were excised from
the PVDF membrane, soaked in 60% acetonitrile for destaining and transferred into the
reaction cartridge of the sequencer.
Coupling: The reagent phenylisothiocyanate (PITC) couples to the free N-terminal ami-
no group of the peptide chain forming a phenylthiocarbamyl (PTC) peptide. The reac-
tion takes place within 15-30 min at a basic pH and a temperature of 40-55 °C in a very
high yield.
Cleavage: The dried PTC peptide is treated with trifluoroacetic acid. The first amino
acid is cleaved as a heterocyclic derivative, the anilinothiazolinone (ATZ) amino acid.
Conversion: The unstable ring structure of the ATZ amino acid is opened by the influ-
ence of aqueous acid and an increased temperature (ca. 60 °C). Rearrangement takes
place, yielding the more stable phenylthiohydantoin (PTH) amino acid.
Identification of the PTH amino acid: PTH amino acids are analysed with a limit in the |  4 4
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and quantification of the UV signals is done by reference to the retention times and the
absorbance of a PTH standard run.
3.5 Enzymatic Cleavage of Gel-separated Proteins
3.5.1 In-gel Digestion
For protein characterization on minute amounts it is straightforward to digest the sam-
ple directly within the polyacrylamide matrix. The protein spots derived from 2-DE gels
were stained either by Coomassie (see 3.2.5.3 or 3.2.5.4) or by silver (see 3.2.5.2). 
The protein spots were precisely cut out of the gels with a scalpel avoiding needless
polyacrylamide in excess, as the ratio of protein to gel is a critical factor for further
analysis. The excised gel spots were diced with a scalpel and prepared for the
enzymatic digestion.
Coomassie-stained spots 
Gel pieces were washed with 0.1 M ammonium bicarbonate and 50% acetonitrile, in
order to remove excess of Commassie Blue dye and to adjust the pH. After destaining,
the gels were shrinked by submerging in pure acteonitrile for 5 min and by subsequent
lyophilization in a vacuum centrifuge for 5-10 min. 0.3-0.5 µg  trypsin diluted in 25 mM
ammonium bicarbonate were added in a volume just enough to re-swell the gel pieces.
When re-swelling was completed some additional 25 mM ammonium bicarbonate buff-
er were added to keep the gel pieces covered with solution. The digestion was per-
formed in a Thermomixer (Eppendorf) overnight at 37 °C (Rosenfeld et al., 1992).
Alternative silver-stained spots
Silver-stained proteins were destained with the chemical reducer potassium ferricya-
nide K3[Fe(CN)6] and the complexing agent sodium thiosulfate which remove the silver
ions. These chemical agents were prepared prior to digestion as two stock solutions of
30 mM potassium ferricyanide and 100 mM sodium thiosulfate, both dissolved in water.
A working solution was prepared by mixing a 1:1 ratio of the above stock solutions. This
working solution is unstable, and therefore should be prepared fresh for each reaction.
30-50 µL of working solution were added to cover the gel pieces and occasionally vor-
texed. After 10-15 min the brownish colour disappeared, then the gel pieces were
rinsed carefully with plenty of water. Next, 200 mM ammonium bicarbonate was added
to cover the gel pieces for 20 min. The gel pieces were then shrinked with pure ace-
tonitrile. The following steps were the same as described for Coomassie-stained spots
(Gharahdaghi et al., 1999). |  4 5
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The cleavage fragments were extracted out of the gel pieces with acidic and organic
solvents by passive diffusion. The digestion buffer was acidified with 10% TFA to a final
concentration of 1% TFA and shaken for 1 h at 60 °C (Otto et al., 1996; Rosenfeld et
al., 1992). The supernatant was saved in a new tube. Next, the peptides were eluted
twice with 60% acetonitrile / 0.1% TFA for 1 h at 60 °C. All supernatants were combined
and dried with a Speed Vac. For the mass spectrometry, the peptides were reconsti-
tuted in 20 µL 0.1 TFA and desalted by ZipTips (Millipore), a micro-adsorptive pipette
tip containing 0.5 µL cast plug of C18 material (15 µm, 300Å). ZipTips were rinsed with
pure methanol and then equilibrated with 0.1% TFA. The binding of the peptides was
performed by 10-15 times of aspirating and dispensing of the sample. Finally, the tip
was washed 3 times with 0.1% TFA. The peptides were eluted with 3 µL 50% MeOH,
1% formic acid and measured by ESI-MS and/or MALDI-MS.
3.6 Mass Spectrometry
3.6.1 Matrix-assisted Laser Desorption/Ionization Mass Spectrometry
For MALDI-MS investigations the TofSpec-2E (Micromass) was used. The mass spec-
trometer was equipped with a nitrogen laser (337 nm wavelength, 4 ns pulse with 180
µJ) and the time lag focusing technique which increases resolution and mass accuracy.
The time-of-flight (TOF) mass analyzer has a path length of 1.15 meter in linear mode
and an effective path length of 2.3 meter in the reflectron mode. In the linear mode,
peptides were accelerated at 20 kV, in the reflectron mode peptides were accelerated
with 20 kV while the reflectron voltage was 26 kV. The data sampling rate was 2 GHz.
A stainless steel 53 mm x 35 mm sample plate with 96 sample spots was used. As de-
tector, a high speed dual microchannel plate was used with a detector voltage of 1600
V. The matrix suppression was kept at 500 Da. The data were acquired with the Micro-
mass MassLynx software package (version 3.4) within the Microsoft Windows NT op-
erating system (version 4.0). The instrument was calibrated externally using the known
masses of sythetic peptides (ACTH 18-39, Angiotensin I, Angiotensin II, each 10 pmol/
µL) and additionally with a lock mass which was either mixed to the matrix (200 fmol/
µL ACTH 18-39) solulution or a tryptic autoproteolyse product was used. Generally, 25-
100 laser shots were averaged for each spectrum. The spectra were processed using
the MassLynx software. The BioLynx software (Micromass) included tools for the inter-
pretation of data and database searching. |  4 6
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The matrix consisted of 10 mg/mL re-crystallized α-cyano-4-hydroxycinnamic acid
(Sigma) in acetonitrile:ethanol (1:1, v/v) spiked with 200 fmol/µL ACTH 18-39 as lock
mass for internal calibration. 0.5 µL of the sample solution were applied on the MALDI
target and then 0.5 µL of the matrix solution. Both solutions were then mixed on the
target and allowed to air dry. The sample was transferred to the vacuum chamber of
the mass spectrometer.
3.6.1.2 Re-crystallisation of α-cyano-4-hydroxycinnamic acid
200 mg α-cyano-4-hydroxycinnamic acid were suspended in 200 mL water. Ammoni-
um hydroxide solution was added until most of the α-cyano-4-hydroxycinnamic acid
dissolved. Concentrated hydrochloric acid was slowly dropped to the solution until a
large amount of α-cyano-4-hydroxycinnamic acid  precipitated (pH 2). The precipitated
α-cyano-4-hydroxycinnamic acid was removed by filtering and washed with 0.1 M HCl.
The matrix was dried in a vacuum centrifuge and stored at -20 °C.
3.6.2 Electrospray Ionization Mass Spectrometry
ESI-MS and ESI-MS/MS experiments were performed with a tandem quadrupole /  or-
thogonal-accelerating time-of-flight mass spectrometer (Q-TOF MS) Q-TofTM equipped
a Z SprayTM ion source (Micromass). For normal mass spectra, the quadrupole was
used in the RF-only mode and the collision cell was not pressurized. In the MS/MS
mode the quadrupole operates in the normal resolving mode, and is able to select pre-
cursor ions up to m/z 4000 for collisional activation in the hexapole gas cell. A collision
energy of 24 -35 V was applied, depending on the charge state of the parent ions. The
argon gas pressure in the collision cell was regulated to 6.0 10–5 mbar. Following de-
composition, the daughter ions were transmitted to the TOF for mass analysis. In both
MS and MS/MS modes, the ions were pulsed into the TOF with an accelerating voltage
of about 7.8 kV. The detector was a dual-stage microchannel plate with a detector volt-
age of 2700 V. The data sampling rate was 500 MHz. 
Samples were dissolved in 50% methanol / 1% formic acid in water and introduced into
the electrospray ion source of the instrument by nano-flow electrospray (Wilm et al.,
1996) using gold coated borosilicate glass capillaries (Nanoflow Tips Type A by Micro-
mass or Medium NanoES capillaries by Protana) with an flow rate of approximately 30
nL/min. A potential of 1.4-1.5 kV was applied to the glass capillaries. The ion source
was operated at a temperature of 30 °C with a nitrogen drying gas flow of about 180 L/
h. The Q-Tof calibration was performed with the fragment masses of [Glu]-fibrinopep-
tide (200 fmol/µL). For MS experiments 10-50 scans were averaged and for MS/MS ex- |  4 7
M e t h o d speriments 10-100 scans were averaged depending on the intensity of the precursor
ion. The data acquisition was performed with the Micromass MassLynx software  (ver-
sion 3.0 - 3.4) running in Microsoft Windows NT operating system (version 4.0).
3.7 Computer-assisted Protein Identification
For the identification of in-gel digested proteins several Word-Wide Web (WWW)
based software programs were used for searching protein sequence databases. 
Peptide masses of the peptide mass fingerprint (PMF) obtained by MALDI-MS were
matched with the theoretical peptide masses of all human proteins of the OWL data-
base using Mascot software (Matrixscience) (http://www.matrixscience.com/cgi/in-
dex.pl?page=/home.html). For protein search monoisotopic masses were used and a
mass tolerance of 10 ppm was allowed.
Database search with ESI-MS/MS fragment masses MS-Tag (http://falcon.lud-
wig.ucl.ac.uk/ ucsfhtml3.2/mstagfd.htm) was used which is located on the Protein
Prospector server of the University of California San Francisco Mass Spectrometry Fa-
cility.  Masses were matched with the theoretical fragment masses of all human pro-
teins of the Swiss-Prot protein sequence database. Alternatively, PeptideSearch (http:/
/www.mann.embl-heidelberg.de/Services/PeptideSearch/FR_PeptidePatternForm.
html) developed by Mann and Wilm (Mann and Wilm, 1994) was used. For protein
search monoisotopic masses of the precursor ion and daughter ions were used and a
mass tolerance of 100 ppm was allowed. 
3.8 Reversed Phase High Performance Liquid Chromatography
3.8.1 RP-HPLC of Cell Lysates 
Liquid chromatography was performed with a Shimadzu system. As stationary phase
a Vydac C4 reversed phase column 2.1 x 150 mm, 5 µm particle size, 300 Å pore size
(Phenomenex) connected to a Vydac C4 guard column was used. Up to 150 µL cell
lysate were loaded on the column corresponding to approximately 900 µg protein. A
step gradient elution was performed using as buffer A 0.1% TFA in water and as buffer
B 0.1% TFA in acetonitrile. After injection the column was carefully washed with buffer
A for 20 min at a flow rate of 0.5 mL/min. The step gradient consisted of 5 steps with
rising concentration of buffer B: 34%, 12 min; 38%, 10 min; 42%, 10 min; 46%, 10 min
and 90%, 5 min. The chromatograms were monitored at 280 nm, and the fractions were
collected automatically every two minutes resulting in 22 fractions. Fractions of every |  4 8
M e t h o d sstep were dissolved in 2-DE buffer and pooled according to the elution profile. 2-DE
buffer consisted of 7M urea, 2M thiourea, 4% CHAPS, 40mM Tris and 5 mM tributyl-
phosphine. The column was cleaned with 100 µL trifluoroethanol.
3.8.2 RP-HPLC of Caspase Cleavage Products
In vitro cleavage products of β-catenin by caspase-3 were separated using a Smart
System (Pharmacia).  As stationary phase  a Vydac C4 reversed phase column 2.1 x
150 mm, 5 µm particle size, 300 Å pore size was used. A gradient with rising concen-
tation of 0.1% TFA in acetonitrile was applied with a flow rate of 100 µL/min. The chro-
matograms were monitored at triple wavelengths (214, 260, 280 nm), and the fractions
were collected automatically. |  4 9
R e s u l t s4 RESULTS
4.1 Identification of Apoptosis-associated Proteins in the Human 
Mammary Epithelial Cell Line H184A1
4.1.1 Induction of Apoptosis and Quantification the Rate of Apoptosis
Anoikis represents a special form of apoptosis in epithelial cells which is induced by the
loss of integrin-mediated matrix contacts. For the identification of proteins which are in-
volved in anoikis the cell line H184A1 was chosen due to their high anoikis-sensitivity.
Anoikis was induced by maintaining the cells in suspension. For this reason, cells were
grown to confluency and harvested by trysination. Subsequently, the cells were trans-
ferred to polyHEMA-coated culture dishes to keep them in suspension for 24 h. The
percentage of apoptotic cells was determined by an APO-BRDU kit labeling single- and
double-strand DNA breaks measured by fluorescence-activated cell sorter (FACS)
analysis. The H184A1 cell line showed a rate of 98% apoptotic cells.
In addition, apoptosis was induced by incubating the cells in medium containing 1 µM
staurosporine (STS), a protein kinase inhibitor, for up to 20 h. After STS treatment, de-
tached (sus) and adherent (adh) cells were harvested separately and analyzed in the
same way as described above. STS sus cells show a rate of apoptosis of 89%, STS
adh a rate of apoptosis of 37%. Control cells were incubated with 0.2% DMSO (Fig. 8).
4.1.2 Sample Preparation and High Resolution Two-dimensional Gel 
Electrophoresis
Apoptosis is a highly regulated biochemical process which is characterized by the re-
cruitment of several regulating proteins and the activation of proteases. For analysing
anoikis and apoptotic processes on the protein level, cell lysates of apoptotic H184A1
cells and of non-apoptotic H184A1 cells as control were separated by high resolution
Figure 8  FACS-analysis of H184A1 cells after induction of apoptosis by staurosporine application. Ap-
optotic cells were labelled by BrdUTP as described in 3.1.2.5. Cells in suspension (sus) had a signifi-
cantly higher rate of apoptosis than adherent cells (adh) after STS application. |  5 0
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Kobalz (Klose and Kobalz, 1995).
Treatment of samples for 2-DE involves solubilization, denaturation and reduction to
completely break protein interactions and to remove nonprotein components such as
nucleic acids. Some improvements in sample preparations were made in this study to
increase protein solubilization and the quality of the 2-DE separation. Urea is a com-
mon constituent of protein sample preparation for 2-DE. It increases sample solubility
and acts as a denaturing agent at higher concentration by unfolding the proteins and
thus exposing their hydrophobic cores. Surfactants which bind to the hydrophobic res-
idues assist protein solubilization. Therefore, 4% of the zwitterionic sulfobetaine sur-
factant CHAPS were used because it is soluble in high concentrations of urea. Proteins
have their lowest solubility at or close to the isoelectric point. This leads to protein
streaking in 2-DE gels and to loss of proteins. Thiourea as an effective chaotrope min-
imizes these effects. Due to its poor solubility in water, thiourea requires high concen-
trations of urea for solubilty. The optimal conditions were 2 M thiourea in 7 M urea.
Furthermore, dithiothreitol (DTT) was replaced by tributyl phosphine (TBP) as reducing
agent. TBP and DTT reduce inter- and intra-polypeptide disulfide bonds leading to pep-
tide unfolding and to increasing accessibility to detergents. Unlike DTT, TBP is nonion-
ic and thus does not migrate during the IEF, therefore maintaining reducing conditions
during the course of the first-dimensional separation. Additionally, the presence of free
thiols, such as DTT, in the second dimension can cause vertical streaking of proteins
and also contributes to high background after silver staining. DTT can also cause arte-
factual vertical point streaking by interaction with dust particles on the surface of, or
embedded in, the second-dimensional gel matrix. 
Urea and thiourea were added to the frozen cell pellet in solid form to avoid dilution of
the protein sample. During sample preparation, the protein samples containing urea
must be kept below 32 °C to avoid carbamylation caused by cyanate ions (a degrada-
tion product of urea) with cysteine residues.
The cell lysates comprised a total protein concentration in the range between 2-8 µg/
µL (depending on the sample and the cell line) determined by amino acid analysis. The
solubilized and denatured proteins of apoptotic and non-apoptotic cells were separated
in the first dimension by isoelectric focusing (IEF) and in the second dimension by so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). During IEF,
proteins are concentrated into narrow bands within a continous pH gradient in polyacr-
ylamide after migrating in the electric field until they reach a position with no protein net
charge, i.e., their isoelectric point. The pH gradients necessary for IEF were generated
by carrier ampholytes. Carrier ampholytes are low molecular weight compounds
(aliphatic oligoamino-oligocarboxylic acids) with different pIs. The mixture of carrier
ampholytes used covered the pH range 2-11, however, proteins with pIs larger than 9.5 |  5 1
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The samples for IEF were loaded on the anodic side of the IEF gel to avoid that very
basic proteins do not migrate into the gel if loaded on the cathodic side. 
The separation matrix for the second dimension also was polyacrylamide. The concen-
tration of acrylamide influences the effective pore size of the matrix. Using an 15% acr-
ylamide concentration, molecules in the range of 10-200 kDa could be resolved in a
logarithmic manner. Glycoproteins and lipoproteins can migrate anomalously as they
are difficult to saturate with SDS. Preparing 11 L of fresh electrophoresis buffer for each
run as recommended by Klose and Kobalz (anode and cathode buffer are identical, to-
gether 11 L) is time consuming and requires large amounts of chemicals. Therefore,
only 1.5-2 L of cathode buffer was prepared freshly. According to the electrophoretic
theory, the anode buffer does not consume chemicals during the run thus no SDS is
needed. Omitting SDS, 10 L of anode buffer were prepared and used for 5-6 runs (the
buffer was stored between the runs within the gel chamber) without any negative effect
on the 2-DE gel images.
Fig. 9 shows a representative analytical, silver-stained gel derived from detached ap-
optotic H184A1 cells after STS treatment (STS sus). Approximately 40-90 µg protein
(depending on sample and cell line) was loaded onto an analytical gel. Isoelectric point
and molecular mass calibration were performed by the identification of 5 protein spots
whose theoretical values were taken from the Swiss-Prot database (Tab. 1). 4000 pro-
tein spots in this gel were determined by Phoretix software using the computer scanned
gel image.
4.1.3 Subtractive Analysis
For the identification of apoptosis-associated proteins the 2-DE protein images of ap-
optotic and non-apoptotic H184A1 cells were compared by subtractive analysis. Apop-
tosis was induced either by anoikis or staurosporine treatment. A prerequisite for
reliable image analysis is the production of a series of good-quality 2-DE gels with low
background staining. At least 10 silver-stained 2-DE gels from both samples were pre-
pared and compared. The visual evaluation focused on clear intensity differences, es-
pecially +/- variants since such differences are more likely involved in apoptosis and do
Spot No. Protein Name Accession No. av. Mw [kDa] pI
S10 thioredoxin P10599 11606 4.8
S33 thioredoxin peroxidase 1 P32119 21892 5.7
S39 annexin I P04083 38583 6.6
S26 pyruvate kinase, M1 isozyme P14618 57746 7.6
S52 PTB-associated splicing factor P23246 76149 9.5
Table 1   Protein spots identified by ESI-MS/MS which were taken for calibration of the 2-DE image. The 
theoretical average Mw and pI are indicated. Accession numbers derived from Swiss-Prot database. |  5 2
R e s u l t sFigure 9  2-DE protein pattern of total cell lysate from apoptotic H184A1 cells (20 h STS sus). The
original gel size was 23 x 30 x 0.075 cm. Proteins were visualized by silver staining. Molecular mass and
isoelectric point calibration were performed by the theoretical values of the identified protein spots S10,
S33, S39, S26, and S52 (see Tab. 1). |  5 3
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stance.
Several significantly altered protein spots could be detected between apoptotic and
non-apoptotic cells. Fig. 10 and Fig. 11 show the enlarged 2-DE gel sections of Fig. 9
with the comparison of non-apoptotic cells, apoptotic cells (STS induced), and cells
treated with caspase-3 like inhibitor Z-DEVD-fmk before induction of apoptosis.
4.1.4 Mass Spectrometric Identification of Protein Spots 
The identification of protein spots from silver-stained gels is not possible for mainly two
reasons: (i) the sensitizing agent glutaraldehyde binds to the free amino groups and
can cross-link proteins, (ii) the protein concentration of the majority of protein spots is
not sufficient for mass spectrometric identification (detection limit for silver staining is
about 1-10 ng per protein). Therefore, preparative gels with a higher protein loading ca-
pacity of approximately 100-250 µg total protein (depending on sample and cell line)
were prepared and stained either by Coomassie or by alternative silver staining omit-
ting glutaraldehyde. Protein spots of interest were excised and digested with trypsin in
the gel matrix. Trypsin cleaves after arginine and lysine residues with high specificity.
For the identification by ESI-MS the extracted tryptic peptide mixtures were desalted
since high salt concentrations lead to signal suppression and clustering effects. 
Figure 10  Enlarged sections I + II of the 2-DE pattern (Fig. 9). Comparison of non-apoptotic cells (NA),
apoptotic cells (A), and cells treated with caspase-3 like inhibitor Z-DEVD-fmk before induction of apo-
ptosis (A+Inh.). Altered spots are marked. Inhibitor could suppress either the appearance or disappear-
ance of potential apoptosis-associated protein spots. |  5 4
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used for the identification of the protein spots. This instrument provides the opportunity
to sequence peptides by tandem mass spectrometry (MS/MS). For database searches
3-6 tryptic peptides per sample were sequenced by MS/MS, but in most of the cases
only one MS/MS spectrum with a concise y-series and good signal-to-noise ratio was
sufficient for an unambiguous database match. For MS/MS experiments doubly
charged precursor ions were used exclusively since they generate during CID predom-
inantly intense, singly charged fragment ions. The database search using MS/MS
spectra was performed with the internet-based software program MS-Tag. The mass
of the precursor ion and of several intensive fragment (daughter) masses were used
for the database search. Possible modifications of some amino acids were taken into
account: the oxidation of methionine to methionine sulfoxide (+ 16 Da) and the adduc-
tion of acrylamide to cysteine resulting in cysteinyl-S-β-propionamide (+ 71 Da). These
cysteine-acrylamide adducts can further be oxidized (+ 87 Da). Furthermore, a mass
tolerance of 100 ppm was allowed and incomplete tryptic cleavages (also termed as
missed cleavage sites) were considered.
Figure 11   Enlarged sections III-VI of the 2-DE pattern (Fig. 9). Comparison of non-apoptotic cells
(NA), apoptotic cells (A), and cells treated with caspase-3 like inhibitor Z-DEVD-fmk before induction
of apoptosis (A+Inh.). Altered spots are marked. Inhibitor could suppress either the appearance or dis-
appearance of potential apoptosis-associated proteins. |  5 5
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ences in expression after staurosporine or anoikis induced apoptosis. The identification
using MS/MS mass data was highly specific since the combination of the parent mass
and of 2-3 fragment masses is a unique signature for each of the proteins. In some cas-
es the database search listed a homologous protein of other species additionally to the
human protein. 
The involvement of some of these identified proteins in apoptosis was described pre-
viously: The apoptosis-induced cleavage of keratin 18 was observed by Caulin et al.
(Caulín et al., 1997) by means of immunofluorescence. Lamins A and C are alterna-
tively spliced products of the same gene and differ only in their carboxy terminal region.
The proteolytic cleavage of lamins could be shown as a requirement for normal pro-
gression of apoptosis (Rao et al., 1996). The heteronuclear ribonucleoproteins C1 and
C2 (hnRNP C1/C2) are components of the spliceosome and are specific targets of cas-
pases in apoptosis (Waterhouse et al., 1996). The fragmentation of desoxyuridine 5´-
triphosphate nucleotidehydrolase (DUT-N) during apoptosis was observed recently on
the protein level by 2-DE (Brockstedt et al., 1998). These proteins represent an addi-
tional control for the induction of apoptosis and for the reliability of subtractive analysis. 
Based on the sequence homology, a similar degradation as for keratin 18 was predict-
ed for keratin 15 (K15) and keratin 17 (K17), however, their cleavages during apoptosis
could not be experimentally determined until know. In the apoptotic gel I could observe
the disappearance of full-length keratin 15 and keratin 17 (Fig. 10, Sec. I) and simulta-
neously, in the same gel fragments of K15 and K17 occured with molecular masses
ranging from approximately 20-27 kDa (Fig. 10, Sec. II). 
Spot No. Identified Protein Accession No.
Spot 
Intensity
Section on 
2-DE Image
P1 keratin 15 (fragment) P19012 + II
P2 keratin 15 (fragment) P19012 + II
P3 keratin 15 (fragment) P19012 + II
P4 keratin 17 (fragment) version I Q04695 + II
P5 keratin 17 (fragment) version I Q04695 + II
P6 keratin 17 (fragment) version I Q04695 + II
P7 lamin A (fragment) P02545 + IV
P8 heat shock 27 kd protein P04792 - IV
P9 DUT-N P33316 - VI
P10 keratin 17 (full-length) version II Q04695 - I
P11 keratin 15 (full-length) P19012 - I
P12 keratin 17 (full-length) version I P08729 - I
P13 keratin 18 (full-length) P05783 - I
P14 hnRNP C1/C2 P07910 + I
P15 hnRNP C1/C2 P07910 + I
Table 2  Differently expressed proteins after induction of apoptosis by staurosporine in H184A1 cells 
as determined by MS/MS. Plus (+) indicates an increased spot intensity in the apoptotic state versus 
the non-apoptotic state; minus (-) indicates a decreased spot intensity in the apoptotic state versus the 
non-apoptotic state. Accession numbers were taken from Swiss-Prot database. |  5 6
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three spots derived from K15 and three spots from K17 indicating that keratin 15 and
keratin 17 are cleaved at at least at two different sites.
P16 hnRNP C1/C2 P07910 + I
P17 hnRNP C1/C2 P07910 + I
P18 hnRNP C1/C2 P07910 + I
P19 hnRNP C1/C2 P07910 + I
P20 lamin a (full-length) P02545 - III
P21 lamin c (full-length) P02546 - III
P22 lamin c (full-length) P02546 - III
P23 keratin 18 (fragment) P05783 + V
Spot No. Identified Protein
Mw [kDa]
Theor.  / Observ.
pI
Theor. / Observ.
Sequence 
Coverage
P1 keratin 15 (fragment) - 22.9 - 4.6 -
P2 keratin 15 (fragment) - 21.3 - 4.4 -
P3 keratin 15 (fragment) - 20.8 - 4.4 -
P4 keratin 17 (fragment) version I - 21.9 - 4.9 -
P5 keratin 17 (fragment) version I - 20.8 - 4.9 -
P6 keratin 17 (fragment) version I - 20.6 - 4.6 -
P7 lamin A (fragment) - 22.4 - 6.1 -
P8 heat shock 27 kd protein 22.8 22.3 7.8 5.5 41
P9 DUT-N 19.3 18.8 8.0 5.9 39
P10 keratin 17 (full-length) version II 47.9 44.5 5.0 5.0 34
P11 keratin 15 (full-length) 49.1 46.2 4.7 4.6 63
P12 keratin 17 (full-length) version I 50.8 45.8 5.0 5.0 60
P13 keratin 18 (full-length) 47.9 41.2 5.3 5.3 27
P14 hnRNP C1/C2 33.3 34.2 5.1 5.3 21
P15 hnRNP C1/C2 33.3 34.2 5.1 5.2 20
P16 hnRNP C1/C2 33.3 34.2 5.1 5.4 12
P17 hnRNP C1/C2 33.3 34.0 5.1 5.4 15
P18 hnRNP C1/C2 33.3 34.0 5.1 5.3 28
P19 hnRNP C1/C2 33.3 34.0 5.1 5.2 31
P20 lamin a (full-length) 74.1 72.2 6.6 6.7 10
P21 lamin c (full-length) 65.1 58.1 6.4 6.7 12
P22 lamin c (full-length) 65.1 58.3 6.4 6.5 15
P23 keratin 18 (fragment) - 22.3 - 6.6 -
Table 3  Details about the identified proteins: theoretical Mw and pI were taken from Swiss-Prot data-
base. Observed Mw and pI were calculated from the gel position using Phoretix software. The se-
quence coverage is the ratio of the number of all amino acids of the identified peptides derived from
mass spectrometry analysis to the total number of amino acids of the protein in percent.
Spot No. Identified Protein Accession No.
Spot 
Intensity
Section on 
2-DE Image
Table 2  Differently expressed proteins after induction of apoptosis by staurosporine in H184A1 cells 
as determined by MS/MS. Plus (+) indicates an increased spot intensity in the apoptotic state versus 
the non-apoptotic state; minus (-) indicates a decreased spot intensity in the apoptotic state versus the 
non-apoptotic state. Accession numbers were taken from Swiss-Prot database. |  5 7
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Members of the caspase family - mainly caspase-3 like caspases - have turned out to
be important effector molecules in apoptosis. To analyse whether caspases are in-
volved in cleavage of keratin 15 and keratin 17 the irreversible cell permeable caspase-
3 family specific inhibitor Z-DEVD-fmk was used prior to induction of apoptosis by stau-
rosporine application. This tetrapeptide inhibitor represents the ideal cleavage site for
caspase-3 like caspases but cannot be cleaved due to modifications which block cas-
pase activity. The Z-DEVD-fmk inhibitor completely blocks the disappearance of full-
length keratin 15 and keratin 17 (Fig. 10, Sec. I) and the appearance of spots P1-P6
(Fig. 10, Sec. II), respectively. These observations lead to the conclusion that K15 and
K17 were cleaved during apoptosis by caspase-3 like proteases or caspases activated
downstream of caspase-3. The cleavage of K15 and K17 during apoptosis could also
be observed by Western blot analysis. Whole cell lysates of adherent cells after STS
treatment (STS adh), detached cells after STS treatment (STS sus), and cells grown in
0.2% DMSO as control were separated by SDS-PAGE. As shown in Fig. 12 A, in a cell
lysate of non-apoptotic cells only full-length K17 could be detected, while the cell lysate
of adherent cells after staurosporine treatment revealed two fragments (A+B), and an
additional fragment C was detectable in the cell lysate of detached cells. The apparent
molecular masses correspond with the K17 fragments observed in 2-DE analysis. In
contrast to K17, no K15 fragments could be detected with the monoclonal K15 antibody
after staurosporine treatment. However, with increasing rate of apoptosis the amount
of full-length K15 decreased, probably due to caspase-mediated cleavage (Fig. 12 B).
For this reason, keratin 15 was in vitro translated using a TNT reticulocyte system in
Figure 12  Western blot analysis of keratin 17 (A) and keratin 15 (B) using H184A1 cell lysate after
induction of apoptosis. Apoptosis of H184A1 cells were induced with 1µM staurosporine (STS) for 15
h. Control cells were incubated with 0.2% DMSO for the same time. After STS treatment, adherent
(adh) cells and cells in suspension (sus) were harvested separately representing an increasing rate of
apoptotic cells (37% for adherent cells and 89% for cells in suspension). Total cell lysates were sepa-
rated by 12.5% SDS-PAGE. After electroporesis, proteins were transferred onto nitrocellulose mem-
brane, blocked, and incubated with monoclonal antibodies to keratin 15 and keratin 17. |  5 8
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and -9 (see 3.3.4). Fig. 13 shows that caspase-6 cleaves K15 into three fragments with
high efficiency, while caspase-3 and -7 removed only a small fragment (Px), presuma-
bly the C-terminal region of full-length keratin 15 which contains the epitope for the anti-
K15 antibody (Waseem et al., 1999).
4.1.6 Mapping the Caspase Cleavage Sites in K15 and K17
Caspase-induced cleavage of K15 and K17 produces at least three fragments of each
protein. Ku et al. (Ku et al., 1997) predicted that K15 and K17 could be cleaved in the
same region as K18 because all three keratin type I proteins show the same caspase
recognition site VEXD at similar positions. To determine the exact cleavage sites, I
used mass spectrometric techniques. For protein identification by electrospray mass
spectrometry a weak Coomassie Blue-stained spot is sufficient. Spots P1 – P6 were
digested in the gel with trypsin. After extraction of the tryptic peptides from the gel ma-
trix and desalting, the peptides were applied to ESI-MS. Firstly, I screened the obtained
spectra for masses that could only be derived from peptides by caspase cleavage.Tab.
Fragment Position Amino acid sequence
P1
T1 1 – 19 MTTTFLQTSSSTFGGGSTR>G
T2 20 - 42 R<GGSLLAGGGGFGGGSLSGGGGSR>S
T3 43 - 50 R<SISASSAR>F
T4 51 - 65 R<FVSSGSGGGYGGGMR>V
T5 107 - 115 K<ITMQNLNDR>L
T6 125 - 136 R<ALEEANADLEVK>I
T7 137 - 143 K<IHDWYQK>Q
Table 4  Sequence of tryptic peptides obtained after in-gel digestion of spots P1, P2, and P3 (Fig. 10 
II) of keratin 15 that were identified by ESI-MS/MS. Amino acids in bold letters indicate caspase cleav-
age sites. The peptides are also schematically represented as black bars in Fig. 17.
Figure 13  In vitro cleavage of keratin 15 with recombinant caspases. K15 substrate was obtained by
using a TNT reticulocyte system in the presence of 35S-methionine. Cleavage reactions were per-
formed with recombinant caspase-2, -3, -6, -7, -8, and -9. |  5 9
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T9 167 - 176 K<IMATTIDNSR>V
T10 177 - 185 R<VILEIDNAR>L
T11 186 - 192 R<LAADDFR>L
T12 195 - 202 K<YENELALR>Q
T13 203 - 213 R<QGVEADINGLR>R
T14 215 - 223 R<VLDELTLAR>T
T15 243 - 249 K<NHEEEMK>E
P2
T1 107 - 115 K<ITMQNLNDR>L
T2 125 - 136 R<ALEEANADLEVK>I
T3 137 - 143 K<IHDWYQK>Q
T4 167 - 176 K<IMATTIDNSR>V
T5 177 - 185 R<VILEIDNAR>L
T6 186 - 192 R<LAADDFR>L
T7 195 - 202 K<YENELALR>Q
T8 215 - 223 R<VLDELTLAR>T
P3
T1 265 - 273 D<AAPGVDLTR>V
T2 274 - 288 R<VLAEMREQYEAMAEK>N
T3 320 - 326 K<TEITDLR>R
T4 344 - 356 K<AGLENSLAETECR>Y
T5 399 - 407 R<LEQEIATYR>S
T6 408 - 416 R<SLLEGQDAK>M
Fragment Position Amino acid sequence
P4
T1 85 - 93 K<ATMQNLNDR>L
T2 94 - 100 R<LASYLDK>V
T3 103 - 114 R<ALEEANTELEVK>I
T4 129 - 135 R<DYSQYYR>T
T5 136 - 143 R<TIEELQNK>I
T6 163 - 169 R<LAADDFR>T
T7 180 - 190 R<LSVEADINGLR>R
T8 192 - 200 R<VLDELTLAR>A
T9 201 - 211 R<ADLEMQIENLK>E
T10 220 - 229 K<NHEEEMNALR>G
P5
T1 242 - 259 D<AAPGVDLSR>I
T2 269 - 277 K<DAEDWFFSK>T
T3 284 - 296 R<EVATNSELVQSGK>S
T4 297 - 303 K<SEISELR>R
T5 321 - 333 K<ASLEGNLAETENR>Y
T6 368 - 373 K<ILLDVK>
T7 376 - 384 R<LEQEIATYR>R
T8 386 - 398 R<LLEGEDAHLTQYK>K
Table 5  Sequence of tryptic peptides obtained after in-gel digestion of spots P4, P5, and P6 (Fig. 10 
II) of keratin 17 that were identified by ESI-MS/MS. Amino acids in bold letters indicate caspase cleav-
age sites. The peptides are also schematically represented as black bars in Fig. 17.
Fragment Position Amino acid sequence
Table 4  Sequence of tryptic peptides obtained after in-gel digestion of spots P1, P2, and P3 (Fig. 10 
II) of keratin 15 that were identified by ESI-MS/MS. Amino acids in bold letters indicate caspase cleav-
age sites. The peptides are also schematically represented as black bars in Fig. 17. |  6 0
R e s u l t s4 and Tab. 5 list all peptides found by MS/MS. In the tryptic digest of K15 spot P3 I ob-
served a signal with a mass that corresponded to the sequence of peptide T1 (Tab. 4,
protein P3). Sequencing by MS/MS confirmed that this signal belongs to a peptide with
the sequence 265AAPGVDLTR273 (Fig. 14). Preceding this sequence is the caspase
recognition sequence VEMD264 indicating that D264 is indeed the cleavage site for cas-
pases in K15. This cleavage site lies in the middle of K15. Identified tryptic peptides
revealed that fragment P3 is derived from the C-terminal half while fragments P1 and
P2 are derived from the N-terminal half of K15 (Tab. 4). Their apparent molecular
weight derived from the 2-DE gel suggests that fragment P2 is considerably shorter
than P1. This fact allows the prediction of a second caspase cleavage site N-terminal
T9 409 - 418 R<TIVEEVQDGK>V
P6
T1 242 - 259 D<AAPGVDLSR>I
T2 269 - 277 K<DAEDWFFSK>T
T3 284 - 296 R<EVATNSELVQSGK>S
T4 297 - 303 K<SEISELR>R
T5 321 - 333 K<ASLEGNLAETENR>Y
T6 357 - 367 R<CEMEQQNQEYK>I
T7 376 - 384 R<LEQEIATYR>R
T8 386 - 398 R<LLEGEDAHLTQYK>K
T9 409 - 416 R<TIVEEVQD>G
Fragment Position Amino acid sequence
Table 5  Sequence of tryptic peptides obtained after in-gel digestion of spots P4, P5, and P6 (Fig. 10 
II) of keratin 17 that were identified by ESI-MS/MS. Amino acids in bold letters indicate caspase cleav-
age sites. The peptides are also schematically represented as black bars in Fig. 17.
Figure 14  Tandem mass spectrum (MS/MS) of the doubly charged precursor ion with [M+2H]2+= 450.3
u with the sequence AAPGVDLTR of keratin 15 spot P3. Some ions are marked with the corresponding
m/z values and their fragment-ion type (see 7.1). |  6 1
R e s u l t sto D264. However, the exact location of this cleavage site could not be determined by
ESI-MS/MS because a suitable tryptic peptide could not be observed. The same pro-
cedure was applied for K17 spot P6. In this case I found a peptide with the sequence
242AAPGVDLSR250 (T1 of P6, Tab. 5) that confirmed caspase-mediated cleavage after
the tetrapeptide VEMD241 (Fig. 15). Furthermore, the sequence 409TIVEEVQD416 (T9 of
P6, Tab. 5) was identified in the same digest and verified the second cleavage site in
K17 at the position EVQD416 (Fig. 16). In the digest of K17 spot P5 the tryptic fragment
409TIVEEVQDGK418 (T9 of P5, Tab. 5) was found which indicated that no cleavage had
occurred at position D416 in this fragment. The cleavage site at position D241 (T1 of
P5,Tab. 5) was also found in P5.
The identification of the cleavage sites in K15 and K17 revealed that caspases specif-
ically cleaved K15 and K17 at the consensus sequence VEMD/A located in the non-
helical linker region L1-2 of the rod domain (Fig. 17). Furthermore, a second cleavage
site was found in the tail domain of K17 at the sequence EVQD/G. A second cleavage
site in K15 is assumed to be in the tail domain at position D445 with the sequence ESVD/
G similar to K17. There are at least two evidences for this assumption. First, in vitro
cleavage of K15 by caspase-3 and -7 showed the loss of a small fragment Px from K15
(Fig. 13). Second, Western blot analysis of whole cell lysate after induction of apoptosis
could not detect a K15 fragment. A possible explanation for this is that the loss of the
C-terminal region, which contains the epitope for the LHK15 antibody, is an early event
and the resulting fragment is too small to be detected. Fig. 17 gives a schematic over-
view of the cleavage sites and resulting fragments. MS/MS experiments revealed that
Figure 15  Tandem mass spectrum (MS/MS) of the doubly charged precursor ion with [M+2H]2+= 443.3
u with the sequence AAPGVDLSR of keratin 17 spot P6. Some ions are marked with the corresponding
m/z values and their fragment-ion type (see 7.1). |  6 2
R e s u l t sfragment P1 starts with the first amino acid of K15 and ends at the caspase cleavage
site at position D264 (Fig. 17A). Fragment P2 originates from the N-terminus as P1 but
is significantly shorter than P1 according to the relative positions of both fragments in
the 2-DE gel. I assume the third caspase cleavage site at position D225 with the se-
quence ARTD/L that is also in coincidence with the observed relative molecular mass-
es of P1, P2, and P3 on the 2-D gel. Fig. 17B displays the results for keratin 17. The
largest K17 fragment is P4 with a molecular mass of 25.9 kDa and 242 amino acids
including the N-terminal half of K17. Fragments P5 and P6 derived from the C-terminus
but P6 is slightly shorter than P5 according to the second caspase cleavage site in the
tail domain at position D416.
4.2 Enrichment of Protein Samples Prior to Two-dimensional Gel 
Electrophoresis
The number of new apoptosis-associated proteins identified by 2-DE in H184A1 cells
was smaller than expected. An explanation for this is the fact that only a minor part of
the proteins expressed by the genome are detectable on a 2-DE gel with current meth-
odologies. Especially regulating proteins as proteins of the Bcl-2 family or caspases,
which have been identified as essential components of the intracellular apoptotic sign-
aling pathways, are low-copy-number gene products and therefore difficult to identify.
For the visualization of less-abundance proteins by 2-DE the protein amounts loaded
onto the gel has to be increased. However, the volume loaded into the glass tubes of
Figure 16  Tandem mass spectrum (MS/MS) of the doubly charged precursor ion with [M+2H]2+= 466.8
u with the sequence TIVEEVQD of keratin 17 spot P6. Some ions are marked with the corresponding
m/z values and their fragment-ion type (see 7.1). |  6 3
R e s u l t sthe first dimension is limited. Therefore, the protein concentration in the cell lysate have
to be increased by removing water.
4.2.1 Enrichment by Protein Precipitation
Circumventing this drawback, proteins of the lysed cells were precipitated and redis-
solved in a small volume of 2-DE sample buffer containing 9 M urea, DTT, ampholytes
and protease inhibitors. The cells were lysed by adding 1/10 vol. of 0.15% deoxycholic
acid. Subsequently, proteins were precipitated by 1/10 vol. of 70% TCA (for details see
3.3.6). The obtained protein pellet was dissolved in 100-150 µL 2-DE sample buffer,
centrifuged at 100 000 g and the supernatant was applied to the first dimension. The
protein detection by silver staining revealed that really no proteins entered the second
dimension. There were two possible explanations for this: (i) the anionic detergent de-
oxycholic acid was not compatible with IEF as it imparts a negative net charge to pro-
tein/detergent micelles which do not migrate into the IEF gel, (ii)  the proteins in the
pellet were not dissolved in the sample buffer.
Avoiding any use of detergents during TCA precipitation, an alternative precipitation
method according to Wessel and Flügge (see 3.3.7) using methanol/chloroform was
Figure 17  Schematic diagram of keratin 15 and 17. The rod domain is composed of the α-helical sub-
domains (1A, 1B, 2A, and 2B) that are connected by non-helical linker regions (L1, L1-2, and L2). The
rod domain is flanked by non-helical N-terminal head and C-terminal tail domains. The hatched areas
mark highly conserved regions of intermediate filament proteins. Arrows indicate caspase cleavage
sites and P1 – P6 the resulting proteolytic fragments. Black areas marked as T1 – T15 indicate inter-
nally sequenced peptides by ESI-MS/MS after in-gel digestion with trypsin. |  6 4
R e s u l t stested. However, the results were the same: no spots were detectable after silver-stain-
ing. The poor solubility of the protein pellet seemed to be the main reason. Solubilising
the proteins in SDS sample buffer by heating to 95 °C is not practicable since SDS is
detrimental to IEF and heating can cause degradation of proteins and is therefore not
applicable for 2-DE analysis. 
4.2.2 Enrichment by Microconcentrators
An other way to remove superfluous water from protein samples was the use of Micro-
con® microconcentraters with a molecular weight cut-off of 3 kDa. The cell pellets were
prepared as usual for 2-DE (see 3.2.1). Cell lysates were then centrifuged in a concen-
trator until half of the volume was removed. The retentate was analyzed by 2-DE. The
obtained 2-DE image revealed intensive, well resolved protein spots. However, the
protein loading capacity when using carrier ampholytes is restricted, and overloading
leads to streaky protein spots and a poor spot resolution. A further enrichment of pro-
teins should be combined with a prefractionation method allowing the preparation of
highly concentrated protein samples which then represent only a part of the whole pro-
teome.
4.3 Prefractionation and Enrichment of Protein Samples by Liquid 
Chromatography
Reversed phase liquid chromatography is a robust and reliable method for the separa-
tion of a great number of proteins and peptides with high reproducibility (Schulz-
Knappe et al., 1997). Therefore, I established a fractionation procedure to enrich less-
abundance proteins using reversed phase liquid chromatography. 
4.3.1 Testing Different Reversed Phase Materials
Firstly, I investigated to which extend RP-HPLC is suitable to separate complex protein
mixtures such as whole cell lysates . Of special interest was whether all proteins loaded
onto the column are eluted and if proteins pass the column without retardation. For this
reason I tested a variety of reversed phase materials from different manufacturers
which I packed in simple guard columns. Proteins of the human breast epithelial cell
line HBL-100 were prepared as described in 3.2.1 and loaded onto the column. After a
wash step with 100% buffer A (0.1% TFA in water) proteins were eluted with 90% buffer
B (0.1% TFA in acetonitrile). The collected eluted proteins were dried by vacuum cen-
trifugation, re-dissolved in 2-DE buffer and applied to the first dimension. The obtained
2-DE images were compared with the 2-DE images of the whole cell lysate before sep-
aration (input). It turned out that the Vydac C4 reversed phase material showed the best
performance. Gel images of samples passing the column and control samples were |  6 5
R e s u l t sidentical. Extreme hydrophobic membrane proteins, which were expected to bind irre-
versibly to the column, were obviously not dissolved during the lysis of the cells. These
proteins remained in the insoluble precipitate after cell lysis and were therefore not
loaded onto the column. Evidently, all proteins which are soluble in the lysis buffer are
also eluted from the column. A positive side effect of the column was that the 2-DE im-
age showed a better resolution, more circular spot shapes and less streaky spots. A
possible explanation for this may be the desalting effect since salts are detrimental to
IEF. Next, I established the optimal separation conditions of a commercial Vydac C4
2.1 x 150 mm column with a particle size of 5 µm and a pore size of 300Å. By searching
a suitable elution profile it turned out that most of the proteins were eluted between 35
and 45% buffer B. Fig. 18B shows a typical chromatogram of a five-step gradient of a
cell lysate eluted from the column and Fig. 18A shows the corresponding gradient pro-
file indicating that a single run takes no more than 50 min. The final 90% step ensured
that remaining hydrophobic proteins were eluted from the column. The separation per-
formance of the gradients was examined by analyzing the collected fractions by SDS-
PAGE. The Coomassie blue stained 15% SDS gel of the collected fractions is shown
in Fig. 19. The proteins were homogeniously distributed among the five steps of  the
gradient. A linear gradient resulted in the formation of one single broad peak in the
chromatogram preventing the reproducible collection of the fractions for subsequent 2-
DE analysis.
Figure 18  (A) Scheme of the five-step gradient with rising concentration of buffer B (0.1 % TFA in ac-
teonitrile). The duration of each step is indicated on the x-axsis. (B) Corresponding HPLC chromato-
gram monitored at a wavelength of 280 nm. |  6 6
R e s u l t s4.3.2 2-DE of Reversed Phase Separated Proteins
A five-step gradient proved to be the optimal way to separate the complex protein mix-
tures. The fractions of one gradient step were dried by vacuum centrifugation, dis-
solved in 2-DE buffer, pooled and loaded onto the first dimension. A comparison of the
2-DE gel of the non-concentrated cell lysate (input) derived from the epithelial cell line
HBL-100 and the proteins eluted from the column is shown in Fig. 20. The complex pro-
tein pattern of the total cell lysate results in five distinct 2-DE patterns. Only very in-
tense spots overlap between adjacent gradient steps. The 2-DE protein pattern of the
34% pool also shows spots in the high molecular weight region suggesting that hydro-
phobicity and molecular weight are not inevitably coherent. The reproducibility was ver-
ified by comparison of the 2-DE gels of different HPLC runs from the same sample.
Using the same HPLC column the 2-DE protein patterns were absolutely identical. The
replacement of the column, however, for another one of same size, same reversed
phase material and of the same manufacturer resulted in different 2-DE protein pat-
terns. I also applied this step gradient to other samples like B cells or tissue of rat lung.
The distribution of the proteins to the five steps was always comparable, demonstrating
that an adjustment of the step gradient to respective samples was dispensable. Fig. 21
shows the partial 2-DE images of the five pools (B - F) in more detail. A comparison
with 2-DE gels of the corresponding part of the 2-DE gel of the unseparated sample
(Fig. 21A) shows that several protein spots were highly enriched, for example spots
LA1 in Fig. 21C and spots LA2 in Fig. 21C+D. The identified proteins are listed in Tab.
6.
Figure 19  SDS-PAGE analysis of HBL-100 cell lysate eluted  from a reversed phase C4 column. The
soluble protein fraction of HBL-100 cells was applied onto the column and eluted in a five-step gradient
(see Fig. 18). The gel was stained with Coomassie Blue. The numbers correspond to the numbers of
the HPLC fractions. Fractions which belong to the same step are indicated with the concentration of
buffer B. T, total cell lysate (input). M, protein size marker. |  6 7
R e s u l t sSpot No. Protein Name Accession No. av. Mw [kDa] pI
LA1 hnRNP C1/C2 P07910 33.3 5.1
LA2 nuclear distribution gene C GI 5729953 32.5 5.1
LA3 nucleophosmin P06748 32.6 4.6
LA4 actin P02570 41.6 5.3
LA5 HSC70-interacting protein P50502 41.3 5.2
LA6 reticulocalbin 1 Q15293 38.9 4.7
LA8 hepatoma-derived growth factor P51858 26.7 4,7
LA10 hnRNP C1/C2 P07910 33.3 5.1
LA11 cytokeratin 18 P05783 47.9 5.4
LA12
ubiquinol-cytochrome c reductase 
complex core protein I
P31930 52.6 5.4
LA13 glutathione synthetase P48637 52.4 5.7
LA14 ribosomal protein SA P08865 32.8 4.8
LA15 stomatin-like protein 2 GI 7305503 38.5 7.5
LA16 tropomodulin 3 GI 6934244 39.5 4.9
LA17 B23 nucleophosphin GI 825671 30.9 4.5
Table 6  Proteins identified by mass spectrometry of HBL-100 cell line. Accession numbers beginning 
with GI were taken from NCBI database, all other were taken from the Swiss-Prot database. The the-
oretical average Mw and pI are indicated.
Figure 20  Silver-stained 2-DE patterns of whole HBL-100 cell lysate (input, A) and the 5 pools of frac-
tions collected after prefractionation/enrichment by RP-HPLC (B-F). The corresponding concentration
of buffer B is indicated. |  6 8
R e s u l t sThe comparison also demonstrates the excellent separation performance of the five-
step gradient. The very intensive spot of actin (LA4) for example is concentrated par-
ticularly in the 46% pool and only minor amounts in the 90% pool. Furthermore, the
fractionation of the cell lysate into five pools opens the possibility to reveal spots, which
are normally covered by intensive spots of high-abundant proteins.
4.3.3 Comparison of 2-DE Images of Apoptotic and Non-apoptotic Cells
In order to investigate whether this procedure is also applicable to the comparison of
the 2-DE gels of HPLC runs of cell lines under different conditions I separated cell
lysates of apoptotic and non-apoptotic HBL-100 cells. For both samples the same lysis
buffer and the same HPLC step gradient was applied. By evaluation of the 2-DE protein
patterns of apoptotic and non-apoptotic cells I expected to discover differences derived
from differentially expressed proteins or from proteins which are processed during ap-
optosis. A comparison of the partial 2-DE images of the 38% pool of apoptotic cells and
non-apoptotic cells is shown in Fig. 22A and revealed six additional spots in apoptotic
LA18 hnRNP F P06748 45.6 5.4
LA20 creatin kinase, B chain GI 125294 42.6 5.4
LA21 dynamitin GI 5453629 44.8 4.9
LA22 proteasome 26S subunit GI 5729991 47.3 4.9
LA25 pot. laminin-binding protein GI 34272 33.3 4.6
Spot No. Protein Name Accession No. av. Mw [kDa] pI
Table 6  Proteins identified by mass spectrometry of HBL-100 cell line. Accession numbers beginning 
with GI were taken from NCBI database, all other were taken from the Swiss-Prot database. The the-
oretical average Mw and pI are indicated.
Figure 21  Silver-stained partial 2-DE gel images of the HBL-100 cell lysate input (A) and of the pools
34% (B), 38% (C), 42% (D), 46% (E), and 90% (F) of fractions collected from RP column. The proteins
were identified either by MALDI-MS or by ESI-MS/MS. The names of the proteins are given in Tab. 6. |  6 9
R e s u l t scells. These spots could be identified as heterogeneous nuclear ribonucleoproteins C1/
C2 (hnRNP C1/C2) by MALDI-MS. The hnRNP C1/C2 proteins were previously identi-
fied in the H184A1 cell line. In another region of the same gels (Fig. 22B) I observed
the appearance of four spots in the apoptotic state which were all determined as frag-
ments of the intermediate filaments protein vimentin. These weak silver stained spots
were enriched by this method to Coomassie visible spots in a concentration sufficient
for a protein identification by mass spectrometry. The fragmentation of vimentin is also
induced by caspases and is assumed to be essential for cytoskeleton reorganization
during apoptosis (Prasad et al., 1998). This indicates that spot differences did not arise
from the prefractionation process but from proteins indeed involved in apoptosis. In ad-
dition, some other significant spot differences could be observed between apoptotic
and non-apoptotic cells (Fig. 23). Spots could be identified as myosin heavy chain and
cofilin which have not been described in apoptosis yet. Tab. 7 comprises a complete
list of all identified variant protein spots.
4.4 Identification of Apoptosis-associated Proteins in Mitochondria
Recently it has been shown that mitochondria play an important role in apoptosis. Mi-
tochondria undergo major changes in membrane integrity before classical signs of cell
death become manifest. To investigate the mitochondrial apoptotic process on the pro-
tein level, mitochondria of MACS-separated apoptotic and non-apoptotic BL60-2 B
Figure 22  Comparison of apoptotic and non-apoptotic HBL-100 cells after prefractionation by RP-
HPLC. (A) Silver-stained partial 2-DE gel images of the 38% pool of non-apoptotic (DMSO control) and
apoptotic (STS) cells. After induction of apoptosis spots H1-H3 and H5-H7 appeared. A comparison
with the corresponding part of the 2-DE of the input (STS input) shows these proteins as very weak
spots which were not visible on a Coomassie Blue-stained gel. (B) Same gels but another region: After
induction of apoptosis 4 additional spots appeared (H10-H13). In the corresponding part of the input
(STS input) these spots were not detectable. |  7 0
R e s u l t scells were isolated and separated by 2-DE. Subcellular fractionation provides an addi-
tional method for the enrichment and separation of cellular proteins. 
Spot 
No.
Protein Name
Accession 
No
av. Mw pI
Spot 
Intensity
H1 hnRNP C1/C2 P07910 33.3 4.9 +
H2 hnRNP C1/C2 P07910 33.3 4.9 +
H3 hnRNP C1/C2 P07910 33.3 4.9 +
H4 myosin heavy chain, nonmuscle type a P35579 Fragment - +
H5 hnRNP C1/C2 P07910 33.3 4.9 +
H6 hnRNP C1/C2 P07910 33.3 4.9 +
H7 hnRNP C1/C2 P07910 33.3 4.9 +
H8 myosin heavy chain, nonmuscle type a P35579 Fragment - +
H9 myosin heavy chain, nonmuscle type a P35579 Fragment - +
H10 vimentin P08670 Fragment - +
H11 vimentin P08670 Fragment - +
H12 vimentin P08670 Fragment - +
H13 vimentin P08670 Fragment - +
H18 cofilin P23528 18.5 8.2 -
H19 cofilin P23528 18.5 8.2 invariant
Table 7   Identified protein of HBL-100 cell line after protein prefractionation which revealed intensity
differences after induction of apoptosis. Plus (+) indicates an increased spot intensity in the apoptotic
state versus the non-apoptotic state; minus (-) indicates a decreased spot intensity in the apoptotic
state versus the non-apoptotic state. The indicated accession numbers were taken from the Swiss-Prot
database. The theoretical average Mw and pI are indicated.
Figure 23  Variable protein spots after induction of apoptosis in HBL-100 cells and after prefraction-
ation by RP-HPLC. (A) Silver-stained partial 2-DE gel images of the 38% pool of non-apoptotic (DMSO
control) and apoptotic (STS) cells. Spots H4, H8, and H9 appeared after induction of apoptosis. (B) Sil-
ver-stained partial 2-DE gel images of the 34% pool of non-apoptotic (DMSO control) and apoptotic
(STS) cells. Spots H18 and H19 were both identified as cofilin. Intensity of spot H18 decreased signif-
icantly after induction of apoptosis. |  7 1
R e s u l t s4.4.1 The Mitochondrial Proteome
Due to their high amount of membrane proteins the mitochondria were treated with the
strong chaotropic reagent thiourea in the presence of the zwitterionic detergent
CHAPS (see for details 3.2.1). 60 µg protein were loaded on an analytical gel and 120-
160 µg were loaded on a preparative gel. Mitochondria of apoptotic cells were isolated
10 h and 24 h after anti-IgM-induced apoptosis. The reproducibility was ensured by the
preparation of at least three analytical 2-DE gels for each time (0 h, 10 h and 24 h).
Silver-stained, analytical gels revealed approximatly 650 protein spots while Coomas-
sie Blue stained, preparative gels revealed only 250-300 spots. The 2-DE patterns
showed an excellent protein spot resolution and a high grade of reproducibility. The
control of the fractionation efficiency of the mitochondria and the calibration of the 2-
DE gel were performed by the mass spectrometric identification of proteins of various
pI and molecular weight (Tab. 8). Out of 11 identified proteins 7 proteins derived from
mitochondrial matrix and 4 derived from the inner mitochondrial membrane.
4.4.2 Subtractive Analysis of Mitochondria after 2-DE
The comparison of  2-DE gels of the mitochondrial proteins derived from apoptotic and
non-apoptotic cells revealed that only minor but reproducible differences were detect-
able. Six significant variant protein spots could be detected which all appeared without
exception after induction of apoptosis. Due to their minute concentration only two of
them could be identified: M11 as pyruvate dehydrogenase E1 component α subunit
(PDH E1α) and M12 as inosine-5'-monophosphate dehydrogenase 2 (IMPDH II) (Tab.
8). The other four were not visible on Coomassie-stained 2-DE gels.
Variant and invariant identified protein spots are indicated in Fig. 24 which shows the
2-DE image of a mitochondrial proteome of apoptotic BL60-2 cells 24 h after anti-IgM
induction.
Spot No. Protein Name Access No. pI av. Mw
M1 prohibitin P35232 5.6 29804
M2
succinyl-CoA:3-ketoacid-coenzyme A transferase 
precursor
P55809 6.0 52089
M3 cytochrome c oxidase polypeptide VA precursor P20674 4.9 12513
M4 mitochondrial matrix protein P1 precursor P10809 5.2 57962
M5 mitochondrial trifunctonal enzyme α subunit precursor P40939 9.0 78969
M6
ubiquinol-cytochrome c reductase complex core protein I 
precursor
 P31930 5.4 49101
M7 ATP synthase gamma chain, mitochondrial precursor  P36542 9.0 30165
M11
pyruvate dehydrogenase E1 component α subunit, 
mitochondrial precursor
P08559 6.5 40228
M12 inosine-5'-monophosphate dehydrogenase 2 P12268 6.4 55769
Table 8    Variant and invariant mitochondrial proteins identified by ESI-MS/MS. Proteins M11 and M12 
appeared after anti-IgM-mediated apoptosis. |  7 2
R e s u l t sFigure 24  Silver-stained 2-DE protein pattern of mitochondrial proteins 24 h after anti-IgM induced
apoptosis. The orginal size is 23 x 30 x 0.075 cm. Proteins are visualized by silver staining. Protein
spots identified by ESI-MS/MS are marked (see Tab. 8). Spots M11 and M12 appeared after induction
of apoptosis. Red circles indicate also variable protein spots which could not be identified.  |  7 3
R e s u l t s4.4.3 Mitochondrial Proteome After in vitro Cleavage with Recombinant 
Caspase-3
The influence of activated caspases on mitochondria was investigated by in vitro cleav-
age of purified non-apoptotic mitochondria with recombinant caspase-3. The intact mi-
tochondria were incubated with active, recombinant caspase-3 for 30 min and the
mitochondrial proteins were subsequently separated by 2-DE. Fig. 25 shows the 2-DE
image of this experiment. By comparison with the 2-DE image of non-apoptotic mito-
chondria up to 20 differential protein spots could be observed. Remarkably, all the
spots appeared additionally after caspase-3 treatment suggesting that they are cleav-
age products of caspase-3. Some of the spots were already observed in Fig. 24. How-
ever, most of them were only present in amounts near the detection limit of silver
staining and hence it was not possible to identify them by analytical techniques.
4.5 Identification of Caspase Cleavage Sites in Apoptosis-
associated proteins
Members of the caspase protease family orchestrate the intercellular biochemical
events that enable cells to kill themselves by apoptosis. Caspases are among the most
specific proteases with an absolute requirement for cleavage after an aspartic acid. A
selected set of proteins is cleaved during apoptosis by caspases in a coordinated man-
ner resulting in a loss or change of function. Identification of the exact cleavage sites
within the molecule would allow speculation about the functional consequences during
apoptosis.
4.5.1 Identification of Caspase Cleavage Sites in β-Catenin
β-catenin is an important regulator of cell-cell adhesion as it links E-cadherin to the ac-
tin cytoskeleton and belongs to the family of Armadillo proteins characterized by the
presence of short stretches of 42 amino acids originally characterized in the Drosophila
Armadillo protein, termed the Armadillo (Arm) repeat motif (Peifer et al., 1994). The β-
catenin core region alone was found to be necessary and sufficient to mediate its cell
adhesion properties. In addition, two unique regions are located to the N- and C-termi-
nus of β-catenin. While the N-terminal region is involved in regulation of the protein sta-
bility (Barth et al., 1997; Munemitsu et al., 1996; Yost et al., 1996), the C-terminal
M14 l-lactate dehydrogenase M chain P00338 8.5 36557
M17 transmembrane protein Q15092 6.1 83667
M18 3-ketoacyl-CoA thiolase mitochondrial  P42765 8.5 42039
Spot No. Protein Name Access No. pI av. Mw
Table 8    Variant and invariant mitochondrial proteins identified by ESI-MS/MS. Proteins M11 and M12 
appeared after anti-IgM-mediated apoptosis. |  7 4
R e s u l t sFigure 25  Silver-stained 2-DE protein pattern of mitochondroal proteins of BL60-2 cells after treatment
with recombinant caspase-3. Red circles indicate protein spots which appeared, red crosses indicate
protein spots which disappeared after caspase-3 treatment. Most of them were not detectable by Coo-
massie Blue staining.  |  7 5
R e s u l t sregion has signalling function in the highly conserved Wnt/Wingless signal transduction
pathway (Willert and Nusse, 1998). In addition, β-catenin functions as an oncogene by
promoting the G1 to S phase transition and protecting cells from suspension-induced
apoptosis (anoikis). It could be shown that β-catenin was cleaved in a time dependent
manner after induction of apoptois either by anoikis or by staurosporine application.
Furthermore, it could be demonstrated by Western blot analysis that members of the
caspase family - mainly caspase-3 - are responsible for the cleavage. Cleavage could
be completely inhibited by the specific caspase-3 like inhibitor Z-DEVD-fmk. For iden-
tification of the cleavage sites a preparative digestion of recombinant His6-tagged β-
catenin with recombinant caspase-3 was performed. Separation of the samples by
SDS-PAGE and subsequent Coomassie staining (Fig. 26B) showed five cleavage
products (A,B,C,D and E). Fragments A-E were transferred onto PVDF membrane, vis-
ualized with Coomassie, excised and prepared for amino acid sequence analysis by
Edman degradation (15 cycles). The newly generated N-termini for fragments A, B, C,
D and E revealed the following amino acid sequences and allowed determination of
recognition motifs (which comprise four amino acids at P1-P4 located N-terminal to the
cleavage site). All amino acids are depicted in the single letter code (Tab. 9).
Sequencing of fragment A revealed the N-terminally located His-tag, indicating that
cleavage had occurred at the C-terminus. The sequence identified for fragment E sug-
gested cleavage at D32, for fragment B at D83, and for fragments C and D both at D115.
The result obtained for fragments C and D indicated that β-catenin has a second C-
terminal cleavage site. The peptides removed from the C-terminus of β-catenin
Figure 26  (A) In vivo cleavage of β-catenin: Confluent H184A1 cells were trysinized and transferred
to polyHEMA coated flasks where they were maintained in suspension for 24 h. Whole cell lysates were
separated by 7.5% SDS-PAGE, and Western blot analysis was performed with monoclonal antibodies
for β-catenin (recognizing aa 571-781). (B) Time course of in vitro cleavage of recombinant 6His-β-
catenin by recombinant caspase-3. Samples were incubated at 37 °C for the indicated time, separated
by 7.5% SDS-PAGE and stained with Coomassie Blue. Arrows with letters indicate the different lower
cleavage products of β-catenin. |  7 6
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sible after comparison of the HPLC profiles of caspase-3 treated and untreated β-cat-
enin. Differing fractions were further analyzed by ESI-MS which identified two peptides
of 1.8 kDa and 1.4 kDa. Subsequent ESI-MS/MS sequencing of the 1.8 kDa peptide
revealed the sequence GLPPGDSNQLAWFDTDL (Fig. 27). This peptide matched
amino acids 765-781 of β-catenin, indicating that cleavage had occurred at D764 at the
caspase-3 consensus sequence DLMD. For the 1.4 kDa peptide the sequence GLP-
DLGHAQDLMD was identified (Fig. 28), which matches amino acids 752-764 at the C-
terminus of β-catenin, showing that cleavage had occurred after D751 (recognition motif
YPVD). Fig. 29 summarizes all results of identified caspase cleavage sites in β-catenin
(Western blot analysis, in vitro cleavage of His6-tagged β-catenin by recombinant cas-
pase-3 was done by U. Steinhusen, Max Delbrück Center).
Fragment
Caspase Recognition 
Motif
Determined Sequence by 
Edman Degradation
Amino Acid in 
β-Catenin
A - MRGSHHHHHH part of the His6-tag
B ADID GQYAMTRAYR 84-93
C TQFD AAHPTNVQRLAEP 116-128
D TQFD AAHPTNVQRLAEP 116-128
E SYLD SGIHSGAT 33-40
Table 9  Results of N-terminal sequencing of the observed fragments A-F (Fig. 26B). Preceding these 
sequences is the caspase recognition motif as indicated in the second column.
Figure 27  Tandem mass spectrum of doubly charged precursor ion [M+2H]2+= 923.1 u. Spectrum in-
terpretation resulted in the sequence 765GLPPGDSNQLAWFDTDL781.  |  7 7
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Cadherins comprise a large family of Ca2+-dependent, homophilic cell-cell adhesion
molecules. They are required for the maintenance of solid tissues and play an essential
role in cell-recognition and cell-sorting during early and late embryogenesis and orga-
nogenesis (Takeichi, 1991). Cell-cell adhesion is conferred by an interaction between
the extracellular domains of cadherin molecules from adjacent cells, the cytoplasmic
domain is associated via catenins with the actin microfilament system (Yap et al.,
1997). To investigate the fate of E-cadherin during apoptosis, lysates of epithelial cells
were examined by Western blot analysis upon induction of apoptosis by staurosporine
treatment for 24 h. E-cadherin was cleaved into two distinct fragments with apparent
molecular mass about 24 kDa (fragment A) and 29 kDa (fragment B). The formation of
Figure 28  Tandem mass spectrum of doubly charged precursor ion [M+2H]2+= 691.3 u. Spectrum in-
terpretation resulted in the sequence 752GLPDLGHAQDLMD764.
Figure 29  Schematic diagram of β-catenin and apoptotic cleavage products as determined by mass
spectrometry and Edman degradation. Caspase-3 cleavage sites (arrows) and recognition sequences
(italics) are indicated. The lines represent the cleavage products A-E. Dashed lines indicate that the C-
termini are not exactly identified. |  7 8
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the formation of fragment B was not effected. To identify the cleavage site, recombinant
mouse E-cadherin cytoplasmic tail expressed as a GST fusion protein was digested in
vitro by caspase-3 resulting in the formation of a 30 kDa and 24 kDa cleavage product.
The sample was separated by SDS-PAGE and subsequently transferred onto PVDF
membrane, visualized with Coomassie, excised and prepared for amino acid sequence
analysis. Edman degradation revealed that the 30 kDa fragment represent the N-ter-
minus of the GST moiety. The N-terminal amino acid sequence of the 24 kDa fragment
was determined as 753NVYYYDEEGGG763 and defined precisely the caspase-3 cleav-
age site C-terminal to DTRD752 (Western blot analysis and in vitro cleavage of recom-
binant E-Cadherin by recombinant caspase-3 was done by U. Steinhusen, Max
Delbrück Center).
4.5.3 Identification of Caspase Cleavage Sites in hHR23B
Human UV excision repair protein RAD23 homolog B (hHR23B) was identified as an
apoptosis-associated protein by proteome-analytical methods (Brockstedt et al.,
1998). XPC/HR23B was originally isolated as a component of a protein complex that
specifically complements nucleotide excision repair (NER) defects of xeroderma pig-
mentosum group C (XPC) cell extracts in vitro and was identified as one of two human
homologs of the Saccharomyces cerevisiae NER gene product Rad23 (Masutani et al.,
1997). It has been shown that the hHR23B protein is characterized by a ubiquitin-like
sequence at the amino terminus, which is important for the biological function of yeast
RAD23 (Sugasawa et al., 1997). The ubiquitin-like domain of hHR23B is necessary
and sufficient to interact with the S5a subunit of the 26 S proteasome in HeLa cell ex-
tracts (Hiyama et al., 1999). Since the majority of hHR23 proteins are free from XPC in
human cells and are not involved in nucleotide excision repair function one might spec-
ulate that the hHR23 protein has an additional function than complexing with the XPC
protein.The human HR23B protein was cleaved in vivo after anti-IgM induced B cell ap-
optosis and UV-induced apoptosis by caspases. To investigate which caspase is re-
sponsible for the cleavage of the HR23B protein in vitro, recombinant hHR23B was
incubated with recombinant caspase-1,-3, -6, -7, and -8 and analyzed by Western blot
analysis with the polyclonal antiserum or an anti-His antibody. The 58 kDa full length
rhHR23B protein was cleaved into a 32 and 29 kDa fragment by caspase-3, whereas
caspase-6 and -7 mainly generated the 29 kDa fragment. In contrast, caspase-8 gen-
erates a 29 kDa and a 19 kDa protein fragment. For identification of the caspase-3
cleavage sites recombinant hHR23B-His protein was incubated with recombinant cas-
pases-3. Cleavage products were seperated on 15% SDS-PAGE and were either
transferred to PVDF membrane and subsequently analyzed by Edman degradation or
cleaved  by in-gel digestion with trypsin for internal sequencing. Tryptic peptides were |  7 9
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product revealed the sequence 166STSGDSSRSN175 and defined precisely the cas-
pase-3 cleavage site C-terminal to TATD165. N-terminal sequencing of the second
cleavage product of about 29 kDa resembles the HR23B protein original N-terminal re-
gion.  Internal sequencing by ESI-MS/MS of the 29 kDa fragment revealed the se-
quence 145QEKPAEKPAETPVATSPTATD165  including the caspase-3 recognition site
TATD suggesting that the 29 kDa fragment ranges from aa 1-165. (Western blot anal-
ysis and in vitro cleavage of recombinant hHR23B by recombinant caspase-3 was
done by A. Rickers, Max Delbrück Center)
4.6 Generation of a Internet-based 2-DE Database of Human Epithe-
lial Proteins
Proteomics generates an enormous amount of data which have to be structured and
catalogued. The data include all information about the identified proteins, their location
on the 2-DE gel and the methods used for identification. To store and to share these
informations, a 2-DE database of the proteome of the human breast epithelial cell line
H184A1 was constructed following the concept of federated databases (Appel et al.,
1996). Providing access from all over the world, the database is located on an internet
server at the Max Delbrück Center. My database comprises information on 109 identi-
fied proteins, apoptosis-associated and non-apoptosis-associated ones. I identified
102 proteins by ESI-MS/MS and 7 proteins by PMF using MALDI-MS.
4.6.1 Construction of a WWW Database
The silver-stained, dried gels were scanned, processed with Photoshop and saved in
tag image file format (TIFF). This file was imported to the graphic software Canvas
where the identified proteins were labeled and marked. The protein pattern was cali-
brated by the theoretical isoelectric point (pI) and molecular weight (Mw) of five identi-
fied proteins using Phoretix software (Tab. 1, p. 53). The 2-DE image was saved as
graphic interchange format (GIF) and transferred to the web design software GoLive.
GoLive was used to create spot clickable gel images and to introduce hyperlinks. The
whole database was transferred as HTML documents to a Cobalt Qube internet server
operated by Linux OS and is accessible via the internet. (URL: http://141.80.156.97/
groups/fg-doerken/2DE_EPI/2-DE/index.html)
4.6.2 Display of Information
The home page of the epithelial 2-DE database is subdivided in frames and windows
(Fig. 30). The left frame acts as a manual for browsing the database while the main
frame displays the results of the browsing operations. According to the rules for con- |  8 0
R e s u l t sstructing a federated 2-DE database, my database is linked to other federated 2-DE
databases including Swiss-2DPage and the heart 2-DE database located on the server
of the Max Delbrück Center. The center of the database is a 2-DE image with all iden-
tified proteins marked  with different symbols and colours dependent on their behavior
after induction of apoptosis: yellow crosses identify additional protein spots, yellow cir-
cles disappearing protein spots, and red crosses mean invariant protein spots (Fig.
31A). These highlighted protein spots are hyperlinked to pages providing further infor-
mation about the protein including the theoretical and calculated molecular mass and
isoelectric point, the protein identification method, and direct access to the Swiss-Prot
database entry (Fig. 31C). In addition, quick access to the protein name is displayed
by moving the mouse over the identified protein spot. All identified proteins are listed
in alphabetical order with hyperlinks to the appropriate Swiss-Prot entry. The 2-DE ep-
ithelial cell line database also provides a detailed description of the two-dimensional
gel electrophoresis technique using carrier ampholytes and used protein identification
methods.
A complete list of all identified proteins together with their Swiss-Prot accession
number, molecular weight and isoelectric point is to be found in the appendix.
Figure 30  Home page of the 2-DE database of human epithelial cells. The left frame (blue
background) is for interactive use and navigates through the database. The main frame dis-
plays the results of the navigator (white background). |  8 1
R e s u l t sFigure 31  2-DE image of apoptotic epithelial cells is displayed in the main frame of the database (A).
Identified proteins are marked as yellow or red dots or crosses depending on their behavior during ap-
optosis. The 2-DE gel image is subdevided in clickable segments. Clicking on a segment enlarges it
and gives a detailed view (B). The protein name is displayed by moving the mouse over the identified
protein spot. Clicking on the spot of interest opens a spot window displaying protein data (C). |  8 2
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Recent evidences have demonstrated a lack of correlation between transcriptional
profiles and actual protein levels in cells. Proteome analysis has therefore become
indispensable and complementary to genomic analysis for an accurate picture of
cellular processes. The combination of 2-DE with mass spectrometry has quickly
become the operating paradigm for proteome analysis. Between both there are several
intermediary steps including gel staining, image analysis, protein spot excision,
digestion and sample preparation for MS. The focus of this study was (i) to optimize the
proteomic techniques for the identification of novel apoptosis-associated proteins in
epithelial cells, (ii) to optimize the proteomic techniques for the identification of novel
apoptosis-associated proteins in mitochondria of B cells, and (iii) the investigation of
known apoptosis-associated proteins by protein-analytical methodologies.
5.1 2-D Electrophoresis
5.1.1 Sample Preparation
DNA and mRNA are physico-chemical homogeneous and "easy to handle" and can be
amplified by polymerase chain reaction methods, hence are amenable to automation.
In contrast to nucleic acid, proteins are vastly more diverse and an universal handling
method is unlikely to be found. Currently the only systematic methods for analyzing the
state of expression of the majority of proteins in a cell are those based on 2-DE. 2-DE
affords high demands on the reproducibility of sample preparation. For substractive
analysis, the samples should be different only in the parameter of investigation. The
cells must be efficiently disrupted and the contents of the cells solubilized completely
in order to obtain a representative protein population sample. The total salt concentra-
tion should not increase 50 mM because high salt concentration interferes with isoe-
lectric focusing. Handling of the material in a thawed condition is accompanied by the
risk of modification of the proteins and enzymatic digestion. Therefore, a protease in-
hibitor cocktail, urea and thiourea were rapidly added to the frozen cell pellets. The sul-
fobetaine surfactant CHAPS supports the solubilization of highly hydrophobic proteins.
As reducing agent dithiothreitol (DTT) was replaced by tributyl phosphine (TBP) be-
cause free-thiol-containing reducing agents as DTT are charged, especially at alkaline
pH, and thus migrate out of the pH gradient during the IEF. This can result in a loss of
solubility for some proteins, especially those which are prone to interaction by disulfide
bonding, such as keratins. Thiourea, CHAPS and TBP can be seen as complementary
reagents because they increase protein solubility through different routes. This combi- |  8 3
D i s c u s s i o nnation of solubilization reagents was successfully applied to mitochondria of B cells
and also used for the analysis for epithelial cells. 
5.1.2 2-D Electrophoresis
The 2-DE technique used in this study was a combination of isoelectric focusing (IEF)
using carrier ampholytes in the first dimension and conventional SDS-PAGE in the sec-
ond dimension. Although immobilized pH gradients for IEF (Gorg et al., 1988) have
some advantages in reproducibility and labor intensity, the maximum of resolution of
over 10 000 protein spots was obtained with carrier ampholytes and a gel size of 30 x
40 cm while 40 cm rod gels were used in the first dimension (Klose and Kobalz, 1995).
One great drawback in IEF is still the incomplete resolution of extreme basic proteins.
This is caused by a lack of commercial basic ampholytes and by the phenomenon of
electroendosmosis when using carrier ampholytes. Electroendosmosis is a cathodic
drift effect that has its origin in the instability of the pH-gradient built up by carrier am-
pholytes. After a certain time, depending on cleanliness of the equipment and purity of
used chemicals, the gradient is mainly drifting to the cathode and the basic proteins are
leaving the gel matrix. To avoid cathodic drift and the loss of basic proteins, the IEF is
finished before reaching equilibrium, a method called nonequilibrium pH gradient elec-
trophoresis (NEPHGE). Finishing IEF before equilibrium means, however, that proteins
have not reached their isoelectric point resulting in streaky spots and inadequate res-
olution. This technique is therefore a compromise between the obtainment of basic pro-
teins and optimal protein spot resolution. Immobilized pH gradients do not drift since
the ampholytes are covalently bonded (immobilized) to the acrylamide matrix. Howev-
er, it was shown that severe quantitative losses were experienced when membrane
proteins were separated by immobilized pH gradients. These losses were attributed to
adsorption of proteins to the immobilized pH gradient matrix at (or close to) the isoe-
lectric point (Adessi et al., 1997).
5.1.3 Spot Detection
The sensitivity of protein spot detection depends on the staining methods. In principle,
the sensitivity in gels increases from Coomassie Brilliant Blue (CBB) R 250 (Eckersko-
rn et al., 1988), negative zink/imidazole stain (Fernandez-Patron et al., 1998),
Coomassie Brilliant Blue G 250 (Neuhoff et al., 1988), fluorescence dyes, silver stain
(Heukeshoven and Dernick, 1985) to radiochemical detection by autoradiography or
fluorography. Despite the development of sensitive fluorescence dyes, Coomassie Bril-
liant Blue R 250 and silver stain are still routinely used in proteome research. The de-
tection limit for CBB R 250 is in the range of about 100 ng (correspond to 5 pmol of a
20 kDa protein), that of silver staining at about 1-10 ng (50-500 fmol) (Jungblut and |  8 4
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tification since almost every spot visible to the human eye is accessible to the mass
spectrometric identification. Fluorescence dyes of the SYPRO® family (Steinberg et al.,
2000; Steinberg et al., 1996) have a comparable detection limit to silver stain, however,
a broader linear range of detection (2-2000 ng) (Lopez, 2000) and are compatible with
subsequent mass spectrometric identification since the dyes interact only with the SDS
coat around the proteins. These fluorescence dyes are relatively expensive, fluores-
cence detectors are necessary for visualization and the stained image does decrease
after several days due to the light sensitivity of the dyes. Detection methods based on
labeling with radioisotopes are extremely sensitive (subattomole) but have the disad-
vantage that their incorporation is dependent upon metabolic activity, resulting in de-
tection of only recently synthesized proteins.
Using highly sensitive silver staining 4000 protein spots could be visualized on 23 x 30
x 0.075 cm gels of H184A1 cells or HBL-100 cells while 600 protein spots could be vis-
ualized on gel of mitochondria from B cells. Due to the incompatibility of silver stain with
in-gel protein digestion and peptide recovery for mass spectrometry, gels were stained
for protein identification with CBB R 250, colloidal CBB G 250 or with alternative silver
staining without glutaraldehyde. For identification, the protein loading capacity was in-
creased by using 1.5 cm rod gels in the first dimension. The sensitivity of colloidal CBB
G 250 and alternative silver staining is slightly higher than the one of CBB R 250 while
the sensitivity of colloidal CBB G 250 and alternative silver stain is comparable. Since
colloidal CBB G 250 is more cost-intensive than alternative silver staining, for identifi-
cation of proteins CBB R 250 and alternative silver stained gels were used in most of
the cases. It could be shown that CBB R 250-stained spots give a higher sequence
coverage during peptide mass fingerprinting than alternative silver-stained spots
(Scheler et al., 1998). However, both these dyes can only visualize a small part of the
spots which are detectable with high sensitive silver staining. In contrast, fluorescence
dyes are almost as sensitive as silver staining and are compatible with mass spectrom-
etry. Due to their extreme sensitivity fluorescence dyes detect a number of protein
spots of minute protein amounts, which are out of the scope of mass spectrometry. In
general, protein amounts less than 100 pmol are difficult to handle. Any preparation
step carries the risk of sample loss caused by unspecific adsorption onto surfaces or
by insolubility after a drying step. All spots I observed on a silver-stained gel, which
were differentially expressed after induction of apoptosis were also detectable on a
CBB R 250-stained gel and thus amenable to mass spectrometric identification. |  8 5
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Since 2-DE is a method consisting of several steps, various problems happened that
were visible after staining of the gel. The problem encountered most often in 2-DE is
horizontal streaking, which occurs always in the first dimension. Possible causes for
this might be that the sample was not completely solubilized prior to application, the
presence of interfering substances such as salts or ionic detergents, the protein
amounts loaded onto the gel were too high or that the focusing time was not long
enough. Vertical steaking occurs in the second dimension. Here, in most of the cases
the buffer solutions were prepared incorrectly or with insufficient SDS. A broad vertical
gap in the middle of the gel might be caused by proteases activity (J. Klose, conference
contribution). Narrow vertical gaps are mostly caused by air bubbles between the rod
gel of the fist dimension and the surface of the SDS-PAGE gel. Point streaking after
silver staining is caused by dirty glass plates used to cast gels or particulate material
on the surface of the gel. DTT and other thiol reducing agents exaberate this effect.
5.1.5 2-DE Image Evaluation
Potential apoptosis-associated proteins were detected by subtractive analysis of 2-DE
images of apoptotic and non-apoptotic cells. A qualitative analysis was performed by
visual evaluation of two silver-stained gels on a transiluminator concentrating on clear
intensity differences, especially the appearance and disappearance of spots. To obtain
data for a quantitative comparison including small up- and down-regulation of spots, a
computerized image analysis with automated spot detection, background subtraction
and spot matching is necessary. The foremost prerequisite for quantitative image anal-
ysis is the production of a series of good-quality 2-DE gels with a high grade of repo-
ducibility to make a statistical statement about a certain spot intensity variation.
Although a variety of different commercial computer programs is available (Melanie III,
PDQuest, Phoretix, Z3), which all carry out the spot detection automatically, approxi-
mately 10-15% of the spots remain and must be manually corrected and further mis-
matches have to be removed. For an adequate spot detection at least 1 h of manual
correction for each gel is necessary. In this study, computer-based evaluation software
was only used for gel calibration and spot number estimation. The visual comparison
was sufficient since the differences between apoptotic and non-apoptotic states were
limited: only 23 clear +/- variants could be detected in the H184A1 cell line. Analysis of
complex 2-DE patterns with up- and down-regulation and the appearance and disap-
pearance of many hundreds of spots per 2-DE image by visual evaluation is impossi-
ble. In this case computerized evaluation is necessary for subtractive analysis. |  8 6
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Apoptosis is a highly regulated process including the recruitment and the processing
of a large number of proteins. Nevertheless, only 23 variant protein spots could be de-
tected in H184A1 epithelial cells after induction of apoptosis demonstrating the funda-
mental limitation of 2-DE: only the abundant proteins in any mixture were being
visualized. A further problem in this study was the low protein concentration in the cell
lysates of epithelial cells which could not be increased over 2-8 µg/µL. For a well
stained and optimal resolved protein pattern, the final protein concentration for appli-
cation to 2-DE should be in the range of 10-30 µg/µL (Jungblut and Thiede, 1997). In
order to increase the protein concentration and to access the less-abundance proteins,
many of which are probably implicated in apoptosis, methods for enrichment and pre-
fractionation of the complete cell lysates were investigated. It became evident that a
simple enrichment of protein samples has its limit in the loading capacity of 2-DE gel
since an overloaded first dimension leads to streaky protein spots and poor resolution.
Therefore, a further enrichment had to be combined with a prefractionation of the pro-
tein sample prior to 2-DE. Reversed phase liquid chromatography proved to be an in-
teresting approach to prefractionate complex protein mixtures. Crude cell lysates
containing urea, thiourea, DTT, ampholytes and other reagents were loaded directly
onto the column. A five-step gradient with increasing concentration of acetonitrile was
used to elute the proteins. The results showed that by this means a third dimension for
2-DE was introduced based on the hydrophobic character of the proteins. I was able to
demonstrate that this method is relatively simple to use, reproducible, and appropriate
to study differential protein expression by substractive analysis. Several apoptosis-as-
sociated proteins could be detected and identified, which were not at all or hardly visi-
ble on the 2-DE gel of the non-enriched sample. The 2-DE protein patterns derived
from the HPLC pools are clearly arranged and ease the software-based evaluation.
This study demonstrates a practical way to prefractionate samples for 2-DE without fur-
ther laboratory equipment besides a HPLC apparatus. However, the high reproducibil-
ity allows the pooling of several consecutive HPLC runs with the aim to enrich less-
abundant proteins. Proteins of faint silver-stained spots could be enriched, yielding
Coomassie Blue-stained spots which could be identified by protein-chemical methods.
5.2 Identification of Gel-separated Proteins
Protein identification in proteome analysis so far starts from the gel-separated protein
spot which can be investigated by a variety of protein-chemical methods (Fig. 32). The
initial aim is to generate the necessary structural information and to identify the proteins
using such information. From the historical point of view, protein electroblotting onto
chemically inert membranes (Aebersold et al., 1986; Vandekerckhove et al., 1985) was |  8 7
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provided a direct link between gel electrophoresis and membrane-based Edman
chemistry (Hewick et al., 1981). With direct on-blot sequencing, the number of
identified residues rarely encompasses thirty cycles (60-70 residues can be obtained
if 5-10 pmol are available). In addition, and particularly when only small amounts of
protein are sequenced, gaps are often encountered in positions where low yield
phenylthiohydantonin amino acids (Ser, Thr, Arg, His) or modified residues are
generated. Furthermore, proteins are often N-terminal blocked in the course of the
biosynthesis or by artificial groups such as free acrylamide present in incompletely
polymerized gels (Moos et al., 1988). Due to these limitations and also because N-
terminal sequencing is generally slow, other, more sensitive methods are used for
protein identification in proteome research. Edman degradation is still used for de novo
sequencing and for problems in which the N-terminal region is of special interest.
However, de novo sequencing became a less frequent issue since the number and
volumes of protein, DNA and EST databases grew in the last years. 
Since the introduction of MS in protein chemistry, peptide mass fingerprint (PMF) anal-
ysis has become the method of choice in high-throughput protein identification. In this
approach, the protein spot of interest is either enzymatically or chemically cleaved and
an aliquot of the obtained peptide mixture is analyzed by MS. A reduction/alkylation
step prior to in-gel digestion was omitted in this study because this step induces sample
Figure 32  Analysis of gel-separated proteins. After separation by 2-DE a protein can either be trans-
ferred onto an inert membrane by electroblotting and analyzed as intact molecule or enzymatically
cleaved inside the gel matrix and identified by using the cleavage products. |  8 8
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tides in the analyte that can lead to misleading or ambiguous results from the PMF da-
tabase search. This uncertainty, however, is overcome by MS/MS analysis of the
peptides. Routinely trypsin is used for protein identification as it cleaves with high
specifity after the basic amino acids arginine and lysine and produces peptides with an
average length of 9 aa, which is ideal for MS and MS/MS analysis. In addition, the basic
amino acids at the C-terminus of the tryptic peptides generate an almost complete y-
series during MS/MS making a manual interpretation or de novo sequencing easier.
Trypsin have a Michaelis-Menten constant KM in the 5-50 µM range depending on the
substrate, which means that trypsin is operating at 50% velocity with a protein concen-
tration of 5 pmol/µL (equivalent to a strong Coomassie-stained spot). With a decreas-
ing protein concentration, the proteolytic activity towards the substrate is becoming
minimal, while autolysis rate is becoming relatively high. There is a correlation between
the decrease in number of peptides produced and protein concentration (Courchesne
et al., 1997; Staudenmann et al., 1998). The critical concentration appears to be
around 100 femtomoles/20 µL; below this, virtually no peptides are recovered
(Courchesne et al., 1997; Staudenmann et al., 1998). Decreasing the gel thickness in
the second dimension as far as possible is a possibility to circumvent the problem in
order to increase protein concentration and increase the sequence coverage. Although
trypsin is very a specific protease with a restriction to the amino acids arginine and
lysine a variety of unspecific and missed (incomplete) cleavages occurred which have
to be considered during the database search. I observed that almost exclusively
missed cleavages occurred after an lysine residue (not considering Lys-Pro which is
not cleaved).
Both, ESI-MS and MALDI-MS are suitable to measure a peptide mass fingerprint of a
given mixture of tryptic peptides. MALDI-MS, however, is the simplest, fastest, and
most sensitive MS approach. Furthermore, MALDI-MS is suitable for automated sam-
ple handling and tolerates moderate buffer and salt concentrations in the analyte mix-
ture and almost exclusively produces singly charged ions. For these reasons it has
become the preferred ionization technique for PMF analysis. The implementation of
delayed extraction and reflectron time-of-flight in MALDI-MS allows much more accu-
rate peptide mass determination. A peptide mass accuracy as high as a few ppm great-
ly increases the success of peptide mass fingerprinting and even allows the
identification of multiple proteins in a single digestion mixture (Clauser et al., 1999). A
mass accuracy of +/- 0.5-5 ppm allows to distinguish peptide elemental composition
and it is possible to match homologous proteins having >70% sequence identity to the
protein being analyzed (Clauser et al., 1999). Green et al. could demonstrate that high-
ly accurate (2 ppm) mass measurements for peptides are not critical for database
searches using peptide masses from a tryptic digest, in which all of the observed spe- |  8 9
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population of extraneous peaks in the digest mass spectrum increases, the probability
of false matches being returned from a database increases. Under these conditions,
high mass accuracy can provide the necessary discrimination to unambiguously iden-
tify a protein, even in the presence of considerable chemical noise (Green et al., 1999).
Peptide mapping methodologies are strongly depending upon the availability of the
protein sequence in the database. They imply that the detected peptides originate from
a single, nonmodified polypeptide and they are not compatible with the identification of
proteins by correlation with EST databases. In cases of ambiguous PMF-based data-
base search results, or when working with proteins originating from species of which
only limited amounts of genetic sequence data are available, additional (sequence) in-
formations are necessary for an unambiguous protein identification. Sequence infor-
mation can be obtained either by MALDI post-source decay (MALDI-PSD) or by
electrospray tandem mass spectrometry analysis (ESI-MS/MS). ESI-MS/MS analysis
of tryptic peptides generates almost exclusively intense fragments derived from the y-
series with good mass accuracy and the MS/MS spectra are relatively easy to interpret.
The extend of fragmentation can be controlled by variation of the collision energy or
collision gas thickness. The measurement of a single MS/MS spectra takes 20 sec - 4
min depending on the intensity of the precursor ion. In contrast, generation of a MALDI-
PSD spectrum takes up to 10 min since the reflectron fields, which are necessary for
the separation of fragment ions, have a limited dynamic separation range for a given
voltage setting. They need to be gradually stepped to lower voltages in order to sepa-
rate and focus the whole fragment mass range of interest, typically 10-15 segments are
obtained. Finally, all segments of PSD spectrum are compiled and mass calibrated by
the computer. Selecting the precursor ion in MALDI-PSD is performed by an ion gate
which have currently a resolution of m/∆m = 100-200 (FWHM). This means that adja-
cent peaks in a distance of ca. +/- 10 u cannot be selected from the precursor ion. Fur-
thermore, PSD spectra reveal a high complexity, primarily caused by various intense
internal fragmentations, a lack of complete backbone fragmentation and a low mass
accuracy of high mass fragments. Due to these limitations, MALDI-PSD is rarely used
for protein identification. 
Although peptide mass fingerprinting by MALDI-MS is the method of choice for high-
throughput protein identification with the capability for automation, ambiguous data-
base search results or rather false positive search results cannot be excluded. Nano-
spray ESI-MS/MS in contrast has the drawback that the sample is introduced via a fine,
fragile glass needle which is not well suited for automation. Online coupling of liquid
chromatography (LC) with ESI-MS/MS can overcome these disadvantages (Davis and
Lee, 1998; Hunt et al., 1992; Qin et al., 1998). Recently, automated protein identifica-
tion by LC-MS/MS and database searching has been demonstrated (Ducret et al., |  9 0
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may be sufficient to unambiguously identify a protein (Yates III, 1998). A high mass ac-
curacy is not crucial, 0.8 Da for mass differences between singly charged product ions
are tolerated for a protein identification (Green et al., 1999). Therefore, 95% of the pro-
teins in this study were identified by ESI-MS/MS, which guarantees a high grade of re-
liability of the obtained results in this study.
Performing identifications of gel-separated proteins either by PMF or by MS/MS exper-
iments means that gel electrophoresis-induced protein modifications have to be con-
sidered. Polymerization of gels is rarely greater than 90% leaving potentially 30 mM of
free acrylamide in the matrix (Chiari and Righetti, 1992). The amino acid residue most
at risk of acrylamide adduction is cysteine, resulting in cysteinyl-S-β-propioamide lead-
ing to a mass increase of 71 Da. This mass increment can fake an alanine residue in
MS/MS experiments which has the same mass. Cysteinyl-S-β-propioamide can further
be oxidized leading to a mass increase of altogether 87 Da, the mass of a serine resi-
due. Oxidation processes may be caused by the presence of residual persulfate in the
gel (Faleiro et al., 1997). Methionine is a further frequent target for oxidation resulting
in methionine sulfoxide which has the same mass as a phenylalanine residue (147 Da).
However, MS/MS spectra of methionine sulfoxide containing peptides reveal a charac-
teristic pattern of peaks with a 64 Da distance probably caused by the loss of sulfur
monoxide (48 Da) and methane (16 Da). While generation of methionine sulfoxide oc-
curs in roughly 50% of the cases, almost all cysteines investigated in this study con-
tained in tryptic peptides revealed the presence of Cys-acrylamide suggesting that
acrylamide adduction is quite frequent.
MS/MS experiments were preferentially performed with doubly charged precursor ions
since it was observed that the total fragmentation yields from doubly charged ions are
appreciably greater than those from their singly charged counterparts. The MS/MS
spectra of [M+2H]2+ ions appear to be "cleaner" with more intense peaks, which provide
more sequence information than do those of the corresponding [M+H]+ ions. In all the
fragment spectra of the [M+2H]2+ precursors the singly charged y fragment series are
complete or almost so, and they dominate the upper half of each spectrum. A possible
explanation for this phenomenon is that in a [M+2H]2+ ion one of the two protons is fixed
at the N-terminal lysine or arginine residue of a tryptic peptide (Gonzalez et al., 1996;
Tang and Boyd, 1992). The other proton moves freely along the backbone of the pep-
tide. Experimental and theoretical studies revealed that protonation of backbone amide
nitrogen atoms enhances peptide fragmentation because the protonation on the amide
nitrogen significantly weakens the amide bond (McCormack et al., 1993; Somogyi et
al., 1994). In cause of the fixed charge at the N-terminus, y fragment ions are prefer-
entially produced. A [M+H]+ precursor ion misses a second proton which could proba-
bly bind to the amide nitrogen, thus backbone cleavages of singly charged ions |  9 1
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intensity.
5.3 Apoptosis-associated Proteins
In this study proteome-analytical methodologies were applied and optimized enabling
the identification of apoptosis-associated proteins in epithelial cells and mitochondria
of B cells. Tab. 10 comprises all proteins found as clear +/- variants by subtractive anal-
ysis of gels derived from apoptotic and non-apoptotic cells. Keratin 18 (Caulín et al.,
1997), hnRNP C1/C2 (Waterhouse et al., 1996), lamin A and C (Brockstedt et al., 1998;
Rao et al., 1996), vimentin (Prasad et al., 1998) and DUT-N (Brockstedt et al., 1998)
were described as apoptosis-associated in previous studies. For keratin 15 and keratin
17 I could show that these experience the same fate as keratin 18 during apoptosis.
The involvement of HSP 27, myosin heavy chain, cofilin and the proteins identified from
mitochondria pyruvate dehydrogenase E1 component and inosine-5´-monophoshate
dehydrogenase 2, was unknown or only assumed. Remarkable is that only hnRNP C1/
C2 could be identified in both epithelial cell lines, all other proteins were identified only
in one cell lines, although most of the proteins belong to the cytoskeleton and thus
should be present in almost every cell. 
Protein
Number of 
identified proteins
Cell Line
Spot 
Intensity
keratin 18 1 H184A1 -
keratin 15 1 H184A1 -
keratin 17 1 H184A1 -
keratin 18 fragment 1 H184A1 +
keratin 15 fragment 3 H184A1 +
keratin 17 fragment 3 H184A1 +
heteronuclear ribonucleoproteins C1 and C2 
(hnRNP C1/C2)
6 H184A1 + HBL-100 +
lamin A 1 H184A1 -
lamin C 2 H184A1 -
lamin A fragment 1 H184A1 +
heat shock 27 kDa protein (HSP 27) 1 H184A1 -
desoxyuridine 5´-triphosphate 
nucleotidehydrolase (DUT-N)
1 H184A1 -
myosin heavy chain 3 HBL-100 +
vimentin fragment 4 HBL-100 +
cofilin 1 HBL-100 -
pyruvate dehydrogenase E1 component 1 BL60 Mito +
inosine-5´-monophoshate dehydrogenase 2 1 BL60 Mito +
Table 10  Overview of all apoptosis-associated proteins identified in this study. The cell line in which
the proteins were found is indicated. Number of identified proteins means how many spots of this spe-
cial protein were observed on the 2-DE gel. Plus (+) indicates an increased spot intensity in the apo-
ptotic state versus the non-apoptotic state; minus (-) indicates a decreased spot intensity in the
apoptotic state versus the non-apoptotic state. |  9 2
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hashi, 1999). Some of the substrates provide insight into how effector caspases cause
dramatic cellular changes. For example, caspases cleave structural proteins, causing
disassembly of cell organization. Some regulators of cytoskeleton are also targets of
caspases and caspases inactivate proteins that protect living cells from degradation. 
Keratin 15 and keratin 17 are intermediate filament (IF) type I proteins that are respon-
sible for the mechanical integrity of epithelial cells. I observed the disappearance of full-
length keratins 15 and 17 in apoptotic gels and in parallel the appearance of six new
fragments of these proteins suggesting a cleavage of K15 and K17 during apoptosis.
Treatment of the cells with the specific inhibitor for caspase-3 like proteases Z-DEVD-
fmk prior to the induction of apoptosis completely blocked the fragmentation of K15 and
K17. This result suggested that caspases are responsible for the degradation of K15
and K17. In addition to STS treatment the different apoptotic stimulus anoikis resulted
in the same fragmentation pattern after 2-DE. Caspase recognition sites could be de-
termined by MS/MS experiments. K17 was cleaved at position D241 at the consensus
sequence VEMD/A and at position D416 (EVQD/G) while K15 was cleaved at position
D264 (VEMD/A). In vitro cleavage of K15 by caspases revealed that caspase-3 and -7
remove a small fragment presumedly by a cleavage at position D445 with the sequence
ESVD/G, which could not be confirmed by MS/MS analysis. The VEMD/A sequence
motif is recognized by caspase-6 while caspase-3 and -7 show only minor activity, if at
all. This VEMD caspase-6 recognition sequence in the linker L1-2 region is also found
in keratin 13, 14, and 16, however, their cleavage during apoptosis could not be exper-
imentally determined until now (Prasad et al., 1999). The caspase cleavage motifs
VEMD (K13, K14, K15, K16, K17), VEVD (K18, K19, lamin B1, and lamin B2) and VEID
(lamin A and C) are well conserved in the L1-2 subdomain of type I and type V inter-
mediate filaments implying that this is an important structural feature. Type II keratins
(K1 – K8) do not contain a similar sequence motif, and they do not seem to be cleaved
during apoptosis. A common feature of these recognition sites is the amino acid homol-
ogy in P1, P3, and P4 position. The variability in the P2 position of valine for methionine
and isoleucine, respectively, is negligibly small. Although the biological relevance of
human keratin fragmentation during apoptosis remains to be determined, the proteol-
ysis of the highly insoluble keratins may facilitate the disposal of the cytoskeleton
framework of epithelial cells. Caspase-mediated cleavage at linker L1-2 region seems
to represent an effective mechanism to disrupt the network of several IF proteins,
namely, lamins A, B, and C, keratin 15, 17, 18, and 19, and vimentin. This part of the
cell death process may support condensation and packing of the cell contents into ap-
optotic bodies and thereby facilitates the phagocytosis of the apoptotic cells by other
cells. Beside the mechanical function of keratins it has been recently shown that normal |  9 3
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TNF-induced cell death (Caulin et al., 2000). 
In the 2-DE gels of non-apoptotic H184A1 cells I could detect two spots which derived
from heat shock protein 27 kDa (HSP27) (Fig. 11, Sec IV) which differed only in their
isoelectric point presuming a phosphorylation. Phosphorylations of proteins change
their isoelectric point in that way that they become more acid. After induction of apop-
tosis the spot of the probably phosphorylated HSP27 became significantly weaker sug-
gesting a dephosphorylation. In general, small heat shock proteins (sHSP) are
molecular chaperones involved in cellular defense mechanisms against several differ-
ent types of stress. It could be demonstrated that sHSP protect against apoptosis in-
duced by different conditions or agents, particular anti-cancer-drugs. For example,
overexpression of HSP27 prevents pro-caspase-9 activation (Garrido et al., 1999) and
cell death in murine fibrosarcome L929 cells after staurosporine application (Mehlen et
al., 1996). Tumor cells usually express high levels of sHSP and anti-cancer-drugs trig-
ger the accumulation of sHSP. Hence, sHSP represent prime targets for therapeutic
intervention (Arrigo, 2000). Under physiological conditions, cellular HSP27 exists as a
single unphosphorylated and one or two more acidic, phosphorylated isoforms (Cairns
et al., 1994) as observed in the non-apoptotic 2-DE gels. After treatment of cells with
arsenite, TNF (Arrigo, 1990) or heat shock, several more phosphorylated and acidic
species of HSP27 are induced (Cairns et al., 1994). The physiological role of HSP27
phosphorylation is not clear, although increasing HSP27 expression in mammalian
cells appears to confer a drug-resisted phenotype (Huot et al., 1991). It can be as-
sumed that phosphorylated HSP27 is the active species in inhibition of apoptosis after
certain stimuli. A successful induction of apoptosis after staurosporine application
should therefore be accompanied by the dephosphorylation of HSP27.
A similar dephosphorylation could be observed for cofilin (Fig. 23 B) after induction of
apoptosis in HBL-100 cells. Cofilin is a widely distributed 21 kDa cytoplasmic actin-
binding phosphoprotein that undergoes dephosphorylation and accumulation within
the nuclei in response to co-stimulation through accessory receptors (Lee et al., 2000;
Samstag et al., 1996). One of its unique properties is that cofilin is capable of reversibly
controlling actin polymerization and depolymerization (Yonezawa et al., 1985). The ac-
tin-binding capacity of cofilin is negatively regulated by phosphorylation (Moriyama et
al., 1996). It can be speculated that dephosphorylation of cofilin may facilitate the
breakdown of the actin cytoskeleton and fragmentation of the cell into apoptotic bodies
during the final stage of apoptosis. Gelsolin, another actin binding protein, is cleaved
by caspases and becomes constitutively active and contributes to actin depolymeriza-
tion in a Ca2+-independent manner (Kothakota et al., 1997).  |  9 4
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which were identified as non-muscle myosin heavy chain type A proteins, probably in
different phosphorylated states, could be observed. Non-muscle myosins are implicat-
ed in diverse biological processes such as cytokinesis, cellularization and cell shape
changes. Two distinct non-muscle myosin heavy chain genes have been reported in all
vertebrates: form A and form B. According to their location in the gel these spots are
assumed to be fragments of myosin heavy chain. Very recently it was reported that my-
osin heavy chain is cleaved in aortic endothelial cell during apoptosis resulting in a well-
defined major 97 kDa fragment (Suarez-Huerta et al., 2000). The molecular weight of
the fragment corresponds to the location in the 2-DE gels. The role of non-muscle my-
osin heavy chain in apoptosis is assumed to be similar to the one of other structure pro-
teins such as keratins and vimentin: the involvement in the execution of the
morphological alterations observed during apoptotic cell death (Suarez-Huerta et al.,
2000).
Two additional spots could be identified in mitochondria isolated from B cells after anti-
IgM-induced apoptosis: pyruvate dehydrogenase E1 α (PDH E1α) and inosin 5´-mono-
phosphate dehydrogenase II (IMPDH II).
The E1α subunit is part of the pyruvate dehydrogenase complex (PDHC). This com-
plex consists of three different enzymes (E1, E2 and E3) which have different tasks
during the catalysis of pyruvate in acetyl-CoA and CO2. The pyruvate dehydrogenase
enzyme E1 itself consists of two subunits (a heterotetramer of 2 x E1α and 2 x E1β)
and catalyze the decarboxylation of pyruvate, the first step of the reaction. The PDH
E1α spot appearance could be observed 10 h and 24 h after induction of apoptosis and
after in vitro cleavage with recombinant caspase-3 prior to 2-DE. This observation sug-
gests that PDH E1α is cleaved during the apoptotic process by caspase-3 and thus los-
es its function.
The IMPDH II spot appeared 24 h after anti-IgM-induced apoptosis. The position of the
spot in the 2-DE gel corresponds with the theoretical molecular weight and isoelectric
point assuming that IMPDH II is up-regulated during apoptosis. IMPDH acts as an en-
zyme during the de novo synthesis of guanine nucleotides and is therefore an impor-
tant component of DNA synthesis in general. An explanation for an up-regulation of this
protein during apoptosis cannot be given. Although this spot was differentially ex-
pressed in several apoptotic 2-DE gels, it cannot be excluded that this spot is an arte-
fact.
5.3.1 Identification of Caspase Cleavage Sites of Apoptosis-associated 
Proteins
β-catenin is an important regulator of cell-cell adhesion and a crucial component of the
Wnt-signaling pathway (Willert and Nusse, 1998). The Wnt/Wg pathway is involved in |  9 5
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1997; Miller and Moon, 1996; Siegfried and Perrimon, 1994). It was shown that β-cat-
enin is cleaved during anoikis by caspase-3 generating the same cleavage pattern in
vivo as well as in vitro. To identify the cleavage sites of β-catenin, recombinant β-cat-
enin was digested with recombinant caspase-3 and the cleavage products were sub-
jected to amino acid sequencing and mass spectrometric analysis. Five different
cleavage sites were determined, three in the N-terminal domain and two in the C-ter-
minal domain of β-catenin. It could be demonstrated by immunprecipitation experi-
ments that all β-catenin cleavage products were still associated with α-catenin and E-
cadherin, indicating that cell-cell-adhesion is apparently not affected (Steinhusen et al.,
2000). Beside the β-catenin pool involved in cell-cell adhesion a cytoplasmic pool β-
catenin, which is involved in signalling in the Wnt-pathway, exists. This β-catenin pool
was increased after induction of apoptosis and was subsequently completely cleaved
by caspases into the same cleavage pattern as described previously. Therefore, it can
be speculated that cleaved β-catenin interferes with its function in the Wnt-pathway.
Gene reporter assay measurements revealed that cleaved β-catenin presumedably in-
terferes in a dominantly negative way with β-catenin´s signalling function (Steinhusen
et al., 2000).
E-cadherin is another molecule involved in cell-cell adhesion that was proteolytically
cleaved after induction of apoptosis into two detectable fragments. The appearance of
one fragment could be completely blocked by incubating the cell with Z-DEVD-fmk cas-
pase-3 like inhibitor. The caspase recognition site of this fragment could be determined
by in vitro cleavage of recombinant fusion protein consisting of GST and the cytoplas-
mic tail of mouse E-cadherin by caspase-3 with subsequent amino acid sequencing.
This cleavage site is located in the cytoplasmic tail close to the transmembrane stretch.
N-terminal sequencing of the other fragment by Edman degradation revealed the GST
domain of the fusion protein. The results suggest that apoptosis induced cleavage of
E-cadherin is only in part caspase-dependent. It was shown that in addition to removal
of the cytoplasmic domain the extracellular part of E-cadherin was cleaved off after in-
duction of apoptosis (Steinhusen et al., unpublished). Removal of the extracellular do-
main has already been shown for VE-cadherin (vascular endothelial cadherin) after
induction of apoptosis in human umbilical vein endothelial cells (Herren et al., 1998).
This observation was described as "shedding" induced by the activation of metallopro-
teases. Metalloproteases are secreted proteases known to cleave extracellular sub-
strates like components of the extracellular matrix. Obviously, only one fragment
results from a cleavage by caspases while the other one is probable derived from the
activity of metalloproteases.
HR23B is able to bind to xeroderma pigmentosum group C (XPC) protein and thus sig-
nificantly stimulate the nucleotide excision repair (NER) activity (Masutani et al., 1997). |  9 6
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teasome (Hiyama et al., 1999) and is characterized by a ubiquitin-like sequence at the
N-terminal region and two ubiquitin-associated domains. It could be demonstrated that
the human HR23B is cleaved by caspase-3 family members. The cleavage products
were investigated by mass spectrometry and Edman degradation after in vitro cleav-
age of recombinant hHR23B with recombinant caspases. The cleavage of the hHR23B
protein at position 165 leads to the generation of a 29 kDa N-terminal fragment which
still contains the ubiquitin domain and a 32 kDa C-terminal fragment lacking the ubiq-
uitin binding domain. A NER assay showed that the cleavage of hHR23B does not af-
fect NER functions in vitro and one can speculate that it does not effect the function in
vivo (Rickers et al., unpublished). Therefore, hHR23B might be involved in other cellu-
lar function. It is assumed that HR23B regulates the proteolysis of ubiquitinated pro-
teins by 26S proteasome via the specific interaction with subunit 5a. Cleavage of the
protein might have an inhibitory effect on the proteasome function and accelerate the
process of apoptosis.
The core substrate recognition motif for caspases is composed of a tetrapeptide, N-ter-
minal to Asp (D) residue (P4P3P2D). Specifity of each caspase is mostly determined by
preference in the P4 residue. Thornberry et al. employed a positional-scanning sub-
strate library to determine the tetrapeptide preference of caspases (Rano et al., 1997;
Thornberry et al., 1997). The result indicated that the optimal tetrapepide recognition
sequence for caspase-1 is WEHD, not YVAD as previously published. The consensus
sequence for caspase-3 and -7 is DXXD, and that for caspase-6 is (V/T/I)EXD. Initiator
caspases, caspase-8 and -9, prefer the sequence LEXD. Tab. 11 reveales all identified
caspase recognition sites in this study. Especially the found cleavage sites of caspase-
3 do not match the optimal tetrapeptide sequences for this caspase in most of the cas-
es. The recognition site in E-cadherin and one of the five β-catenin cleavage sites
match the DXXD tetrapeptide. A glutamic acid could be found in the P4 position of the
Protein Caspase recognition site Caspase
keratin 15 VEMDAAP caspase-6
keratin 17 VEMDAAP caspase-6
EVQDGKV caspase-3
E-cadherin DTRDNVY caspase-3
β-catenin SYLDSGI caspase-3
ADIDGQY caspase-3
TQFDAAH caspase-3
DLMDGLP caspase-3
YPVDGLPD caspase-3
hHR23B TATDSTS caspase-3
SP1 NSPDAQP caspase-3
Table 11  Caspases and their substrates: in this study identified caspase recognition sites, |  9 7
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trast, the found cleavage sites of caspase-6 in keratin 15 and keratin 17 match the op-
timal tetrapeptide sequence. The fact that mainly cleavage sites of caspase-3 and
caspase-6 were found supports the reputation of these caspases as the executioner or
workhorses of cell death responsible for the morphological changes characteristic for
apoptosis. However, the question remains why so many caspases could be identified
in human if only a few do "the work"? Some of the answers are speculative but they are
in agreement with what we know today: (i) caspases are activated in a tissue-specific
manner, (ii) caspases are specialized in their substrate recognition, (iii) different cas-
pases function in specific subcellular compartments and (iv) different caspases are re-
quired to respond to different apoptotic stimuli.
5.4 Conclusion
Proteome research has been proven as a powerful tool for the identification of disease-
associated proteins (Alaiya et al., 2000; Jungblut et al., 1999). In this study, proteome
research should be applied to identify novel proteins involved in apoptosis, especially
in anoikis. However, most of the found proteins were identified as apoptosis-associated
proteins previously. These include mainly nuclear structural proteins (lamins) or cy-
toskeletal proteins (keratins, vimentin) and their regulators (cofilin), proteins which are
abundant in the cell. Regulatory proteins, which might be interesting for the under-
standing of apoptosis, are out of range by this approach. Even a promising prefraction-
ation method by RP-HPLC could not reach the required protein amount for such
proteins. Therefore, this study demonstrates very clearly that the proteomic approach
has reached its limit. It can be assumed that all apoptosis-associated proteins in a con-
centration range sufficient for 2-DE are already identified, finding interesting novel pro-
teins is very unlikely. The protein amounts necessary for the detection and
identification of novel apoptosis-associated proteins could be shown very recently.
Starting from a 250 mL cell pellet, derived from 100 L of suspension cultured HeLa cells
(5 x 106 cells/mL) which were resuspended in 1 L buffer, Du and co-worker could iden-
tify a novel mitochondrial protein that promotes cytochrome c-dependent caspase ac-
tivation by eliminating IAP inhibition (Du et al., 2000). This approach is of course far
away from a global protein analysis but a protein amount of several hundreds of grams
cannot be loaded onto a single 2-DE gel and a method which could separate low-abun-
dant proteins from high-abundant proteins prior to 2-DE is not yet found. However, the
global approach of 2-DE facilitated the surveillance of a large number of proteins in the
cell and affirmed that apoptosis is a well defined biochemical process: the 2-DE protein
patterns did not reveal a complete degradation of cellular proteins, although cleavage
of structual proteins such as lamins and keratins occur during the final stage of apop-
tosis. In this case the lower molecular weight region of the 2-DE gel should be over- |  9 8
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observation demonstrates that even at this state (20 - 24 h after induction of apoptosis)
apoptosis is highly regulated without random proteolysis of proteins.
In summary it may be said that two-dimensional gel electrophoresis is due to its limita-
tions the bottleneck in proteome research. The perspectives of proteome research are
highly dependent upon an alternative separation method to 2-DE. Many alternative ap-
proaches exploit the sensitivity and the high-throughput capacity of mass spectrometer
via coupling to LC instruments with previous tagging of certain amino acids (Spahr et
al., 2000) but a real substitute for 2-DE is not in sight up to now. |  9 9
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A p p e n d i x7 APPENDIX
7.1 Nomenclature of Fragment Ion Series
7.2 Abbreviations and Molecular Masses for the Twenty Common 
Amino Acids
Amino Acid Abbreviation Average Mass [u] Monoisotopic Mass [u]
Alanine Ala or A 71.078 71.037
Arginine Arg or R 156.187 156.101
Asparagine Asn or N 114.103 114.042
Aspartic Acid Asp or D 115.088 115.026
Cysteine Cys or C 103.144 130.009
Glutamic Acid Glu or E 129.115 129.042
Glutamine Gln or Q 128.130 128.058
Glycine Gly or G 57.052 57.021
Histidine His or H 137.141 137.058
Isoleucine Ile or I 113.159 113.084
Leucine Leu or L 113.159 113.084
Lysine Lys or K 128.174 128.094
Methionine Met or M 131.198 131.040
Phenylalanine Phe or F 147.176 147.068
Proline Pro or P 97.116 97.052
Serine Ser or S 87.078 87.032
Threonine Thr or T 101.105 101.047
Tryptophan Trp or W 186.213 186.079
Tyrosine Tyr or Y 163.176 163.063
Valine Val or V 99.132 99.068
Figure 33  Peptide backbone depicting the typical backbone-cleavage ions. Low-energy ion activation 
of triple-quadrupole or Q-TOF mass spectrometer yields mainly bn, an and yn type ions. The subscript 
numbers associated with these fragment-ion types indicate the position of the backbone-cleavage site 
from the N- or C-terminus, depending on the ion type being considered. This nomenclature according 
Biemann (Biemann, 1988) is a modified form of the Roepstorff and Fohlman nomenclature (Roepstorff 
and Fohlman, 1984). |  11 0
A p p e n d i x7.3 Masses of Common Peptide Standards
7.4 SI-Prefixes
Peptide Sequence Average Mass [u] Monoisotopic Mass [u]
Angiotensin II DRVYI HPF 1046.194 1045.534
Angiotensin I DRVYI HPFHL 1296.494 1295.677
[Glu]-Fibrinopeptide EGVND NEEGF FSAR 15705.928 1569.669
ACTH clip 18-39 RPVKV YPNGA EDESA EAFPL EF 2465.702 2464.191
1024          yotta    Y 10-1           deci     d
1021          zetta    Z 10-2           centi    c
1018          exa      E 10-3           milli    m
1015          peta     P 10-6           micro    µ
1012          tera     T 10-9           nano     n
109           giga     G 10-12         pico     p
106           mega     M 10-15         femto    f
103           kilo     k 10-18         atto     a
102           hecto    h 10-21         zepto    z
101           deca     da 10-24         yocto    y |  111
A p p e n d i x7.5 Identified Proteins in 2-DE Database
Figure 34  Standard 2-DE pattern of proteins of human mammary epithelial cell line H184A1 after in-
duction of apoptosis. The original gel size was 23 x 30 x 0.075 cm. Proteins were detected by silver 
staining. Calibration of isoelectric point and molecular weight was performed with theoretical values 
of identified spots. All identified proteins are marked with white crosses and numbers. White circles 
indicate spots which disappear after induction of apoptosis. |  11 2
A p p e n d i xProtein Name Spot Nr. SwissProt
theo. av. 
Mw.
obs. 
Mw.
theo. pI obs. pI
CALRETICULIN PRECURSOR S1 P27797 46466 73618 4.9 4.4
GUANINE NUCLEOTIDE-BINDING PROTEIN BETA 
SUBUNIT-LIKE PROTEIN 12.3
S2 P25388 35076 27903 7.6 7.2
PHOSPHOGLYCERATE KINASE 1 S3 P00558 44596 38379 8.3 7.2
GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE S4 P00354 35876 33495 6.6 7.9
TRIOSEPHOSPHATE ISOMERASE S5 P00938 26538 22457 6.5 6.83
GLUTATHIONE S-TRANSFERASE P S6 P09211 23225 21526 5.4 5.6
14-3-3 PROTEIN SIGMA S7 P31947 27774 23702 4.7 4.5
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A S8 P05092 17881 18105 7.8 7.2
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A S9 P05092 17881 18100 7.8 7.6
THIOREDOXIN S10 P10599 11606 17378 4.8 5.0
THIOREDOXIN PEROXIDASE 2 S11 Q06830 22110 21042 8.3 7.6
HEAT SHOCK 27 KD PROTEIN S12 P04792 22327 23136 7.8 6.0
PROFILIN I S13 P07737 14923 17488 8.5 7.4
FATTY ACID-BINDING PROTEIN S14 Q01469 15164 17533 6.6 6.19
ACTIN, CYTOPLASMIC 1 (BETA-ACTIN) S15 P02570 41606 40485 5.3 5.3
MITOCHONDRIAL MATRIX PROTEIN P1 PRECURSOR S16 P10809 57963 57185 5.2 5.3
T-COMPLEX PROTEIN 1, EPSILON SUBUNIT S17 P48643 59671 57723 5.5 5.6
ANNEXIN II S18 P07355 38473 32260 7.6 7.0
TROPOMYOSIN, CYTOSKELETAL TYPE S19 P12324 29033 25410 4.8 4.6
L-LACTATE DEHYDROGENASE M CHAIN S20 P00338 36558 29833 8.5 7.6
T-COMPLEX PROTEIN 1 S21 P80314 57447 48939 6.0 6.3
ALPHA ENOLASE S22 P06733 47038 45323 7.0 6.8
FRUCTOSE-BISPHOSPHATE ALDOLASE A S23 P04075 39289 38741 8.4 7.8
TRANSFORMATION-SENSITIVE PROTEIN IEF SSP 3521 S24 P31948 62639 63662 6.4 6.5
TRANSKETOLASE S25 P29401 67878 70814 7.6 7.3
PYRUVATE KINASE, M1 ISOZYME S26 P14618 57746 59803 7.6 7.3
CYTOKERATIN 6A S27 P02538 59914 53490 8.1 7.1
T-COMPLEX PROTEIN 1, ALPHA SUBUNIT S28 P17987 60344 60520 5.8 5.9
ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC S29 P41562 46734 40801 6.5 6.7
MASPIN PRECURSOR S30 P36952 42138 34294 5.7 5.7
COFILIN, NON-MUSCLE ISOFORM S31 P23528 18502 18506 8.2 7.2
PHOSPHOGLYCERATE MUTASE, BRAIN FORM S32 P18669 28673 29531 6.8 5.6
THIOREDOXIN PEROXIDASE 1 S33 P32119 21892 20486 5.7 5.6
ACTIN, CYTOPLASMIC 1 S34 P02570 Fragment 24845 - 5.6
PROBABLE PROTEIN DISULFIDE ISOMERASE ER-60 
PRECURSOR
S35 P30101 54265 55742 5.6 5.8
NUCLEOSIDE DIPHOSPHATE KINASE B S36 P22392 17298 18332 8.5 7.8
CYTOKERATIN 7 S37 P08729 51203 50131 5.4 5.6
CYTOKERATIN 10 S38 P13645 Fragment 20409 - 6.7
ANNEXIN I S39 P04083 38583 32839 6.6 6.5
UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 
CORE PROTEIN 2 PRECURSOR
S40 P22695 46811 42111 7.7 7.3
ELONGATION FACTOR 1-ALPHA 1 S41 P04720 50141 49802 9.1 8.5
POLYADENYLATE-BINDING PROTEIN 1 S42 P11940 70671 73182 9.5 8.4
ANTIOXIDANT PROTEIN 2 S43 P30041 24904 22902 6.0 6.4
CARBONIC ANHYDRASE II S44 P00918 29115 23797 6.9 7.2
MALATE DEHYDROGENASE, MITOCHONDRIAL 
PRECURSOR
S45 P08249 33123 31802 8.4 8.0
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS 
A2/B1
S46 P22626 37430 31163 9.0 7.8
PROHIBITIN S47 P35232 29804 24316 5.6 5.6
CHLORIDE INTRACELLULAR CHANNEL PROTEIN 1 S48 O00299 26924 25439 5.0 5.1
MITOCHONDRIAL STRESS-70 PROTEIN PRECURSOR S49 P38646 68858 72077 5.5 5.5
FUMARATE HYDRATASE, MITOCHONDRIAL 
PRECURSOR
S50 P07954 50082 43581 7.0 7.1
ALPHA ENOLASE S51 P06733 47037 38307 7.0 6.8
PTB-ASSOCIATED SPLICING FACTOR S52 P23246 76149 99463 9.5 8.1 |  11 3
A p p e n d i xELONGATION FACTOR 2 S53 P13639 95338 95216 6.4 6.7
VOLTAGE-DEPENDENT ANION-SELECTIVE CHANNEL 
PROTEIN 1
S54 P21796 30641 29152 8.6 7.5
NUCLEOLIN S55 P19338 Fragment 34004 - 7.3
HEAT SHOCK COGNATE 71 KD PROTEIN S56 P11142 Fragment 24189 - 7.2
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1 S57 P09651 38715 30414 9.3 8.6
TROPOMYOSIN, FIBROBLAST NON-MUSCLE TYPE S58 P07226 28522 25557 4.7 4.5
LAMIN A S59 P02545 74139  ND 6.6 ND
GLUTAMATE DEHYDROGENASE 2 PRECURSOR S60 P49448 56052 51713 7.0 7.0
INTERFERON GAMMA UP-REGULATED I-5111 PROTEIN 
PRECURSOR
S61 Q06323 25962 24089 5.6 5.9
EZRIN S62 P15311 69268 81779 6.0 6.3
ACONITATE HYDRATASE S63 Q99798 82659 87131 6.7 7.2
MACROPHAGE CAPPING PROTEIN S64 P40121 38518 37673 5.9 6.0
HEAT SHOCK COGNATE 71 KD PROTEIN S65 P11142 70898 69059 5.4 5.4
HEAT SHOCK COGNATE 71 KD PROTEIN S66 P11142 70898 66370 5.4 5.5
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3 S67 P51991 39686 39035 8.7 8.5
ATP SYNTHASE ALPHA CHAIN S68 P25705 55209 50131 8.3 6.8
ATP SYNTHASE ALPHA CHAIN S69 P25705 55209 50242 8.3 7.0
PROFILIN I S70 P07737 14923 17409 8.5 7.6
78 KD GLUCOSE-REGULATED PROTEIN PRECURSOR S71 P11021 70261 76044 5.0 5.0
78 KD GLUCOSE-REGULATED PROTEIN PRECURSOR S72 P11021 70261 76240 5.0 4.9
 FUMARATE HYDRATASE S73 P07954 50082 43492 7.0 7.0
 26S PROTEASE REGULATORY SUBUNIT 8 S74 P47210 45653 41944 8.2 7.0
 LAMIN C S75 P02546 65135  ND 6.4 ND
PROTEASOME SUBUNIT XAPC7 S76 stpO14818  27887 24368 8.8 7.8
PROTEASOME COMPONENT C5 S77 P20618 26489 23290 8.3 7.7
CYTOKERATIN 1 S79 P04264 65886 26859 8.2 8.1
CYTOKERATIN 15 S80 P19012 Fragment 22902 - 4.6
CYTOKERATIN 17 (VERSION 2) S81 Q04695 Fragment 21954 - 4.9
CYTOKERATIN 17 (VERSION 2) S82 Q04695 Fragment 20839 - 4.9
CYTOKERATIN 17 (VERSION 2) S83 Q04695 Fragment 20565 - 4.6
CYTOKERATIN 15 S84 P19012 Fragment 20882 - 4.4
LAMIN A S85 P02545 Fragment 22380 - 6.1
HEAT SHOCK 27 KD PROTEIN S86 P04792 22327  ND 7.8 ND
CYTOKERATIN 17 (VERSION 1) S87 Q04695 47974  ND 4.97 ND
GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE S88 P04406 35922 30831 8.6 7.2
ALPHA ENOLASE S89 P06733 Fragment 33607 - 5.9
ALPHA ENOLASE S90 P06733 Fragment 33663 - 6.1
PYRUVATE KINASE, M1 S91 P14618 Fragment 31115 - 6.0
CYTOKERATIN 7 S92 P08729 51203 42365 5.4 5.3
CYTOKERATIN 18 S93 P05783 47927  ND 5.3 ND
CYTOKERATIN 17 (VERSION 2) S94 P08779 50568  ND 5.0 ND
CYTOKERATIN 15 S95 P19012 Fragment 21333 - 4.4
GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE S96 P04406 35922 32574 8.6 7.6
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS 
A2/B1
S97 P22626 37430 31953 9.0 7.5
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS 
C1/C2
S98 P07910 33298 34236 5.1 5.3
CYTOKERATIN 15 S99 P19012 49168  ND 4.7 ND
ESTROGEN RESPONSE ELEMENT BINDING PROTEIN S100 stpO77798 38537 41944 8.3 7.0
DESTRIN S101 P18282 18506 18387 8.1 7.4
CYTOKERATIN 18 S102 P05783 Fragment 22323 - 6.6
DEOXYURIDINE 5'-TRIPHOSPHATE 
NUCLEOTIDOHYDROLASE PRECURSOR
S103 P33316 19346  ND 8.0 ND
TRIFUNCTONAL ENZYME BETA SUBUNIT S105 P55084 47485 46187 9.2 8.5
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L S108 P14866 60186 70458 6.7 7.2
APOPTOSIS-INDUCING FACTOR AIF S109 stpO95831 66900 71895 9.6 7.1
Protein Name Spot Nr. SwissProt
theo. av. 
Mw.
obs. 
Mw.
theo. pI obs. pI |  11 4
A p p e n d i x PROTEIN DISULFIDE ISOMERASE PRECURSOR (PDI) S110 P07237 55294 54976 4.7 4.7
LAMIN C S112 P02546 65135  ND 6.4 ND
CREATINE KINASE, UBIQUITOUS MITOCHONDRIAL 
PRECURSOR
S113 P12532 43080 42793 7.3 7.5
NUCLEOSIDE DIPHOSPHATE KINASE B S114 P22392 17298 18970 8.5 6.0
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS 
A2/B1
S115 P22626 37492 ND 9.0 ND
TRANSLATIONALLY CONTROLLED TUMOR PROTEIN S116 P13693 19595 ND 4.84 ND
ATP SYNTHASE GAMMA CHAIN, MITOCHONDRIAL 
PRECURSOR
S117 P36542 30165 ND 9.0 ND
GTP-BINDING NUCLEAR PROTEIN RAN S118 P17080 24354 ND 6.6 ND
Protein Name Spot Nr. SwissProt
theo. av. 
Mw.
obs. 
Mw.
theo. pI obs. pI |  11 5
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